Mutational Analysis of Ubiquitin Shuttle Receptor Docking Sites on the 26S Proteasome by Gomez, Tara Adele
MUTATIONAL ANALYSIS OF UBIQUITIN SHUTTLE RECEPTOR 
DOCKING SITES ON THE 26S PROTEASOME  
 
 
 
 
Thesis by  
 
Tara Adele Gomez 
 
 
 
 
 
In Partial Fulfillment of the Requirements  
 
 
for the Degree of  
 
 
Doctor of Philosophy  
 
 
 
 
 
 
 
 
 
 
 
 
 
California Institute of Technology  
 
Pasadena California  
 
2011 
 
(Defended May 20, 2011) 
 
 
 
 
 
 
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2011 
 
Tara Adele Gomez 
 
All Rights Reserved 
 iii 
 
ACKNOWLEDGMENTS 
 
 
“Only love has no limits. In contrast, our predictions can fail, our communication can 
fail, and our knowledge can fail. For our knowledge is patchwork, and our predictive 
power is limited. But when perfection comes, all patchwork will disappear.”   
(1 Cor. 13:8–10) 
 
I am extremely grateful to have had the chance to work in the lab of Dr. Raymond 
Deshaies. Ray is one of the smartest people I have ever met.  His scientific brilliance is 
however, matched by his master negotiation skills.  I am thankful that I learned not only, 
how to be a better scientist from Ray, but also, some business savvy! I am grateful for all 
of the support and help Ray offered me. I feel truly privileged to have received said 
support and encouragement.  
 
I would also like to thank my thesis committee members: Dr. Judy Campbell, Dr. David 
Chan, Dr. William Dunphy, and Dr. Angelike Stathopoulos. My committee was 
immensely supportive and helpful in giving me both excellent suggestions and 
encouragement.  
 
I am also very indebted to my colleagues in the Deshaies lab. I would like to thank the 
Deshaies’ lab graduate students for continued advice, community, and support.  I will 
miss our monthly “Grad Student Lunches”. I would like to especially thank KJ Chang 
and Natalie Kolowa for being great colleagues, work-out companions, and friends. In 
addition, Nathan Pierce, Michael Rome, and Ruzbeh Mosadeg were great inspirations. 
 
I am also very grateful to Rati Verma for sharing with me her 26S knowledge, which 
helped propel my project forward during its darkest days. Gary Kleiger was also 
extremely helpful in helping my project during dark days, and helped teach me how to be 
a better scientific writer. The technical support of Heenam Park and Rob Oania 
undoubtedly deserve my accolades as well.  
 
I would be remiss to not thank the summer students I worked with during my time in the 
Deshaies lab. Marvin Gee, a Caltech SURF student, performed an experiment that 
contributed to my publication. Caitlin Rugani did many experiments that never made it to 
the paper, but were essential and for which I will be eternally grateful. My 2008 summer 
high school student volunteer, Derek Tu, would open my centrifuge tubes for me and 
kept me company during my RY2H screen!  
 
I am thankful for the amazing undergraduate and postbach research opportunities I was 
provided with in the lab of Dr. Steven G. Clarke, my undergraduate thesis advisor. His 
continued support throughout my graduate career allowed us to publish several papers 
during my tenure here at Caltech, although unfortunately, they were not allowed in my 
Caltech thesis!  
 
 iv 
I would also like to acknowledge the following programs, offices and people at Caltech 
and in the Pasadena area that made what could have become a very mundane five years, a 
much more balanced five years: Liz Ayala, Gwen Murdock, Denise Nelson-Nash, the 
YESS program, Caltech Classroom Connection (CCC), Huntington Library and 
Botanical Gardens, Eye Dreams, Biology Graduate Student Invited Speaker Series, 
Caltech Public Events Office for letting me host Reel Science and Science Saturdays, 
MSE/CCD office, Grad Chats, Women’s Center, GSC and the Caltech Y. 
 
To my closest friends, and graduate school mentors: Julianne Lyons, Dr. Chris Lyons, 
Sindhuja Kadambi, Michelle Fontes, Nicole Tetreault, Brianna Williams, Schetema 
Stevens, Chinney Idigio, Dr. Princess Imoukhuede, Dr. Kelle Cruz, Nneka Williams, Dr. 
Jennifer Keefe, Dr. Cecilia Zurita-Lopez, Dr. Tanya Porras-Yakushi, and Dr. Melissa 
Gulmezian, I would like to thank you for advice, companionship, and mentorship 
throughout the PhD process. I would especially like to thank the Lyons who walked this 
path with me the closest, and are the absolute best friends one could ever wish for.  
 
I would like to thank my entire family and extended family. To my in-laws, the Hampton 
clan, you are extraordinary people that have enriched my life and remind me to laugh as 
much as I can! To my brother Jason Gomez, I think 2011 was a big year for the both of 
us. I am proud of you. To my sister, Felicia Gomez, I am very blessed to have you as a 
sister. Your love and support are unwavering and just what I need. Furthermore, I love 
that we have a shared passion for seeing the world and a similar sense of humor that 
allows us to share the world together.  
 
And to my biggest supporters in this world, who are undoubtedly my parents and my 
husband, I realize I am where I am today because of you! This thesis is dedicated to my 
mother, who swears that I was the “best dancer” in the 2011 Caltech Dance Show, not 
because this is a fact (it isn’t), but because she believes in me more than anyone I have 
ever met. This thesis is also dedicated to my father who loves me deeply and cultivated 
my knowledge as a child. When I was a child, he even exchanged landscaping work for 
tuition fees at my private elementary school to ensure I got an amazing education. This 
thesis is also dedicated to my husband Tyron Hampton, who honestly thinks that I am 
capable of anything and puts up with all of my temper tantrums. I don’t know how he 
does it!  
 
Finally, I am most thankful for the grace and guidance of God. Despite sin and 
imperfection, God offers His grace. I believe I am here today because of the silent and 
merciful hand that He put out for me to reach hold to. “The LORD is the stronghold of 
my life…” Psalm 27:1. 
 v 
ABSTRACT 
 
Protein degradation is essential for many basic cellular functions.  Most 
intracellular protein degradation occurs via the ubiquitin proteasome system.  Cellular 
proteins are marked for degradation by the appendage of an ubiquitin chain. Ubiquitin 
receptor proteins recognize the ubiquitin chains and play a “garbage man” function in 
ensuring delivery of the protein trash to the cell’s degradation machinery, the proteasome. 
One such class of ubiquitin receptor proteins, known as UBA-UBL proteins, 
recognizes ubiquitylated substrates and shuttles them to the proteasome. These shuttle 
receptors include Rad23, Dsk2, and Ddi1. The goal of this dissertation research has been 
to understand how these UBA-UBL proteins interact with the proteasome. In budding 
yeast, Saccharomyces cerevisiae, Rpn1 has been proposed to be the major docking site 
for UBL-containing proteins. More recent studies suggested that proteasome subunits 
Rpn10 and Rpn13, may also bind UBA-UBL proteins. However, no cis proteasome 
mutants existed to address these plausible redundant modes of delivery to the 
proteasome.  
The specific aims of this proposal were to: identify the sites on the proteasome 
that are necessary for specific UBA-UBL receptor docking, to study the consequence of 
the deletion of these sites (such as the effects on protein turnover), and to assess if the 
elimination of these sites is the same as elimination of the receptor proteins themselves.  
Here, I describe a two-pronged genetic screen I conducted to identify a specific 
docking site within Rpn1 for UBA-UBL proteins. I uncover a highly conserved residue, 
D517A that appears to impinge on the ability for both Ddi1 and–in the absence of Rpn13 
or the dual absence of the ubiquitin interaction motifs of Rpn10 and Rpn13–Dsk2 to 
 vi 
interact with the proteasome. However, under no set of genetic conditions does a 
mutation at Rpn1-D517 have any effect on Rad23 or the UBL-containing ubiquitin 
isopeptidase Ubp6. Taken together, my observations point to unanticipated diversity and 
complexity in the mechanisms underlying the recruitment of UBA-UBL proteins to the 
proteasome.   
Hence, I show that docking sites on the proteasome are not completely exclusive, 
both Ddi1 and Dsk2 share the D517 residue of Rpn1.  However, there may be exclusive 
sites for docking Rad23 and Ubp6. There are also appears to be a layer of complexity and 
redundancy in docking UBA-UBL proteins to the proteasome.  Follow-up studies on 
these proteasome cis mutatnts have also uncovered roles of the proteasome in regulating 
mitochondrial protein import and the methyl cycle.  
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Chapter 1: 
 
Introduction to substrate  
recognition  
by the 26S proteasome 
 2 
 
 
 Individual proteins, pairs of proteins, or small protein complexes, carry out many 
important cell processes. However, in some cases, very large assemblies of proteins form 
complicated quaternary structures, resembling nanomolecular machines, and they carry 
out pivotal jobs in the cell as well. These large protein complexes are enigmatic. Why is 
such a large complex required to complete the job? Such large protein complexes include 
the nuclear pore complex (~ 120 mDA), ribosomes (2–10 mDA), the largest known 
eukaryotic protease, tripeptidyl peptidase II (~ 6 mDa), and the 26S proteasome (~ 2.5 
mDa). While we may never truly understand why evolution selected for such complex 
molecular machines, it appears to be factual that the complexity of the machine itself 
represents only a small fraction of the complexity found in the biological system it 
regulates. The 26S proteasome is no exception to this rule. 
 
The 26S proteasome  
 
 The 26S proteasome is analogous to a recycling center. Cellular protein trash is 
delivered to the proteasome and the proteasome proteolyzes the target into small peptides 
that can be recycled in the cell for the creation of new proteins. The proteasome has ~ 33 
unique protein subunits making up a ~ 66-protein subunit complex (Figure 1.1). The 
proteasome is composed of two main components: A 19S regulatory particle (RP) and the 
20S core. The 19S caps one or both ends of the 20S catalytic cylindrical core (CP).  The 
19S regulatory particle is itself composed of two subcomplexes, the lid that is composed 
of ~ 11 non-ATPase subunits, and the base that is made up of two non-ATPase subunits, 
Rpn1 and Rpn2, that act as scaffolding subunits, and six ATPase subunits, Rpt1–6, that 
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require energy for the unfolding of substrates.  The 19S RP recognizes an ubiquitin tag 
found on protein substrates, unfolds the substrate, and sends it into the channel of the 20S 
CP.  Using three different proteolytic activities, the 20S degrades the substrate into small 
peptides (Pickart and Cohen, 2004). 
 
The ubiquitin proteasome system 
 
 Degradation of cellular proteins is a selective process, that in many cases, is even 
controlled at a spatial and temporal level (Grabbe et al., 2011). Ubiquitin (Ub) is a small 
76-amino acid protein whose conjugation to target proteins precedes degradation, and is 
the crux of the ubiquitin protesome system (UPS). Ubiquitin is added to protein 
substrates through a series of three reactions involving enzymes known as E1s, E2s, and 
E3s. An E1 enzyme activates a free mono-Ub molecule by forming a covalent thioster 
bond. This activated ubiquitin is then transferred to an E2 conjugating enzyme and finally 
to an E3 ubiquitin ligase enzyme. Each E3 enzyme acts only on specific substrates and 
adds one of many levels of selectivity to the UPS (Hershko and Ciechanover, 1998).  
Polyubiquitin (polyUb) chains can be built onto substrates through the sequential addition 
of ubiquitin molecules to one another via the E1, E2, E3 enzymatic steps (Pierce et al., 
2009). Ubiquitin molecules form isopeptide linkages with one another through their 
lysine resides. Ubiquitin has multiple lysine residues through which multiple types of 
chain linkages can be produced. 
 Polyubiquitin tags of different linkages play diverse cellular roles. Lys-48 
polyubiquitin chain appendages target proteins to the proteasome for degradation. A Lys-
48 tetraubiquitin chain has been shown to be the minimal signal necessary for 
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proteasomal recognition (Thrower et al., 2000).  Alternatively, polyubiquitin chains made 
from Lys-63 or Lys-29 linkages generally have non-proteasomal signaling roles in the 
cell (Ikeda and Dikic, 2008).  
 
Substrate delivery to the proteasome 
 
 In 1995, the discovery that a human proteasome subunit, S5a, bound 
polyubiquitin, led to the first insights into how ubiquitylated substrates are recognized by 
the proteasome (Deveraux et al., 1995a).  Homologs of S5a, including the yeast homolog, 
Rpn10, were also found to bind polyubiquitin and to be necessary for the proper turnover 
of artificial substrates (van Nocker et al., 1996).  Rpn10 is believed to create a hinge 
between the 19S and 20S (Glickman et al., 1998) and contains an ubiquitin interacting 
motif (UIM) that was found to be responsible for this recognition of Ub chains (Young et 
al., 1998) and necessary for the efficient delivery of ubiquitinated targets to the 
proteasome (Lambertson et al., 1999). However, deletion of RPN10 did not lead to 
phenotypes suggestive of large-scale deficits in cellular protein degradation (Saeki et al., 
2002a), and only 27% of all UPS substrates are influenced by RPN10 (Mayor et al., 
2007). This all leads to the belief that there are multiple cellular proteins involved in 
recognizing substrates for degradation at the proteasome.  
 Such a belief was confirmed shortly. After the discovery of Rpn10 as an intrinsic 
ubiquitin receptor, receptors known as UBA-UBL (ubiqitin association-ubiquitin-like) 
proteins–namely, Rad23, Dsk2, and Ddi1–were discovered. These proteins are sub-
stoichiometric interactors with the proteasome.  They act as shuttles that bind and unbind 
the proteasome rapidly and transiently (Wang and Huang, 2008). They contain an amino 
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terminal ubiquitin like domain (UBL) that is responsible for docking to the proteasome 
and a carboxyl terminal ubiquitin association domain (UBA) that binds ubiquitin chains 
(Chen et al., 2001; Wilkinson et al., 2001).  Binding to ubiquitin chains via the C-
terminal and the proteasome via the N-terminal presented a novel mode of translocation 
for ubiquitylated targets to the proteasome.  These UBA-UBL proteins are conserved 
from yeast to man (Mueller and Feigon, 2002; Zhu et al., 2007), although they are not 
essential (Díaz-MartÌnez et al., 2006). The yeast proteaome has an array of proteins 
containing UBA and/or UBL domains (Table 1.1). However, Rad23, Dsk2, and Ddi1 
represent a very small group of proteins that actually contain both domains (Table 1.1). 
The UBA-UBL proteins have been the focus of my dissertation research and each of 
them has unique attributes that appear to play a role in their function in substrate delivery 
to the proteasome.  
   
Rad23, the best-characterized shuttle receptor  
 
 Rad23 is a highly conserved from yeast to man (Bertolaet et al., 2001a). It was 
originally identified as a gene important for cellular resistance to UV stress; specifically 
it plays a role in nucleotide excision repair (Miller et al., 1982). It was later discovered 
that the UBL domain of Rad23, which shares 23% identity with ubiquitin (Bertolaet et 
al., 2001a), binds the proteasome. Rad23 was the first UBA-UBL domain protein of its 
kind to be invoked in the UPS system, and the discovery of this role made it plausible 
that other similar proteins behave in the same way (Schauber et al., 1998).  
 To date, Rad23 is the best-characterized UBA-UBL protein. Distinguishing it 
from other yeast proteins in its family, Rad23 has two UBA domains, each of which 
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appears to have different affinities for Lys-48 and Lys-63 chains (Raasi et al., 2005). 
Nonetheless, as a whole, Rad23 has a greater affinity for binding Lys-48 linked chains 
than for any other, suggesting that its major cellular role is recognition of proteasome 
substrates (Raasi et al., 2005).   
 The roles Rad23 plays in UV stress response and in proteasome substrate delivery 
are not necessarily individual separable tasks. For instance, rad23ΔUBL mutants are 
sensitive to UV irradiation and other DNA damage responses (Watkins et al., 1993). 
Additionally, only partial complementation of a RAD23 mutant can be achieved by 
transformation with rad23ΔUBL (Lambertson et al., 2003).  These results may indicate 
that Rad23 needs to bind the proteasome for full activity in DNA damage responses.  
 
Dsk2, the next best-characterized UBA-UBL protein 
 
 Budding yeast Dsk2 was first described as a receptor by Funakoshi and colleagues 
in 2002, who showed that it preferentially bound Lys-48 chains in comparison to Lys-63 
chains (Funakoshi et al., 2002). Like Rad23, Dsk2 also plays multiple roles in the cell. 
Specifically, it is important for spindle pole body duplication (Biggins et al., 1996). 
Overexpression of DSK2 causes accumulation of cellular Ub conjugates and is a lethal 
event (Funakoshi et al., 2002). Multiple papers show that Dsk2 and its homologs bind the 
proteasome (Chandra et al., 2010; Fatimababy et al., 2010; Saeki et al., 2002b; Wilkinson 
et al., 2001). The UBA domain of Dsk2 has been proposed to bind monoUb and Lys-48, 
Lys-63, and Lys-29 chains with similarly strong affinities (Raasi et al., 2005). Another 
recent study also suggests that Dsk2 binds Lys-63 linkages more tightly than any of the 
other UBA-UBL proteins (Fatimababy et al., 2010). However, structural models of the 
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Dsk2 UBA domain agree with the original Funakoshi paper in that it would actually 
selectively bind Lys-48 chains over any other linkage (Lowe et al., 2006).  Nonetheless, it 
has been found to be necessary for the proper proteolytic turnover of several endogenous 
cellular proteins and model substrates (Barbin et al., 2010; Liu et al., 2009; Medicherla et 
al., 2004; Richly et al., 2005).  
 
Ddi1, the most controversial shuttle receptor  
 
 Before its role in the UPS was uncovered, Ddi1 was identified as a DNA damage-
inducible gene, and was studied for its role in binding v-SNARE proteins (Liu and Xiao, 
1997; Lustgarten and Gerst, 1999). Ddi1 is expressed in the nucleus and the cytoplasm 
and has a high level of sequence conservation and representation throughout all 
eukaryotic genomes (Gabriely et al., 2008; Krylov and Koonin, 2001). Interestingly, Ddi1 
appears to be the most divergent of the UBA-UBL protein family. Its UBL domain only 
shares 16% identity to ubiquitin (Bertolaet et al., 2001a) and such a distinction is the key 
element that differentiates the proteolytic functions of Rad23 and Ddi1 (Kim et al., 2004). 
The S. pombe homolog of Ddi1, Mud1, was first linked to the UPS when it was identified 
as a suppressor of the temperature-sensitive phenotype for a Rpn1/Mts4 mutant 
(Wilkinson et al., 2001).  
 The role of Ddi1 in substrate delivery has been harder to understand. Supporting a 
role for Ddi1 in targeting substrates to the proteasome are observations such as the fact 
that its UBA domain binds longer Ub chains better than shorter chains (Trempe et al., 
2005; Wilkinson et al., 2001), albeit to much less of an extent than Rad23 and Dsk2 
(Kaplun et al., 2005; Saeki et al., 2002b). It is noteworthy that the expression of 
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proteasomes is also mainly nuclear and ctyoplasmic and that the localization of Ddi1 to 
these regions is dependent on presence of UBA and UBL (Gabriely et al., 2008; Peters et 
al., 1994). However, there are at least three publications that cast doubt on the role of 
Ddi1 as a shuttle receptor. Some researchers have not been able to detect binding of Ddi1 
or its homologs to the proteasome or subunits of the proteasome (Chandra et al., 2010; 
Fatimababy et al., 2010; Kim et al., 2004). Despite this controversy, Ddi1 is necessary for 
turnover of some proteins (Ivantsiv et al., 2006; Kaplun et al., 2005). Furthermore, a 
ddi1∆UBL mutant does not properly turnover the Ddi1 substarate, HO. This result 
suggests that the interaction of Ddi1 with the proteasome is necessary for HO degradation 
(Ivantsiv et al., 2006).  
 It should also be noted that conflicting data regarding the role of both Rad23 and 
Rpn10 in acting as ubiquitin receptors had also been raised. For instance, over-expression 
experiments of RAD23 suggested that it might actually antagonize the turnover of 
endogenous and model substrates instead of enhancing it (Ortolan et al., 2000). Rpn10 
was also cast into doubt when a published report failed to see it bind polyubiquitin in the 
context of an intact proteasome and when the Arabidopsis thaliana ortholog was seen to 
inhibit proteolysis (Deveraux et al., 1995b; Lam et al., 2002). However, currently in the 
field, these doubts have subsided (Elsasser et al., 2004; Verma et al., 2004). 
Controversy aside, the role of Ddi1 in the UPS is further confounded by the 
knowledge that Ddi1 and its orthologs share a conserved retroviral aspartyl protease 
sequence signature, D[S/T]G (Krylov and Koonin, 2001). Based on the fold of this 
aspartyl protease domain, Ddi1 is predicted to be proteolytically active (Sirkis et al., 
2006). However, there are no published reports showing definitive proof that the protease 
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domain of Ddi1 has cellular activity. The presence of this protease domain may even 
suggest that Ddi1 may play a novel deubiquitinating enzymatic role, although this is an 
unproven hypothesis (Krylov and Koonin, 2001). One might also ask if any of the 
identified Ddi1 substrates are solely dependent on Ddi1 acting as a receptor, or solely or 
dually dependent on its aspartyl protease activity. 
However, the closest the field is to understanding if the aspartyl protease domain 
of Ddi1 has any biological implications comes from the study of Pds1, an important cell 
cycle checkpoint factor that must be degraded to promote anaphase progression (Ciosk et 
al., 1998). The aspartyl protease domain is necessary for Ddi1 homodimerization and for 
suppression of the temperature sensitivity phenotype of a pds 1-128 mutant (Clarke et al., 
2001; Gabriely et al., 2008). This result is intriguing because the deletion of the UBA or 
the UBL domain of Ddi1 is also required for suppression of the pds1-128 temperature-
sensitive phenotype (Gabriely et al., 2008). This phenotype suppression may be due to 
the ability of Ddi1 to regulate the stability of cellular levels of Pds1. Supporting this is 
the fact that over expression of RAD23 has also been implicated in pds1-128 suppression 
(Clarke et al., 2001).  
 
Overlapping and distinct roles for the UBA-UBL shuttle 
receptors 
 
 An outstanding question has been: How do these UBA-UBL proteins work 
together, if they do at all, for delivery of substrates to the proteasome? It is suggested that 
Dsk2 delivers polyUb substrates to the proteasome cooperatively with other UBA- 
containing proteins (Lowe et al., 2006). Additionally, UBA-UBL proteins have been 
 10 
shown to form heterodimers with one another, and tetraubiquitin can simultaneously bind 
two different ubiquitin receptor proteins (Kang et al., 2006). In conflict with this idea are 
studies which conclude that UBA-UBL proteins do not bind Ub as dimers (Bertolaet et 
al., 2001a). Another study concluded that the conflict may be resolved by structural 
studies that imply that the UBA domain may interact with Ub as well as with other 
proteins in more than one way while utilizing the same binding surface (Mueller et al., 
2004). 
 Cooperation of the UBA-UBL proteins is still rather uncertain. The overlapping 
roles of these proteins in the cell cycle seem to further confound their independent 
cellular contributions (Díaz-MartÌnez et al., 2006). Further, none of the UBA-UBL 
proteins are essential for cell viability. Even the full deletion of all three UBA-UBL 
proteins in budding yeast is not lethal, although it does cause cell cycle delay at high 
temperatures (Díaz-MartÌnez et al., 2006; Kim et al., 2004).  
 The UBA-UBL shuttle receptors are generally believed to specifically bind Lys-
48 polyUb chains with a high affinity (Raasi et al., 2005; Rao and Sastry, 2002; 
Wilkinson et al., 2001). However, they each do so with varying affinities for multi-
ubiquitin chains (Table 1.2), and they have been shown to each have a unique repertoire 
of substrates whose degradation they promote (Verma et al., 2004). Their ability to bind 
the proteasome also appears to be a disparity between them (Saeki et al., 2002b), 
although there may be some cooperativity between the UBA-UBL receptors, such as in 
the case where two or more UBA-UBL proteins are necessary for substrate turnover 
(Medicherla et al., 2004). In agreement with this, rad23∆dsk2∆ mutant proteasomes have 
drastically reduced levels of Ub conjugates (Elsasser et al., 2004). However, there are 
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also undoubtedly some individual roles they each play in substrate turnover as well, as 
many substrates have been identified that are specifically regulated by only one UBA-
UBL protein.   
 In addition to there being potential redundancy between the UBA-UBL proteins, 
there may also be redundancy and/or cooperation between them and the intrinsic receptor 
Rpn10. Rad23 and Rpn10 have some overlapping and redundant functions. For instance, 
delivery of Ub conjugates by Rad23 to the proteasome is largely unaffected by loss of the 
UIM domain of Rpn10 (Elsasser et al., 2004; Fatimababy et al., 2010). However, Rpn10 
can rescue the turnover defects of rad23∆ proteasomes (Verma et al., 2004).  
 
Proteins implicated in binding UBA-UBL proteins 
 
 When this dissertation research began, the UBA-UBL proteins had been 
implicated in binding the leucine-rich repeat region one (LRR1) of Rpn1 (a base 
component of the proteasome) (Elsasser et al., 2002; Seeger et al., 2003).  LRR regions 
are horseshoe-shaped motifs thought to be important in protein-protein interactions.  The 
LRR domains of Rpn1 have been defined. Rpn1 is made up of  9 repeat segments that are 
composed of 35–40 residues each (Lupas et al., 1997).  The first five repeat segments 
constitute LRR1.  A 134-acidic amino acid stretch separates LRR1 and LRR2, which 
encompass the last four repeat segments (Elsasser et al., 2002; Lupas et al., 1997).  
Through a combination of yeast two- hybrid and GST pull-down assays, it was 
determined that the minimal region sufficient for Rad23 binding to Rpn1 is limited to 
amino acids 417–628, which is comprised of LRR1 and a 21-acidic amino acid stretch 
adjacent with the region (Elsasser et al., 2002).  
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 While the current dissertation research was underway, several insights were 
additionally made in understanding recruitment of UBA-UBL proteins to the proteasome. 
For instance, a proteasome subunit, Rpn13, was discovered to be an intrinsic ubiquitin 
receptor (Husnjak et al., 2008).  Rpn13 is conserved from yeast to man, binds ubiquitin, 
and is important in turnover of model substrates (Husnjak et al., 2008; Verma et al., 
2000). Additionally, Dsk2 was found to bind both Rpn10 and Rpn13 and Rad23 was 
found to bind a proteasome ATPase subunit, Rpt6, and Rpn10 (Fatimababy et al., 2010; 
Matiuhin et al., 2008b; Zhang et al., 2009).  
 The exact mechanism by which UBA-UBL receptors deliver targets to this wide 
array of proteasome subunits, Rpn1 and intrinsic receptors, Rpn10 and Rpn13, is a 
mystery. For instance, do UBA-UBL proteins utilize all of these binding surfaces 
simultaneously? Does docking at specific subunits at the proteasome regulate degradation 
of only specific substrates?  
  
Research objectives 
 
  With the current tools available, addressing the separate contributions of Rad23, 
Dsk2, and Ddi1 to protein turnover has been difficult to resolve. This enigma leaves a 
multitude of questions, such as: Is the fate of a proteasome substrate dependent on the 
receptor by which it is delivered (Elsasser et al., 2002)?   
 
This dissertation addresses three gaps in the existing knowledge:  
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1) Where do Ub receptors dock the proteasome? This is discussed extensively in  
  Chapter 3, which comes from an article published in BMC Biology.  
  Chapter 2 describes optimizing the screen I used in Chapter 3.  
2) What is the consequence of the elimination of these cis binding sites? I will  
  discuss the quantitative mass spectrometry technique I used to discover  
  consequences in Chapter 6.  
3) Is elimination of these sites equivalent to the elimination of the receptors  
  themselves? In Chapter 4 I delve into this topic and show that the   
  physiology of a proteasome cis mutant has some unanticipated surprises.   
 
 I have discovered that the binding landscape at the proteasome for UBA-UBL 
proteins is rather complex.  A single mutation in Rpn1 at residue D517 is able to reduce 
the binding of Ddi1 to the proteasome. However, such is not the case for any other UBL- 
containing protein. Dsk2 is seen to interact less with the proteasome only when there are 
multiple simultaneous mutations present in Rpn1, Rpn13, and Rpn10. It will be 
interesting for future research to follow up on how the substrate repertoire of these UBA-
UBL proteins depends, if at all, on which subunit of the proteasome they dock to.  
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Table 1.1. Identified Yeast UBA and UBL containing Proteins a  
Interacts with ORF Name UBL/
UBX 
UBA Intrxn
Rpn1  Rpn2 Rpn10 Cdc48 Rpn13 Ufd2 
Ede1 --        
Ubx1/Shp1     b     
Atg8  --       
Ubp14 --        
Atg12  --       
Ubx7         
Ste50  --       
Ubx3  --       
Rub1  --       
Ubc1 --        
Don1 --        
Swa2 --        
Ubx5         
Esc2  --       
Smt3  --       
Pac2  --       
Ddi1         
Ubp6  --       
Cue3 --        
Gts1 --        
Egd2 --        
Rpl40a  --       
Ubx6  --       
Cue2 --        
Rpl40b  --       
Ubi4  --       
Dcn1 --        
Rps31  --       
Ylr419w --        
Ubx2         
Usa1  --       
Vps9 --        
Ubx4  --       
Dsk2    b      
Hub1  --       
Mdy2  --       
Cue5 --        
Rup1 --        
Mex67         
Atg11  --       
Rad23         
a This list was composed using www.yeastgenome.org 
bgenetic interaction.  All other noted interactions are via Affinity Capture MS or Y2H 
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Table 1.2. UBA-UBL receptors have varying affinities for the different forms 
of ubiquitin. 
Kd (or relative binding affinity)a  
Ub Type (Reference) Rad23 Dsk2 Ddi1 
monoUB 
 (Trempe et al., 2005) nd nd 390 µM* 
 (Bertolaet et al., 2001a) 8 µM  nd 10 µM  
 (Raasi et al., 2005) nd 15 µM  nd 
 (Lowe et al., 2006) nd 8 µM  nd 
 (Hobeika et al., 2007) 19  µM 
12.9  µM2 
nd 
nd 
nd 
nd 
 (Ohno et al., 2005) nd 14.8  µM nd 
Lys-48 diUB 
 (Trempe et al., 2005) nd nd 3 µM* 
Lys-48 ≥tetra-UB 
 (Fatimababy et al., 2010) +++ +++ + 
 (Raasi et al., 2005) ++/+1 +++ ++ 
 (Wilkinson et al., 2001) nd nd 30 nM* 
 (Hobeika et al., 2007) 7.8  µM 
6.1  µM2 
nd 
nd 
nd 
nd 
Lys-63 diUB 
 (Trempe et al., 2005) nd nd 140 µM* 
Lys-63 ≥tetra-UB 
 (Fatimababy et al., 2010) + ++ + 
 (Raasi et al., 2005) +/++1 +++ ++ 
 
a In some publications, no Kd was provided, instead a “+” system is used, where more 
pluses means there is better binding. 
* Mud1, the S. pombe homolog of Ddi1 was used for these measurements. 
1 Rad23 has two UBA domains; the affinities for UBA1 and UBA2 were measured 
separately. 
2 Two separate measurements of the Rad23 UBA2 domain were made in this study. 
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Figure 1.1. The eukaryotic proteasome 
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Chapter 2: 
 
Reverse-yeast two-hybrid 
screening for putative 
interaction-defective  
alleles of Rpn1  
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Introduction 
 
 The ubiquitin proteasome system (UPS) is conserved throughout the eukaryotic 
branches of life.  Recent studies have even found a prokaryotic ubiquitin-like degradation 
system in myobacteria (Burns et al., 2009; Pearce et al., 2008). The proteasome is a large 
multi-subunit catalytic machine that selectively degrades proteins that have been marked 
for destruction with an ubiqutin appendage. Ubiquitylated substrates are also selectively 
delivered to the proteasome by ubiquitin receptors, as extensively reviewed (Finley, 
2009).  
 Shuttle ubiquitin receptors, such as the UBA-UBL proteins Rad23 and Dsk2, have 
been speculated to act as “trans” targeting activators of degradation. Their ubiquitin 
association domain (UBA) brings the degradation initiation sites of their substrates in 
close proximity to the proteasome (Prakash et al., 2008; Schauber et al., 1998). They are 
able to deliver their cargo by binding to the proteasome with their ubiquitin-like domain 
(UBL), without becoming substrates themselves (Heessen et al., 2005). Such a role, 
allows UBA-UBL proteins to regulate the degradation of many important cellular 
proteins, some of which may be involved in intricate complexes that require the selective 
degradation of a single subunit–for example, Sic1 must be degraded while in complex 
with cyclin-CDK (Verma et al., 2001).  
 Each of these UBA-UBL shuttle receptors delivers a specific subset of cellular 
proteins to the proteasome (Verma et al., 2004).  However, there are not a sufficient 
number of genetic and biochemical tools available to understand the individual 
contribution each one of these UBA-UBL receptors has in the selective degradation of 
the majority of the cell’s proteome (Rock et al., 1994). Such an understanding of the 
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specific repertoire of each shuttle receptor could lead to better understanding of how the 
UPS system is regulated and possibly even to future medical advances. For instance, 
human Rad23 (hHR23) has been implicated in the stability of p53, a tumor suppressor 
(Glockzin et al., 2003).   
 Hence, I aimed to create a proteasome cis mutant that would be unable to bind 
UBA-UBL proteins Rad23 and Dsk2. At the inception of my dissertation project, it was 
believed that Rad23 and Dsk2 primarily bound Rpn1, and some crosslinking data 
suggested it possibly bound Rpn2 (Elsasser et al., 2002; Saeki et al., 2002b; Seeger et al., 
2003). The first step in the creation of a proteasome cis mutant would be to identify 
amino acids on Rpn1 necessary for binding UBA-UBL proteins. I employed the use of a 
reverse-yeast two-hybrid system to screen for these putative amino acid residues.    
  Reverse-yeast two-hybrid (RY2H) systems allow for identification of interaction-
defective alleles (IDAs).  One of the major faults of traditional reverse-yeast two-hybrid 
screens is the large number of false positives, due to truncated proteins.  To alleviate this 
error, Gray and colleagues created an in vitro library assembly protocol, in which the bait 
of interest is inserted in frame with a gene responsible for kanamycin resistance in E. 
coli.  Hence, a selection for full-length clones is created.  This approach also allows for 
creation of a high-coverage allele library that will subsequently be transformed into yeast 
(Gray et al., 2007).  
 I report here, that Rpn1 has relatively weak yeast two-hybrid interactions with 
UBA-UBL proteins. This weak affinity may be a consequence of these proteins being in 
non-endogenous chimera states, or may be a consequence of a physiologically relevant 
weak affinity that allows them to transiently interact with one another for the disposal of 
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ubiquitylated proteins. Further, despite the advantages offered by this new RY2H system, 
of the 11 unique amino acid substitutions that were identified in this screen, none of them 
yielded IDA phenotypes in the context of fully intact proteasomes. The IDA phenotype 
exhibited in the RY2H screen was not transferable in a physiologically relevant 
environment. However, some of the identified residues appeared to destabilize 
proteasome stability, underlining potential causative reasons for why such alleles 
appeared in this screen.  
  
 
Methods 
 
Cloning RY2H bait and prey proteins 
The entire ORF of Rpn1 was PCR amplified from RDB2078 with oligos TG36 and 
TG37.  The PCR product was BP cloned into pDONR-EXP, thus creating pENTR-RPN1 
(RDB2167). pEXP-DB-RPN1 (RDB 2169) was created by LR cloning pENTR-RPN1 
with pDEST-DB (a gift from the Marc Vidal lab). RAD23, DSK2, and RPN10 were 
similarly PCR amplified and cloned into pDONR-Express and LR cloned into pDEST-
AD. 
 
RPN1391-640 allele library construction 
Described in detail in Chapter 3. 
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2µ activation-domain yeast two-hybrid vector construction  
pDEST-AD, a kind gift from the Marc Vidal lab, was used as template for amplification 
of the ADH1 promoter, the NLS, the GAL4 Activation Domain, the gateway cloning 
sites attR1,  the chloramphenicol resistance marker, the ccdB gene, the attR2 site, and the 
ADH1TT terminator.   This entire 4.1 kb fragment was amplified with forward and 
reverse primers, respectively, TG43 5’-
GCGCATCGATGGATCGAAGAAATGATGGTA-3’ and TG42 5’-
GCGCACTAGTTCGGCATGCCGGTAGAGGTG-3’ and cloned into the Spe1/Cla1 
sites of pRS424, which is a high copy 2µ vector. The resultant vector, pRS424-
GAL4pAD (RDB 2178) was created. pENTR-clones were LR cloned into this vector.  
 
Yeast two-hybrid interaction assay 
Plasmids were transformed into the reporter strain MaV203 (MATα; leu2-3,112; trp1-
901; his3Δ200; ade2-101; cyh2R; can1R; gal4Δ; gal80Δ; GAL1::lacZ; 
HIS3UASGAL1::HIS3@LYS2; SPAL10 UASGAL1::URA3). Transformants were plated 
onto synthetic medium prepared with 2% dextrose and lacking tryptophan and leucine 
with or without 3-AT and 5FOA. After 3 d incubation at 30ºC, the plates were analyzed 
for growth. 
 
Reverse-yeast two-hybrid screen 
The reverse-yeast two-hybrid assay was performed as described (Gray et al., 2007).  
Briefly, pEXP-DB-Rpn1 allele library was cotransformed with pEXP-AD-Rad23 or 
pEXP-AD-Dsk2 into the reporter strain MaV203 using lithium acetate transformation 
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procedures.  The transformation was plated onto SC-Leu-Trp + 0.2% 5FOA.  Plates were 
grown for about 1 week, and putative 5FOAR colonies were picked and screened for 
reporter phenotypes. Interaction-defective alleles were tested for absence of activation on 
GAL1::lacZ, failure of growth on SC-HIS+3-amino-1,2,4-triazole (3-AT). Mild 
interaction-defective alleles showed some growth on 3-AT. pEXP-DB Rpn1 allele library 
plasmids were either purified or PCR amplified from yeast colonies that displayed 
5FOAR phenotypes ,and sequenced using primer 5’-GGC TTC AGT GGA GAC TGA 
TAT GCC TC-3’ (Li et al., 2004).  Clones containing mutations were than retransformed 
into MaV203 and retested for proper reporter phenotypes.   
 
LacZ reporter assay 
Yeast colonies were frogged onto a hybond nylon membrane atop YPD agarose media.   
After ~ 2–3 days of growth at 30°C, the membranes were submerged into liquid nitrogen 
and freeze thawed two times.  After allowing the membrane to completely thaw, it was 
placed atop Whattman filters soaked in ~ 6 ml of buffer (60 mM Na2HPO4, 40 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4, 0.7 M 2-mercaptoethanol, 21 mM X-gal).  The 
soaked membranes were sealed in an airtight bag and placed at 37°C for 4–24 h.   
 
Putative Rpn1 IDA insert sequencing 
Direct PCR amplificiation of the pEXP-DB-Rpn1 insert was done as described in Li and 
Vidal.  Briefly, yeast colonies were resuspended in 15 µl lysis buffer (50 units zymolase 
in 0.1 M Na-Phosphate buffer pH 7.4) and incubated for 15 min at 37°C and 10 min at 
95°C. For PCR reactions, 0.3 µl of the lysed cells were used as template and amplified 
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using primers 5'-GGCTTCAGTGGAGACTGATATGCCTC and 5'-
GGAGACTTGACCAAACCTCTGGCG.  
 
RPN1 mutant strain construction 
RPN1 was replaced by Kanmx6 using a one-step PCR-mediated technique (Longtine et 
al., 1998).  Kanmx6 with RPN1 5’ and 3’ UTR homology was amplified from the pFA6a-
KanMX6 vector (Longtine et al., 1998) by PCR using oligonucleotides TG20 
(GGTCTACATAAGGTGCGATTCGTATAAATTTGGAAGACAATTGCAAGAAAC
GGATCCCCGGGTTAATTAA) and TG21 
(GGTTTTGAATTTTTCCTATTCTGGTTGATATTGCCCAAAAGCTATTCAGTGAA
TTCGAGCTCGTTTAAAC).  The PCR product was transformed into a diploid W303 
strain (RJD381) creating strain RJD4166 which lacks the entire RPN1 ORF.  This diploid 
strain was transformed with a CEN/ARS URA3 plasmid, pRS316-RPN1 (RDB--), 
sporulated, and used to select for haploid strains resistant to G418 and able to grow on 
SD-Ura.  The resultant strain, RJD4189 was used for plasmid shuffling.   
 
Construction of putative Rpn1 IDA plasmids  
The RPN1 locus, including 200 bp regions upstream and downstream of the gene, were 
PCR amplified from purified S. cervisiea genomic DNA using primers TG18 
(GGGCGCCTCGAGGTTGACTATTTACAGCTCATC) and TG19 
(GCGCCCGAGCTCAGCGCATCCATATTTACT).  The resulting PCR product, 
containing XhoI/SacI restriction sites, was digested and ligated into pRS315 and pRS316 
CEN/ARS vectors.  Silent mutations via a single nucleotide change resulted in an AvrII 
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restriction site at bp 1174 (amino acid 392) and an EagI site at bp 1920 (640).  The 
mutations were engineered into the wild-type RPN1 locus using the Multisite Directed 
Mutagenesis Kit (Stratagene) and oligonucleotides TG12 (5’ 
GTCATTTGTCAACGGGTTCTTAAACCTAGGTTATTGTAACGATAAATTAAT 3’) 
and TG14 (5’ GCAGATGAAGAAGAAACGGCCGAAGGACAGACTA 3’).  Mutations 
identified on pEXP-DB-Rpn1 plasmids in the reverse two-hybrid screen were introduced 
into this construct by double digestion and ligation into the AvrII and EagI sites.  
 
Growth assays 
For plating assays, strains were grown overnight in YPD and diluted to an OD600 of 0.3 in 
YP.  Five-fold dilutions were prepared in YP and spotted onto YPD plates supplemented 
with various additives as described in the text.  Plates were incubated at 30°C or 37°C for 
2–3 days. 
 
Small-scale yeast extract preparation for native gels 
Extracts were prepared as described (Elsasser et al., 2005). Briefly, 50 mLs of saturated 
culture grown overnight to late log phase was harvested by centrifugation and the pellet 
was weighed. Pellets were resuspended in 1.5 mL of lysis buffer (50 mM Tris-HCl [pH 
8.0], 1 mM EDTA, 5 mM MgCl2, and 1 mM ATP, 1X ATP Regeneration System) per 
gram of wet weight. An equal volume of glass beads was added and cells were lysed in a 
fastprep machine (ThermoSavant, Holbrook, NY) for 60 s at a speed of 6.5. Extracts are 
cleared by centrifugation at 20,000 g at 4°C for 30 minutes. Cleared extracts were then 
filtered through a milipore spin column.  
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26S native gel analysis 
Described in detail in Chapter 3.  
 
Native immunoprecipitaion of proteasomes  
Described in detail in Chapter 3.  
 
 
Results 
 
Optimizing the Rpn1 reverse-yeast two-hybrid interaction  
My goal was to create an Rpn1 cis mutant that would be unable to bind UBA-UBL 
proteins through the use of a genetic reverse-yeast two-hybrid screen. The first step in 
accomplishing this goal was to confirm and optimize forward yeast two-hybrid 
interactions between Rpn1 and prey proteins of interest. The RY2H system we employed 
to assay interactions between Rpn1 and various PIPs has several reporter genes that can 
be simultaneously assayed.  Positive interactions result in growth in the absence of uracil, 
in the presence of the drug 3-AT (with strong interactors being resistant to higher 
concentrations of 3-AT), and induction of lacZ. The RY2H system has the additional 
advantage of allowing for the selection of non-interacting bait and prey pairs. Growth in 
the presence of the drug 5FOA, which normally causes toxicity in the presence of the 
URA3 protein product, signals non-productive Y2H interactions. Since it had been shown 
that a region encompassed by amino acids 391–642 or Rpn1 was necessary for 
interaction with UBA-UBL proteins (Elsasser et al., 2002; Seeger et al., 2003), the 
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interaction between Rpn1391-642-DB was assayed with multiple baits including: Rad23-
AD, Rad23∆UBL-AD, Ubp6, Ubp6∆UBL-AD, Dsk2-AD and Rpn10-AD. A full-length 
Rpn1-DB bait was also tested for interactions with these prey. Unexpectedly, in all tested 
combinations, growth was not seen on medium lacking uracil and induction of lacZ was 
only detected after several hours. However, growth on 50 mM 3-AT for Rad23-AD and 
Dsk2-AD in combination with Rpn1391-642-DB was observed (Figure 2.1).  However, 
when the polarity of this interaction was reversed so that Rpn1391-642-AD was tested for 
interaction with prey, no productive interactions were detectable (data not shown). Taken 
together, these results are consistent with a very weak interaction occurring between 
Rpn1-DB, both the full-length and truncated forms, and the tested prey proteins.  
 
Expression of baits on a 2µ plasmid enhance positive and false-positive 
signals   
We postulated that interaction between Rpn1-DB and its prey might be improved by over 
expression of one of the interacting partners.  It is possible that Rpn1-DB and Rad23-AD 
are interacting with endogenous proteins, and we might detect an increased reporter gene 
signal if we increase the pool of prey or bait proteins.  To query this hypothesis, a high 
copy number 2µ Y2H pAD vector was created. In testing the strength of the interactions 
with this clone, several observations were made.  Firstly, the importance of the polarity of 
the interaction was again observed, positive interactions were detected between Rpn1-DB 
pairs and activation-domain-carrying baits and not vice versa (data not shown).  
Furthermore, there is an increase in putative negative interacting partners.  Unexpectedly, 
pAD-2µ vectors cause growth on 5FOA, in most tested cases. For instance, pAD-2µ-
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Rad23 grows on uracil whereas its CEN/ARS plasmid counterpart does not, but it also 
grows on 5FOA (Figure 2.1). Hence, the pAD-2µ vectors appear to create false positive 
and negative signals and would not be optimal for use in a RY2H screen.  
 
Isolation of putative Rpn1 IDAs 
Using the strongest forward-yeast two-hybrid interactions we could detect (those between 
Rpn1391-642-DB and Dsk2 and Rad23 CEN/ARS baits, we proceeded with the RY2H 
screen. The Rpn1391-642-DB allele library, containing over 500,000 individual clones, was 
co-transformed with either Rad23-AD or Dsk2-AD.  Transformations were plated 
directly onto medium containing 5FOA and incubated at 30°C until putative IDAs grew.  
A total of 964 5FOAR colonies appeared and were screened in a Rad23/Rpn1 assay.  For 
the Dsk2/Rpn1 assay, a total of 322 colonies were screened.  Of those, 90 Rpn1-Rad23 
IDAs and 22 Rpn1-Dsk2 IDAs appeared positive when screened for the proper reporter 
phenotypes and were subsequently sequenced. For the Rpn1-Rad23 screen, 22% of all 
putative positives contained a mutation, either silent (2.2%), a truncation or frameshift 
(3.3%), or a single or double mutation (16.7%).  For the Dsk2-Rpn1 screen, again, 
roughly 22% of all putative positives contained a mutation of some sort, with 18.2% of 
these clones containing single or double mutations (Table 2.1). When these putative 
positive Rpn1 IDAs were retransformed with either Rad23 or Dsk2, only 10% of 
Rad23/Rpn1 IDAs retested as positives and 75% of Dsk2 clones.  The mutations 
identified in this screen are shown (Table 2.2).  
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Rpn1 IDAs appear universal in their ability to disrupt binding to UBL 
proteins 
The Rpn1 IDAs identified in the Rad23 and Dsk2 screens were tested for their ability to 
interact with other UBLs, including Rad23, Dsk2, and the deubiquitinase UBL-
containing enzyme, Ubp6.  It was found that in all tested cases, every Rpn1 IDA 
hampered to some degree the interaction with any tested UBL in comparison to the wild- 
type interaction.  Additionally, similar levels of 3-AT were found necessary for inhibition 
of growth (Table 2.3).   
 
Putative Rpn1 IDA alleles have wild-type phenotypes when introduced into 
Rpn1 null cells 
To assess the physiological consequences of the putative Rpn1 IDAs I identified in the 
RY2H screen, mutant LEU2 plasmids were plasmid shuffled into rpn1Δ haploid cells 
sustained by a low copy URA3 plasmid containing RPN1. Transformants were plated 
onto 5FOA to evict the wild-type RPN1 plasmid, and clones sustained by the 
mutagenized plasmid were sought. All alleles of rpn1 were viable with the exception of 
rpn1-F534S (Figure 2.2).  
 To identify mutants that exhibited broad defects in the ubiquitin–proteasome 
system, we tested these alleles for growth defects. Proteasome mutants often show 
growth defects under conditions that induce protein misfolding, such as in a variety of 
proteasome assembly mutants (Saeki et al., 2009). Strains lacking multiple ubiquitin 
receptors, such as the double and triple UBA-UBL strains, rad23∆dsk2 and 
rad23∆dsk2∆ddi1∆, are also sensitive to protein misfolding, salt, and ethanol stress 
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(Husnjak et al., 2008; Kim et al., 2004; Lambertson et al., 1999). I postulated that if any 
of the identified Rpn1 IDAs diminished binding of UBA-UBL proteins in vivo, they 
would show sensitivity to stress conditions. Two rpn1-1 mutant isolates were also used in 
this assay as positive controls. The rpn1-1 strain is an unmapped mutation within RPN1 
that was identified in a genetic screen for mutants that accumulate 3-hydroxy-3-
methylglutaryl-CoA reductase  (Hampton et al., 1996). The rpn1 mutants were tested for 
their ability to grow on YPD medium at 30oC and 37oC.  In addition, their ability to grow 
in the presence of ethanol (EtOH) and the proline analog AZC (L-azetidine-2-carboxilic 
acid) was also tested. Proteasome mutants exhibit stress when grown on AZC, as it 
promotes misfolding in proteins and presumably overloads the proteasome (Fowden and 
Richmond, 1963). Surprisingly, all of the rpn1 mutant strains show similar viability in 
comparison to wild type under all tested conditions (Figure 2.3). As expected, the rpn1-1 
strains show sensitivity to elevated temperature and AZC. 
The rpn1 mutants were also tested for ubiquitin conjugate accumulation by 
Western blotting cell extracts. All of the mutants seemed to show wild-type levels of 
Ub conjugate accumulation (data not shown).  
  
Rpn1 mutant proteins assemble into fully intact and active 26S 
proteasomes  
Cell extracts were resolved in non-denaturing gels in the presence of ATP and MgCl2 and 
visualized with the fluorogenic substrate SUC-LLVY-AMC. Rpn1 IDA mutants 
contained wild-type ratios of double-capped 26S proteasomes, single-capped 26S 
proteasomes, and 20S core particles (Figure 2.4A).  Thus, we conclude that there are no 
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assembly defects. Additionally, using a fluorogenic chymotrypsin activity assay, mutant 
proteasomes were found to have wild-type levels of chymotrypic activity (Figure 2.4B).  
 
RY2H derived Rpn1 IDA alleles do not impair the interaction between the 
proteasome and the UBA/UBL proteins in vivo  
Despite the rpn1 mutants showing no other physiological signs that they may have 
impaired delivery of ubiquitinated substrates to the proteasome, I performed 
immunoprecipitation experiments to examine recruitment of UBA-UBL proteins to 
mutant proteasomes. To determine which UBA-UBL proteins were able to interact with 
26S proteasome complexes from wild type and rpn1 mutants, I subjected strains 
expressing Pre1-Myc to native immunoprepcipitation. In wild-type cells, Rad23, Dsk2, 
and Ubp6 were detected (Figure 2.5A).  These UBA/UBL proteins were also detected in 
rpn1 mutants V447H, D503G, L506S, A531T, N539D, and I546T (Figure 2.5A and data 
not shown). Notably, rpn1 mutants A418V, N549D, F565V, and G571S seemed to 
destabilize proteasomes during the IP procedure, as they showed reduced levels of the 
UBA-UBL proteins Rad23, Dsk2, and Ubp6, but also of proteasome subunits Rpn10 
(base), Rpt6 (base), and Rpn11 (lid), indicating that the proteasome subcomplexes were 
disassociated during the immunoprecipitation (Figure 2.5A). Because the presence of the 
proteasome inhibitor MG262 has been shown to increase proteasome stability (Kleijnen 
et al., 2007), the rpn1 mutants that showed proteasome instability were reassayed with 
exogenous 2 µM MG262 added to the extracts and under milder native buffer IP 
conditions (75 mM NaCl and 0.1% NP40). Under these conditions, all mutants that had 
showed instability in the prior assay now remained assembled, with the exception of 
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rpn1-A418V.  In addition, none of these mutants interfered with the proteasomes’ ability 
to co-immunoprecipitate with Rad23 or Dsk2 (Figure 2.5B and data not shown).   
 
Discussion 
 
 Approximately 250 of the residues that had previously been determined to be 
necessary for binding UBA-UBL proteins were in included in the aforementioned RY2H 
screen (Elsasser et al., 2002; Seeger et al., 2003). A  ~1 50 residue span was identified 
within this ~ 250 amino acid fragment, containing 11 residues that perturbed Rad23 
and/or Dsk2 binding to Rpn1 within the context of a yeast two-hybrid interaction. 
However, when these mutations were used to replace endogenous Rpn1 within a yeast 
cell and probed for their ability to bind UBA-UBL proteins, unexpectedly, binding was 
not diminished.  
 It is hard to ascertain why such a discrepancy in binding occurred between the 
results of the genetic screen and the results of following full-length physiologically 
relevant protein interactions.    
 Considering the large number of IDAs identified that decreased proteasome 
stability (4 IDAs out of 11 total IDAs), it is plausible that the RY2H screen selected for 
residues that enhanced misfolding of Rpn1, which in turn eliminated binding of UBA-
UBL proteins. Since a truncated version of Rpn1 was used in the screen, misfolding 
events are conceivable. Supporting this claim is an electron microscopy study of Rpn1 
which shows that truncated forms of Rpn1 do not fold correctly (Effantin et al., 2009). 
Interestingly, one residue uncovered in the RY2H screen caused lethality. Since Rpn1 is 
the largest subunit of the proteasome, misfolding events that lead to improper scaffolding 
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of adjacent subunits could very well be a lethal event. It may be interesting to do in vitro 
studies with mutant Rpn1-F534S protein to determine if this residue causes severe 
misfolding of Rpn1 that impinges on proteasome function. 
 Another reason true IDAs were not identified in the RY2H screen may be due to 
the inherent nature of the proteasome to interact with GAL1-10 promoter in vivo through 
binding the activation domain of (AD) of Gal4.  Gal4-AD interacts with proteasome 
subunits, Sug1/Rpt6, Sug2/Rpt4, and Rpn1, Rpn2 (Gonzalez et al., 2002). This may have 
allowed Rpn1-DB to naturally interact with Gal4-AD containing proteins. Admittedly, 
since all forward Y2H interactions were quite weak (Figure 2.1) this may be the weakest 
argument. However, the possibility exists that this natural tendency for endogenous 
proteasome subunits to interact with Gal4-AD may have compounded other intrinsic 
problems with this genetic screen.  
 It is also possible that in the context of the RY2H screen the interactions between 
Rpn1 are truly impaired with UBA-UBL proteins. However, in vivo, a lot of binding 
redundancy exists that precludes the exhibition of phenotypes from a single residue 
mutation in Rpn1. This hypothesis was examined and will be the focus of a subsequent 
chapter (Chapter 3).  
 At the time this work was completed, there were two rpn1 allele mutations that 
had been crudely defined in the literature, rpn1-1 and rpn1-821. The rpn1-1 mutation was 
identified in a genetic screen for mutations that stabilized cellular HMG-CoR levels 
(Hampton et al., 1996). In my hands, I saw that this mutant was sensitive to temperature 
and AZC stress, so I was attracted to follow up on its possible role in UBA-UBL protein 
binding. However, after extensive sequencing analysis of the RPN1 from this strain, I 
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found no apparent mutation in the ORF, or within at least 200 bp of the 5’or 3’ UTR of 
this gene. Hence, I believe the mutation was improperly mapped to RPN1 and stopped 
pursuing it as a potential RPN1 allele of interest. The rpn1-821 mutation was identified in 
a screen for mutants that suppressed the Dsk2 over-expression lethality (Funakoshi et al., 
2002). However, this allele was not of interest to follow up as it was determined to have 
assembly defects (Funakoshi et al., 2009).   
 While these studies were largely unsuccessful, there may be insights into 
proteasome stability, Rpn1 structure, and still, possibly even UBA-UBL protein 
interactions that may become apparent in future lines of research.  
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Figure legends 
 
 
 
Figure 2.1. Forward-yeast two-hybrid interactions between Rpn1-DB and 
prey proteins.  
Positive interactions (growth on –URA and 3-AT) and negative interactions (growth on 
5FOA) of prey proteins can be observed with either a truncated form of Rpn1391-642 or full- 
length Rpn1 with various prey proteins. Yeast cells were co-transformed with plasmids 
expressing Gal4-DBD fused to Rpn1 and Gal4-AD fused to either Rad23, Dsk2 
expressed on CEN/ARS plasmids or Rad23, Rad23∆UBL, or Rpn10 expressed on 2µ high 
expression plasmids.  Protein-protein interaction is indicated by growth on 50 mM 3-AT 
and lack of growth on 0.2% 5FOA. 
 
Figure 2.2. Most putative Rpn1 IDAs produce viable yeast strains. 
Mutant rpn1 alleles identified in the RY2H screen were reconstructed into full-length 
pRS315-RPN1-LEU2 vectors and plasmid shuffled into an rpn1∆ pRS316-RPN1-URA3 
yeast strain. RPN1 alleles that produce viable strains were able to evict the wild-type 
URA3 plasmid and sustain growth on 5FOA. Empty pRS315 vector is used as a negative 
control.  
 
Figure 2.3. Mutant rpn1 alleles do not display typical proteasome mutant 
phenotypes. 
Five-fold serial dilutions of cells were plated onto the indicated media. The rpn1 mutants 
(rpn1*) were grown at either 30°C or 37°C, with 5 mM AZC (a proline analog), or on 
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12% ethanol. Two isolates of a rpn1-1 mutant were used as control. Some of the mutants 
shown in the figure will be discussed in Chapter 3.  
 
Figure 2.4. Mutant rpn1 alleles do not interfere with proteasome assembly. 
(A) Proteasomes isolated from rpn1 mutants are intact. Cell lysates from the indicated 
rpn1 mutant were run on non-denaturing gels. The native gel was incubated with Suc-
LLVY-AMC in the presence of ATP and 0.05% SDS to visualize RP and CP activity. (B) 
Chymotryptic activity of cell lysates was quantitatively measured using Suc-LLVY-AMC 
in the presence and absence of SDS.  
 
Figure 2.5. Select RY2H screen rpn1 alleles reduce proteasome stability but 
do not impinge on UBA-UBL binding to the proteasome. 
(A) Affinity-purified rpn1 mutant proteasomes do not contain reduced levels of UBA-
UBL proteins. However, some rpn1 mutant proteasomes disassociate during the course of 
affinity purification. Reduced levels of Rpn10 (base), Rpt6 (base), and Rpn11 (lid) are 
seen in rpn1-A418V, N549D, F565V, and G571S mutants. (B) rpn1 mutants that showed 
proteasome stability defects were purified under more gentle immunoprecipitation 
conditions: low salt, gentle detergent, and in the presence of proteasome inhibitor 
MG262. All tested mutants, with the exception of rpn1-A418V were stable under these 
conditions. Association with Rad23 is observed with these mutant proteasomes under 
these conditions. 
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  Table 2.1. RY2H statistics 
 
Rad23/Rpn1  
 
Dsk2/Rpn1 
 
 
# (%) 
 
# (%) 
Total Colonies Screened 964 322 
Total Colonies Sequenceda 90 22 
Clones containing mutations 20 (22.2%) 5 (22.9%) 
Truncated or Frameshifted 
Clones 
3 (3.3%) 1 (4.7%) 
Silent Mutation Clones 2 (2.2%) 0 (0%) 
Single or Double Mutant Clones 15 (16.7%) 4 (18.2%) 
Positive Clones Post Retransformationb 9 (10%) 3 (75%) 
 a Of the total colonies that grew on 5FOA after the RY2H transformation, only 
 those that retested for 5FOAR and showed proper reporter phenotypes were 
 selected for sequencing. 
 b This number is shown as a percentage only of single/double mutant clone 
 isolates from the above column. 
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Table 2.2. Point mutations in Rpn1 that disrupt binding to either Rad23 or 
Dsk2 in a RY2H system. 
 
 
Position 
 
AA Change 
WT →Mutant 
 
 
Hitsb 
 
Identified in 
pEXP-AD-X 
Screen 
418 A→V 1 Rad23 
447 V→H 
V→D 
2 Dsk2 
Dsk2 
503 D→G 1 Rad23 
506 L→S 1 Rad23 
531 A→T 1 Rad23 
534 F→S 1 Rad23 
539 N→D 1 Rad23 
546 I→T 1 Rad23 
549 N→D 1 Rad23 
565 F→V 1 Rad23 
571 G→S 1 Dsk2 
a Position indicates the amino acid residue identified 
b Only hits that tested positive after retransformation are shown.  
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Table 2.3. 3-AT resistance of bait/prey pairs 
3-AT phenotype (mM)a  
 
Allele Rad23 Dsk2 Ubp6 
A 418 A 100 nd nd 
V 447 H >100 >100 nd 
V 447 D >100 >100 nd 
D 503 G 100 nd nd 
L 506 S 100 nd nd 
A 531 T 100 100 100 
F 534 S 50 50 50 
N 539 D 100 >100 nd 
I 546 T 50 50 50 
N 549 D 50 50 nd 
F 565 V 50 nd nd 
G 571 S 100 >100 nd 
a The (3-AT) listed is the concentration required to inhibit growth 
under histidine selection. 
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Figure 2.1. Forward-yeast two-hybrid interactions between Rpn1-DB and 
prey proteins  
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Figure 2.2. Most putative Rpn1 IDAs produce viable yeast strains. 
 
 
 41 
Figure 2.3. Mutant rpn1 alleles do not display typical proteasome mutant 
phenotypes. 
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Figure 2.4. Mutant rpn1 alleles do not interfere with proteasome assembly 
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Figure 2.5. Select RY2H screen rpn1 alleles reduce proteasome stability 
but do not impinge on UBA-UBL binding to the proteasome. 
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Chapter 3: 
 
Identification of a 
functional docking site in 
the Rpn1 LRR domain for 
the UBA–UBL domain 
protein Ddi1 
 
 
 
**This chapter was accepted for publication by BMC Biology. The authors for this 
chapter are: Tara A. Gomez, Natalie Kolawa, Marvin Gee, Michael J. Sweredoski, and 
Raymond J. Deshaies.  
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Abstract  
 
Background  
 
The proteasome is a multi-subunit protein machine that is the final destination for cellular 
proteins that have been marked for degradation via an ubiquitin (Ub) chain appendage. 
These ubiquitylated proteins either bind directly to the intrinsic proteasome ubiqutin 
chain receptors Rpn10, Rpn13, or Rpt5, or are shuttled to the proteasome by Rad23, 
Dsk2, or Ddi1. The latter proteins share an Ub association domain (UBA) for binding 
poly-Ub chains and an Ub-like-domain (UBL) for binding to the proteasome. It has been 
proposed that shuttling receptors dock on the proteasome via Rpn1, but the precise nature 
of the docking site remains poorly defined. 
 
Results 
To shed light on the recruitment of shuttling receptors to the proteasome, we performed 
both site-directed mutagenesis and genetic screening to identify mutations in Rpn1 that 
disrupt its binding to UBA–UBL proteins. Here we demonstrate that delivery of Ub 
conjugates and docking of Ddi1 (and to a lesser extent Dsk2) to the proteasome are 
strongly impaired by an aspartic acid to alanine point mutation in the highly-conserved 
D517 residue of Rpn1. Moreover, degradation of the Ddi1-dependent proteasome 
substrate, Ufo1, is blocked in rpn1-D517A yeast cells. By contrast, Rad23 recruitment to 
the proteasome is not affected by rpn1-D517A. 
 
Conclusions 
These studies provide insight into the mechanism by which the UBA–UBL protein Ddi1 
is recruited to the proteasome to enable Ub-dependent degradation of its ligands. Our 
studies suggest that different UBA–UBL proteins are recruited to the proteasome by 
distinct mechanisms.  
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Background  
 
 Protein degradation via the ubiquitin proteasome system (UPS) is one of the cell’s 
tools for selective negative regulation of intracellular proteins. Degradation via the UPS 
has roles in maintaining protein quality control, signaling, and cell cycle progression 
(Hershko, 1997; Vembar and Brodsky, 2008). Ubiquitin is a small protein that is highly 
conserved in eukaryotes and is the crux of the UPS system.  The UPS system is built 
upon three classes of enzymes—E1, E2, and E3– that act sequentially to build ubiquitin 
chains on protein substrates. Once a protein substrate has been modified by a chain of at 
least 4 ubiquitins, it is then degraded by the 26S proteasome in an ATP-dependent 
manner (Pierce et al., 2009; Thrower et al., 2000).   
 The proteasome is a 33-subunit protein complex that is responsible for degrading 
a minimum of 20% of the yeast proteome (SCUD; http://scud.kaist.ac.kr/index.html). 
Other lines of evidence suggest that the vast majority of cytoplasmic protein turnover is 
mediated by the proteasome (Rock et al., 1994). The proteasome is composed of two 
main components: A 20S catalytic core particle (CP) and a 19S regulatory particle (RP).  
The 19S regulatory particle can be dissected into two sub-complexes, the lid and the base.  
The base sub-complex is composed of two non-ATPase subunits, Rpn1 and Rpn2, as well 
as six ATPase subunits (Rpt1–6) that feed unfolded substrate into the CP. 
 How ubiquitylated substrates converge onto the proteasome is an active area of 
research that has been studied with the greatest depth in Saccharomyces cerevisiae.  So 
far, at least two independent mechanisms have been discovered.  In the first case, the 
yeast proteasome contains two intrinsic receptors, Rpn10 and Rpn13, that contain defined 
ubiquitin binding domains (Husnjak et al., 2008; van Nocker et al., 1996). Mammalian 
proteasomes contain a third intrinsic receptor, Rpt5 (Lam et al., 2002). Rpn10 contains a 
highly conserved ubiquitin interaction motif (UIM), whereas Rpn13 binds ubiquitin via a 
pleckstrin motif that was not previously known to interact with ubiquitin (Husnjak et al., 
2008; van Nocker et al., 1996). Although neither Rpn10 nor Rpn13 is essential, rpn10∆ 
and rpn13∆ mutants exhibit phenotypes consistent with a role for these proteins in 
docking of substrates to the proteasome. Rpt5 can be cross-linked to ubiquitin chains, but 
the means by which it binds ubiquitin and the genetic significance of this activity remain 
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to be determined. Substrates may be able to bind the proteasome directly via these three 
intrinsic receptors.  
In the second mode of delivery to the proteasome, a class of receptors 
encompassing the budding yeast Rad23, Dsk2, and Ddi1 proteins contain an N-terminal 
ubiquitin like domain (UBL) that binds to the proteasome and a C- terminal ubiquitin 
association domain (UBA) that binds to ubiquitin chains (Bertolaet et al., 2001a; Chen et 
al., 2001; Funakoshi et al., 2002; Wilkinson et al., 2001). Unlike Rpn10 and Rpn13, these 
proteins are not stoichiometric subunits of the proteasome. Instead, it is thought that this 
class of proteins rapidly cycles on and off the proteasome (Wang and Huang, 2008), 
serving as ‘shuttle’ receptors that bind substrates in the cytoplasm and nucleus and 
deliver them to the proteasome. The UBA–UBL proteins dock at the proteasome by 
binding the largest subunit of the proteasome, Rpn1 (Elsasser et al., 2002; Funakoshi et 
al., 2002; Kaplun et al., 2005), although recent evidence suggests that the UBA–UBL 
proteins also bind other subunits within the proteasome. For example, multiple lines of 
evidence suggest that in yeast Dsk2 may also be able to interact with Rpn10 and Rpn13, 
and yeast Rad23 may also bind Rpt6 (Fu et al., 2010; Husnjak et al., 2008; Matiuhin et 
al., 2008b; Zhang et al., 2009). Human Rad23 is also able to bind both human Rpn10 and 
Rpn13 (Husnjak et al., 2008) and in an NMR experiment, binding of yeast Rad23 to 
Rpn10 was observed (Zhang et al., 2009). 
 While it is clear that substrates can use two different mechanisms to engage the 
proteasome, we still do not understand how each pathway controls the fate of each 
substrate of the proteasome.  While there is evidence that some protein substrates utilize 
both the intrinsic and shuttling receptors (Kang et al., 2006), some proteasomal substrates 
are entirely dependent on either Rpn10 or Rad23 (Verma et al., 2004).  Moreover, 
although Rpn10 and Rpn13 are undoubtedly important receptors, electron microscopy 
and quantitative mass spectrometry data suggest that there are two populations of 
proteasomes–those containing and those not containing the intrinsic receptors (Bohn et 
al., 2010; Fôrster et al., 2010; Nickell et al., 2009b). Furthermore, deletion of RPN10 or 
RPN13 does not lead to profound deficits in cellular protein degradation (Husnjak et al., 
2008; Saeki et al., 2002a; van Nocker et al., 1996).  Finally, while highly conserved 
(Mueller and Feigon, 2003), the UBA–UBL proteins are not essential for yeast cell 
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growth (Díaz-MartÌnez et al., 2006; Kim et al., 2004; Saeki et al., 2002a).  Thus, although 
the proteasome itself is essential, none of the receptors that link substrates to the 
proteasome (with the exception of Rpt5) is essential.  This has led to the assumption that 
targeting of substrates to the proteasome occurs by multiple, partially redundant 
mechanisms. Obtaining a clear understanding of how each pathway contributes to 
substrate recognition by the proteasome is of considerable importance given the central 
role of the UPS in regulatory biology and the clinical significance of the proteasome as a 
target for cancer therapy (Fisher et al., 2006; Richardson et al., 2005).   
 Rpn1, the largest subunit of the proteasome, is composed of 9 repeat segments, 
known as leucine rich repeats (LRR), which adopt horseshoe-shaped structures that are 
thought to be generally important for protein–protein interactions (Kobe and Kajava, 
2001). The LRR portions of Rpn1 are thought to form a slightly open monomeric α-
solenoid (Effantin et al., 2009; Kajava, 2002). The first five contiguous repeat segments 
constitute LRR1, whereas the next four contiguous LRR repeats form LRR2. A 134-
acidic amino acid stretch links LRR1 and LRR2 (Elsasser et al., 2002; Lupas et al., 
1997). The minimal region sufficient for Rad23 binding to Rpn1 has been mapped to 
residues 417–628, which comprise LRR1 and an adjacent 21-residue acidic stretch on the 
C-terminal side. The UBL domains of Dsk2 and Ddi1 have also been shown to interact 
with the LRR domain of Rpn1 (Elsasser et al., 2002; Kaplun et al., 2005; Leggett et al., 
2002; Saeki et al., 2002b; Seeger et al., 2003).  
 To gain a better understanding of how substrate delivery to the proteasome is 
controlled, we sought to identify an Rpn1 mutant that is defective in binding the UBA–
UBL receptor proteins. We identified two mutations that disrupted binding of the UBA–
UBL protein Ddi1 to the proteasome. Docking of Dsk2 to the proteasome was also 
moderately affected by these mutations in rpn13∆ and rpn10-uim rpn13-KKD strain 
backgrounds. The delivery of ubiquitin conjugates to the proteasome is diminished in an 
rpn1-D517A single and even more so in an rpn13∆ rpn1-D517A double mutant. Lastly, 
we show that an rpn1-D517A mutant stabilizes the Ddi1 substrate, Ufo1.  
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Methods 
 
Yeast strains and growth conditions  
Strains used in this study are listed in Supplemental Table 3.2. Listed strains are 
derivatives of the wild-type strain RJD 360 (W303 background). Standard yeast genetic 
techniques were used.  Unless otherwise stated, strains were grown at 30°C and cultured 
on YPD.  
 
Plasmids 
The RPN1 locus including 200 bp upstream and downstream of the ORF was amplified 
by polymerase chain reaction (PCR) from purified S. cervisiae genomic DNA using 
primers TG18 (5’ GGGCGCCTCGAGGTTGACTATTTACAGCTCATC 3’) and TG19 
(5’ GCGCCCGAGCTCAGCGCATCCATATTTACT 3’).  The resulting PCR product 
containing flanking XhoI and SacI restriction sites was digested with these enzymes and 
ligated into pRS315 and pRS316 CEN/ARS vectors.  Silent mutations introduced by site-
directed mutagenesis with oligonucleotides TG12 (5’ 
GTCATTTGTCAACGGGTTCTTAAACCTAGGTTATTGTAACGATAAATTAAT 3’) 
and TG14 (5’ GCAGATGAAGAAGAAACGGCCGAAGGACAGACTA 3’) resulted in 
an AvrII restriction site at bp 1174 (amino acid 392) and an EagI site at bp 1920 (amino 
acid 640). Rpn1 mutations identified in the reverse two-hybrid screen or generated by the 
‘rational’ approach were introduced into this construct by double digestion and ligation 
into the AvrII and EagI sites or by site mutagenesis. pEXP-Rpn1391-640  was created by 
PCR amplification with primers TG1 (5’ GGGGACA AGT TTG TAC AAA AAA GCA 
GGC TCTATGATGAACCTAGGTTATTGTAACGATAAA 3’) and TG2 (5’ GGG 
GAC CAC TTT GTA CAA GAA AGC TGG GTT 
TTCGGCCGTTTCTTCTTCATCTGCATC 3’) and cloned using BP Gateway into 
pDONR-Express (Invitrogen) and LR-cloned into pDEST-AD. RAD23, DSK2, DDI1, 
UBP6, and RPN2 were amplified by PCR and cloned into pDONR-Express and 
subsequently LR-cloned into pDEST-AD.  All plasmids used in this study are listed in 
Supplemental Table 3.3.  
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RPN1391-640 allele library construction 
Rpn1 amino acids 391-640 were chosen as the target area to test for forward and reverse- 
yeast two-hybrid interactions. The pEXP-Rpn1391-642 clone was used as a template for the 
allele library generation.  Using attB primers TG4 (GGGGACA AGT TTG TAC AAA 
AAA GCA G) and TG5 (GGGGAC CAC TTT GTA CAA GAA AGCT), bp 1174–1926 
were amplified by 25 cycles of PCR in 48 independent reactions, concentrated, and gel 
purified. Approximately 150 ng of gel-purified product was BP-cloned into pDONR-
Express and transformed via electroporation into TOP10 Electro-comp cells (Invitrogen).  
Plasmid DNA was collected from bacterial clones containing functional pENTR-Rpn1391-
642 clones.  A yield of 500,000 clones was desired for good library coverage and this 
number was exceeded. Approximately 250 ng of purified pENTR-Rpn1 allele library 
DNA was LR-cloned into pDEST-DB and transformed via electroporation into E. coli.  
Again, over 500,000 colonies were pooled and the resulting pEXP-Rpn1 allele library 
DNA was purified. 
 
Forward and reverse-yeast two-hybrid screen 
The reverse yeast two hybrid assay was performed as described (Li et al., 2004).  Briefly, 
pEXP-DB-Rpn1 allele library was cotransformed with pEXP-AD-Rad23 or pEXP-AD-
Dsk2 into the reporter strain MaV203 using the lithium acetate procedure.  The 
transformation reactions were plated onto SC-Leu-Trp + 0.2% 5FOA.  Plates were grown 
for ~ 1 week, and putative 5FOAR colonies were picked and screened for reporter 
phenotypes. Interaction-defective alleles were tested for lack of activation of GAL1–lacZ 
and failure to grow on SC-HIS+3-amino-1,2,4-triazole (3-AT). Mild interaction-defective 
alleles showed some growth on 3-AT. pEXP-DB Rpn1 allele library plasmids were either 
purified or amplified by PCR from yeasts colonies that displayed 5FOAR phenotypes and 
sequenced using primer 5’-GGC TTC AGT GGA GAC TGA TAT GCC TC-3’.  Clones 
containing mutations were than retransformed into MaV203 and retested for proper 
reporter phenotypes.  Direct PCR amplification of their pEXP-DB-Rpn1 insert was done 
as described (Li et al., 2004).  Forward interactions were tested by assaying for growth on 
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50 mM or 100 mM 3AT and 0.1% or 0.2% 5FOA.  The plates were scored between 24–
72 hours.  
 
Plasmid shuffling of rpn1 alleles  
RPN1 was replaced by Kanmx6 (Longtine et al., 1998) by amplifying a cassette from 
pFA6a-KanMX6 using oligonucleotides TG20 (5’ 
GGTCTACATAAGGTGCGATTCGTATAAATTTGGAAGACAATTGCAAGAAACG
GATCCCCGGGTTAATTAA 3’) and TG21 (5’ 
GGTTTTGAATTTTTCCTATTCTGGTTGATATTGCCCAAAAGCTATTCAGTGAA
TTCGAGCTCGTTTAAAC 3’).  The PCR product was transformed into a diploid W303 
strain (RJD381) creating strain RJD4166.  This diploid strain was transformed with 
pRS316-RPN1 (RDB 2090), sporulated, and haploid segregants were selected for growth 
on G418 and SD-Ura.  The resultant strain, RJD 4189, was used for plasmid shuffling. 
Plasmids were transformed into RJD 4189 and then transformants were selected for 
growth on 5FOA-containing media.  
 
26S proteasome native gel analysis 
Native gels were prepared and run as described (Kleijnen et al., 2007). Briefly, 2 mL of 
5X native buffer (450 mM Tris base, 450 mM boric acid, 25 mM MgCl2, 2.5 mM EDTA 
[pH 8]), 0.9 ml 40% acrylamide/Bis solution (37.5:1), 7 ml H2O, 10 μl 0.5 M ATP, 90 μl 
10% APS, and 9 μl TEMED) were combined and allowed to set using the BioRad Mini-
Protean Tetra gel system. About 90–300 µg of protein supplemented with xylene cyanol 
and glycerol, was loaded per lane. Either purified proteasomes or cell extracts were run 
on native gels. Extracts were prepared as described (Elsasser et al., 2005). Gels were run 
at 100 V for 3.5–4 hours with 1X native buffer supplemented with 1 mM ATP. The gels 
were then soaked in 25 mL of developing buffer (50 mM Tris pH 7.5, 5 mM MgCl2, 1 
mM ATP) followed by a 15 minute incubation at 30°C in substrate solution (50 mM Tris 
pH 7.5, 5 mM MgCl2, 1 mM ATP, 20 µM SVC LLVY AMC, 0.02% SDS). Cleavage of 
the fluorogenic substrate was visualized by exposure to UV light using an alphaimager.  
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Native immunoprecipitaion of proteasomes for probing associated UBA–
UBL proteins 
Native immunoprecipitations were carried out as described (Verma et al., 2011). Briefly, 
yeast cultures were grown to an OD600 between 1–2 in YPD and harvested by 
centrifugation. Pellets were washed in ice cold water and then flash-frozen in liquid 
nitrogen. Thawed pellets were resuspended in 1 mL of lysis buffer (composition 
described below) per 100 O.D. units. One milliliter of this lysate was mixed with an 
equivalent volume of glass beads and cells were disrupted by vortexing using the 
FastPrep-24 at a setting of 6.5 for 60 s, cooling on ice, and then repeating. Lysates were 
clarified by centrifugation at 14,000 rpm at 4°C for 15 min. Clarified supernatants were 
bound to anti-epitope beads for 1.5 hours at 4°C. The beads were washed 4 times with 
lysis buffer containing detergent (50 mM Tris, pH 7.5, 150 mM NaCl, 15% glycerol, 
0.2% Triton X-100, 25 mM b-glycerophosphate, 25 mM NEM, 1X Protease Inhibitor 
tablet (minus EDTA), 0.5 mM AEBSF, 2 mM ATP, 5 mM MgCl2), and 2 times with 
buffer B (25 mM Tris pH 7.5, 10 mM MgCl2, 2 mM ATP).  An equal bead volume of 2X 
SDS buffer was added prior to boiling for 3 mins. Samples were resolved on 10% or 
12.5% SDS-PAGE gels, transferred to nitrocellulose and immunoblotted. Antibodies 
used in this study are listed in Supplemental Table 3.4. 
 
Purification of 26S proteasomes for immunoblotting  
26S proteasomes were purified as described (Verma and Deshaies, 2005). Briefly, Pre1-
Flag (20S subunit) or Rpn11-Flag tag containing strains were grown as large-scale 
cultures (2 L), and lysed by grinding with a mortar in pestle in the presence of liquid 
nitrogen. Lysates were thawed in buffer A (50 mM Tris pH 7.5,  150 mM NaCl, 10% 
glycerol, 5 mM MgCl2, 5 mM ATP), bound to anti-Flag resin (Sigma), washed three 
times with buffer A supplemented with 0.2% Triton X-100, then washed two times with 
buffer B (25 mM Tris pH 7.5, 10 mM MgCl2, 2 mM ATP) prior to elution with Flag 
Peptide (Sigma).  
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Turnover of CPY*HA and GST-Ufo1  
For CPY*HA turnover, pCPY*HA/URA3-containing yeast strains were grown to an 
OD600 ~ 0.5, shifted to 37°C for one hour, and then treated with 100 µg/ml 
cycloheximide, at which point a chase was initiated. Turnover of galactose-inducible 
Ufo1 was carried out as described (Ivantsiv et al., 2006). Briefly, cells containing pEGH-
Ufo1 (Open Biosystems) were grown overnight in SRaffinose-URA medium and diluted 
the next day to an OD600 0.2. At an OD600 ~ 1, 2% galactose was added. Induction was for 
14 hours. Cells were filtered and washed in YP and then resuspended in YP containing 
2% dextrose. Samples were taken at intervals post dextrose addition, centrifuged, and 
flash frozen. Protein was extracted using boiling SDS-PAGE sample buffer, resolved by 
SDS-PAGE, transferred to nitrocellulose and immunoblotted. Blots were quantified by 
LI-COR Odyssey with IR dye-linked secondary antibodies (Invitrogen).  
 
Growth assays 
For plating assays strains were grown overnight in YPD or SRaffinose-URA and diluted 
to an OD600 of 0.3 in water.  Serial five-fold dilutions were prepared in water and spotted 
onto either YPD or minimal plates supplemented with various additives as described in 
the text.  Plates were incubated at 30°C for 2–3 days. 
 
SILAC analysis of purified proteasomes  
RPN11FLAG yeast strains auxotrophic for lysine and arginine, were grown in either CSM 
with 2% dextrose containing 20 mg/L lysine and arginine or in “heavy” medium with 20 
mg/L 13C615N2-lysine and 13C6-arginine. Cells were grown to an OD600 of 2, harvested, and 
flash frozen before grinding in liquid nitrogen. Equivalent amounts of heavy and light 
cells were mixed 1:1 before proceeding with a proteasome affinity purification. 
Proteasomes were eluted in 8 M urea.  After purification, Lys-C (Wako Chemicals) was 
added for a 4-hour digestion, followed by an overnight tryptic digestion in 2 M urea. The 
tryptic peptides were desalted on a C18 macrotrap (Michrom Bioresources) and 
concentrated in a speedvac.  Dried samples were resuspended and subject to StageTip- 
based strong anionic exchange (SAX) as previously described (Wis niewski et al., 2009). 
Samples were eluted, concentrated, and then acidified with 0.2% formic acid prior to 
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mass spectrometric analysis.  All mass spectrometry experiments were performed on an 
EASY-nLC (Thermo Scientific) connected to a hybrid LTQ-Orbitrap Classic  (Thermo 
Scientific) with a nanoelectrospray ion source (Thermo Scientific).   Peptides were 
resolved using a 240-minute gradient from 4% to 25% acetonitrile in 0.2% formic acid at 
a flow rate of 350 nl per minute. The mass spectrometer was operated in data-dependent 
mode to automatically switch between full-scan MS and tandem MS acquisition.  All 
settings were as previously described (Lee et al., 2010). Raw data files were analyzed by 
MaxQuant (v 1.0.13.13) (Cox and Mann, 2008) and searched against the Saccharomyces 
Genome Database. The search parameters included tryptic digestion, a maximum of two 
missed cleavages, fixed carboxyamidomethyl modifications of cysteine, variable 
oxidation modifications of methionine, variable protein N-terminus acetylations, and a 
variable Gly-Gly tag on lysine residues with a 1% FDR thresholds for both peptides and 
proteins.  At least two peptides were required for protein identification and at least two 
different scanning events were required for protein quantification. 
 
In vitro UBA–UBL proteasome binding assays  
GST proteins were purified using standard methods and dialyzed into 50 mM Tris pH 
7.5, 50 mM NaCl, 1 mM DTT, 10% glycerol. For co-immunoprecipitation experiments 
with UBA–UBL proteins and purified 26S proteasomes, 1 µM of GST or GST-fusion 
protein was mixed with 0.2 nM of 26S proteasome in the presence of IP buffer (50 mM 
Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM EDTA, 1mM DTT, 0.2% triton X-100, 10% 
glycerol, 10 mM MgCl2, and 5 mM ATP). The reaction was incubated with rotation for 1 
hour at 4˚C, after which point 30 µl of glutathione-sepharose beads were added to each 
reaction and reactions were incubated for another hour at 4˚C. Beads were washed with 1 
mL of IP buffer 3 times. Each sample was boiled in 2X SDS and loaded onto a 10% tris-
glycine gel. Gels were both commassie stained and immunoblotted.  
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Results 
 
Rpn1391-642 interacts with UBL domain proteins.  
To screen for mutations in Rpn1 that disrupt binding to UBA–UBL proteins, we 
engineered a reverse-yeast two-hybrid system that reports on association between a 
fragment of Rpn1 (amino acids 391–642), a fragment including regions previously shown 
to be necessary and sufficient for UBA–UBL binding, and four distinct UBL-containing 
proteins (Rad23, Dsk2, Ddi1, and the deubiquitinase Ubp6) known to interact with the 
proteasome (Elsasser et al., 2002; Leggett et al., 2002; Seeger et al., 2003; Stone et al., 
2004; Verma et al., 2000). Productive binding between Rpn1391-642 and UBL proteins was 
expected to drive expression of HIS3 and URA3, resulting in growth on 3-aminotriazole 
(3-AT) and inability to grow on 5-fluororotic acid (5FOA)(Figure 3.1A). Growth assays 
revealed that Rpn1391-642 was capable of binding to Rad23, Dsk2, Ddi1, and Ubp6 in yeast 
cells, whereas a Ddi1 fragment lacking its UBL domain, and Rpn2, a proteasomal 
subunit, were unable to bind Rpn1391-642 (Figure 3.1B).  
 
Identification of mutations in Rpn1391-642 that block binding to UBL domain 
proteins 
Using growth on 5FOA as a positive selection for loss of interaction between Rpn1391-642 
and UBL proteins, we screened a PCR-mutagenized allele library containing over 
500,000 individual clones coding for Rpn1391-642 and selected for mutants that could no 
longer interact with Rad23 (964 colonies were isolated) or Dsk2 (322 colonies). We 
screened these 1,286 transformants for their ability to reproduce their 5FOAR phenotype. 
One hundred and ninety colonies that again tested 5FOAR were sequenced. Forty-two of 
the sequenced 5FOAR clones contained a mutation; single amino acid substitutions were 
identified in thirty-two clones, while silent mutations (4), and truncation or frameshift 
events (6) made up the remainder. Plasmids containing single Rpn1 mutations were then 
retransformed and assayed for their ability to reproduce the 5FOAR phenotype. Twelve 
amino acid substitutions in 11 different residues of Rpn1 were identified as testing 
positive after being retransformed into our RY2H system (Figures 3.1C and 3.1D). Given 
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that a structural model of the LRR region of Rpn1 exists (Kajava, 2002), we also 
generated a panel of 6 ‘rational’ mutations that perturb residues predicted to be on the 
outside surface of the LRR domain (Figure 3.1D). The relative positions of the mutations 
discovered in the ‘reverse-yeast two-hybrid’ screen and the rational mutations are shown 
on the model structure of the Rpn1 LRR domain (Figure 3.1E).  
 
Mutant rpn1 alleles display synthetic growth defects in combination with 
ubiquitin receptor mutants. 
To evaluate whether any of the mutations in our panel of 18 substitutions had an effect on 
proteasome function, we reconstructed them into full-length RPN1 and performed a 
‘plasmid shuffle’ to replace the essential RPN1 gene with each of our mutant alleles. A 
yeast rpn1∆ strain sustained by wild-type RPN1 on a URA3 plasmid was individually 
transformed with a LEU2 plasmid bearing each mutant rpn1 allele and the cells were 
plated on 5FOA to identify clones from which the URA3 plasmid was evicted. We 
recovered 5FOA-resistant colonies from all transformants with the exception of rpn1F534S, 
indicating that 17 of our alleles retained at least partial RPN1 function. To evaluate the 
impact of our Rpn1 mutations on proteasome function, we plated cells on medium 
supplemented with the proline analog l-azetidine-2-carboxylic acid (AZC). Cells with 
defective proteasome function are sensitive to AZC (Fowden and Richmond, 1963; Saeki 
et al., 2009), presumably because its incorporation into proteins causes misfolding, 
thereby placing an elevated demand on cellular quality-control pathways. As shown in 
Figure 3.2A (and more RY2H-derived alleles are shown in Figure 3.S1A), none of our 
mutants was hyper-sensitive to AZC.  
Multiple receptors dock ubiquitinated substrates to the proteasome, including not 
only the UBL domain proteins but also Rpn10 and Rpn13 (Husnjak et al., 2008; Verma et 
al., 2004). Unlike the other subunits of the proteasome, Rpn10 and Rpn13 are not 
essential. Therefore, we sought to test whether mutations in these receptors might 
sensitize cells to our rpn1 alleles. Deletion of RPN13 by itself did not cause sensitivity to 
AZC (compare top rows of Figures 3.2A and 3.2B). However, a subset of our rpn1 
mutants (both rational and RY2H-derived) exhibited striking sensitivity to AZC when 
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combined with rpn13∆ (Figure 3.2B and Figure 3.S1B). To test whether this synthetic 
defect was due to the role of Rpn13 as an Ub receptor, the five rpn1 mutants showing the 
most striking phenotypes were introduced by plasmid shuffle into an rpn13-KKD strain 
that contains a triple-point mutation that inactivates the ubiquitin binding domain 
(Husnjak et al., 2008). Four of the five tested rpn1 alleles showed a similar synthetic 
growth defect in the rpn13-KKD mutant background (Figure 3.2C). These data indicate 
that our Rpn1 mutant proteins sensitized cells to loss of an intrinsic proteasome ubiquitin 
receptor. 
Given the synthetic effects seen with RPN13 alleles, we sought to test whether our 
rpn1 mutants exhibited genetic interaction with RPN10. Rpn10 contains two domains–a 
VWA domain that appears to play a structural role and an ubiquitin-binding UIM 
domain. We used plasmid shuffle to introduce rpn1 alleles into a mutant, rpn10-uim, in 
which the UIM domain is inactivated by a cluster of point mutations (Elsasser et al., 
2004; Fu et al., 1998). Whereas neither the individual rpn1 mutants (Figure 3.2A) nor 
rpn10-uim (Figure 3.2D) was hypersensitive to AZC, the double mutants exhibited 
striking sensitivity (Figure 3.2D).  Similarly, we also found that most of our rpn1 mutants 
in a rpn13-KKD rpn10-uim double mutant background were slightly more sensitive than 
the rpn13-KKD rpn10-uim strain (Figure 3.2E). 
As a test for specificity, we introduced the same set of rpn1 mutations into an 
rpn4∆ background. Rpn4 is a transcription factor that promotes proteasome gene 
expression, and rpn4∆ mutants have reduced proteasome levels and show synthetic 
phenotypes with a number of mutations that impinge on proteasome function (Ju et al., 
2004; Xie and Varshavsky, 2001). In contrast to the results seen with rpn13∆, rpn13-
KKD, and rpn10-uim, none of the five rpn1 mutants tested exhibited a synthetic AZC-
sensitive phenotype when combined with rpn4∆ (Figure 3.2F). Taken together, these data 
suggest that the rpn1 mutant alleles impinge specifically on compromised receptor 
function, and do not cause general proteasome impairment. 
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Recruitment of Ddi1, Dsk2, and ubiquitin conjugates to proteasomes is 
compromised in rpn1-D517A and rpn1-K484A mutants. 
We next aimed to determine if any of the rpn1 mutations that showed genetic interactions 
with rpn10-uim and rpn13-KKD led to defects in recruitment of UBL-containing proteins 
to the proteasome. To address this question, we first tagged RPN11 with sequences 
encoding the Flag epitope in a selection of rpn13∆ rpn1 mutants. We included rpn13∆ in 
this analysis due to potential redundancy between Rpn13 and Rpn1 for binding UBL 
domains. Proteasomes were immunoprecipitated from these strains and immunoblotted 
for the presence of UBL proteins. All double mutant proteasomes that were analyzed 
contained equivalent levels of associated Rad23, Dsk2, and Rpn10, except for rpn1-
D517A and rpn1-K484A, both of which exhibited reduced levels of bound Dsk2 (Figure 
3.3A). None of our rpn1 single mutants by themselves or in the rpn10-uim background 
showed reduced levels of Dsk2 (see, for example, the rpn1-D517A mutant in Figure 
3.S2A and 3.S2B; additional data not shown). To see if we could identify additional 
binding-defective rpn1 mutations, we generated an additional set of ‘rational’ rpn1 alleles 
and tested them by using plasmid shuffle to introduce the alleles into an RPN11FLAG 
rpn1∆ rpn13∆ background, followed by immunoprecipitation of the proteasomes and 
immunoblotting for UBL proteins. None of these mutants, which are listed in Table 3.S1, 
exhibited a greater UBL binding defect than the D517A or K484A alleles and so they 
were not pursued further.  
 Based on the proteasome association studies, we focused our attention on the 
K484A and D517A mutants. To evaluate the association of UBL proteins in greater 
depth, we retrieved proteasomes from both mutants (in an rpn13∆ background) and 
immunoblotted the immunoprecipitates to determine their content of Rad23, Dsk2, Ddi1, 
Ubp6, and total ubiquitin conjugates. The immunoblots are shown in the left panels of 
Figure 3.3B and densitometric quantification of the results is presented in the right panel. 
Proteasomes from both rpn1 rpn13∆ mutants contain normal or near-normal levels of the 
UBL proteins Ubp6 and Rad23. In this experiment the levels of Dsk2 were higher than 
those observed in Figure 3.3A, possibly because the immunoprecipitation was done under 
less stringent conditions. Interestingly, proteasomes recovered from rpn13∆ rpn1-D517A 
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cells contained reduced levels of Ddi1 and total ubiquitin conjugates compared to 
proteasomes retrieved from either wild-type or rpn13∆ rpn1-K484A cells.  Similar results 
were obtained with proteasomes from rpn1-D517A and rpn10-uim rpn1-D517A cells 
(Figure 3.S2A and 3.S2B). These results indicate that mutation of the D517 residue of 
Rpn1 by itself was sufficient to destabilize Ddi1 docking, and, in combination with loss 
of Rpn13, modestly destabilized Dsk2 binding.  
 We were intrigued by the mild defect in recruitment we observed for Dsk2 in 
rpn13∆rpn1-D517A proteasomes and questioned if proteasomes retrieved from strains 
containing mutations in both intrinsic Ub receptors and containing the rpn1-D517A 
mutation might yield a stronger defect in recruitment of Dsk2 since interaction of the 
UBL proteins has been observed with Rpn10 and Rpn13 (Matiuhin et al., 2008b; Zhang 
et al., 2009). We retrieved proteasomes from both a double rpn10-uim rpn13-KKD and a 
triple rpn10-uim rpn13-KKD rpn1-D517A mutant and immunoblotted the 
immunoprecipitates to determine their content of Dsk2 and Ddi1. As expected, the rpn10-
uim rpn13-KKD rpn1-D517A immunoprecipitated fewer Ub conjugates in comparison to 
an isogenic strain containing wild-type Rpn1 (Figure 3.S2C). Additionally, we quantified 
the change in the binding of Ddi1 and Dsk2 and again observed a defect in the 
recruitment of Ddi1 and Dsk2 in the presence of the Rpn1-D517A mutation (Figure 
3.S2C, right panel). This led us to investigate the effect of the Rpn1-D517A mutation in 
greater detail. 
 To determine whether Rpn1-D517A proteasomes were generally defective, we 
characterized them biochemically and found them to be completely normal by multiple 
methods. Purified Rpn1-D517A proteasomes exhibited a normal subunit composition 
when evaluated by SDS-PAGE (Figure 3.3C, left panel). Moreover, native nondenaturing 
gel electrophoresis verified that these proteasomes (Figure 3.3C, right panel) and those of 
all of the other strains indicated in Figure 3.1D (data not shown) were properly assembled 
and had normal chymotryptic activity. In fact, although we were manipulating the largest 
scaffolding subunit of the proteasome, only a small number of the mutations we studied 
had any negative consequences on proteasome stability (Figure 3.1D and 3.S3). To 
characterize in detail the impact of the Rpn1-D517A mutation on proteasome 
composition, we performed a quantitative mass spectrometry technique, SILAC (stable 
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isotope labeling with amino acid in cell culture). For this experiment, rpn13∆ cells were 
grown in medium supplemented with heavy isotopes of lysine and arginine while rpn13∆ 
rpn1-D517A cells were grown in medium with ‘light’ lysine and arginine. The two 
cultures were mixed immediately prior to lysis and proteasomes were purified by affinity 
chromatography on an anti-Flag resin. The purified sample was then analyzed by 
multidimensional mass spectrometry and the heavy/light ratios for peptides derived from 
proteasome subunits were determined (Figure 3.3D). This sensitive analysis confirmed 
that rpn1-D517A does not cause any apparent physical change in the proteasome.  
 While we did measure a slightly reduced level of Rad23 in rpn13∆ rpn1-D517A 
proteasomes by immunoblotting, our SILAC data indicated that the levels of Rad23 and 
Ubp6 were largely unaffected in rpn13∆ rpn1-D517A proteasomes, as they had heavy-to- 
light (H/L) ratios of 0.9 and 0.98, respectively. This is not unexpected, since it was 
reported in a prior SILAC study that the free and proteasome-bound pools of human 
Rad23 rapidly equilibrate in cell lysate (Wang and Huang, 2008). Unfortunately, Ddi1 
and Dsk2 peptides were not seen in our SILAC experiment. Capturing the association of 
all three UBA–UBL receptor proteins with proteasomes in native preparations is 
challenging, likely because these proteins interact very dynamically with the proteasome 
(Wang and Huang, 2008). For instance, the association of Dsk2 with the proteasome has 
been reported to be difficult to capture (Matiuhin et al., 2008a). Additionally, only one 
published mass spectrometry study has been able to simultaneously capture Rad23, Dsk2, 
and Ddi1 with the proteasome, and that study relied on chemical cross-linking to stabilize 
the association of dynamically-bound proteasome interactors (Guerrero et al., 2008). 
 
In vitro confirmation of a Ddi1 binding defect of Rpn13-deficient Rpn1-
D517A mutant proteasomes  
Due to the challenge in capturing all of the UBL-containing proteins at the proteasome in 
one experiment, we sought to perform an in vitro binding assay that would confirm our 
analysis of proteasomes purified from mutant cells. Proteasomes were affinity purified 
from cells expressing Flag-tagged Rpn11 and incubated with recombinant GST–UBA–
UBL proteins. Proteasomes affinity purified from rpn13∆ cells were successfully pulled-
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down by all three baits. However, Rpn13-deficient Rpn1-V447H K484A D517A (VKD) 
proteasomes exhibited strongly diminished binding capacity for Ddi1 (Figure 3.4). It 
should be noted that Rpn13-deficient Rpn1-V447H K484A D517A proteasome mutants 
behaved just as  Rpn13-deficient Rpn1-D517A mutant proteasomes in native 
immunoprecipitation experiments (Table 3.S1 and data not shown). However, it was 
surprising that we did not see a loss of Dsk2 interaction with proteasomes isolated from 
an rpn13∆rpn1-VKD strain as we did in our native immunoprecipitations (Table 3.S1). 
Our native immunoprecipiation experiments may be more demanding than our in vitro 
binding assay. For instance, the binding of mutant rpn1 proteasomes to Dsk2 may have 
been driven by the high level of bait used in this experiment.  
 
rpn1-D517A mutants exhibit a selective defect in protein degradation. 
It is thought that UBA–UBL proteins exhibit some degree of selectivity in targeting 
specific substrates to the proteasome (Verma et al., 2004). We hypothesized that the 
decrease of Ddi1 binding to proteasomes in an rpn1-D517A mutant might therefore result 
in turnover defects of substrates that are particularly reliant on Ddi1.  In agreement with 
the normal binding of Rad23 and Dsk2 to the proteasome in an rpn1-D517A single 
mutant, no defect was seen in turnover of the Rad23/Dsk2-dependent substrate, CPY* 
(Figure 3.5A, and a replicate experiment is shown in Figure 3.S4B) (Medicherla et al., 
2004), nor the Dsk2 substrate Kre22 (Figure 3.S4A) (Chang et al.). However, when we 
tested the Ddi1-dependent substrate, Ufo1 (Ivantsiv et al., 2006), we saw nearly complete 
stabilization in comparison to a wild-type strain (Figure 3.5B).  Note that the steady-state 
levels here for the rpn1-D517A are higher than for the ddi1∆ mutant. In two of three 
replicate experiments, this higher level of expression was seen. We do not know if there 
is any physiological relevance to the higher level of expression or if this is simply due to 
the stochastic expression due to using plasmids for expression. A replicate of this 
experiment is also shown (Figure 3.S4C). In agreement with the turnover data, we 
observed that over-expression of Ufo1 was toxic to ddi1∆ and rpn1-D517A cells but not 
to wild-type cells (Figure 5C).  This effect was exquisitely specific—neither rpn13∆ 
(Figure 3.5C) nor any other mutation in rpn1 that we tested (Figure 3.5D) conferred 
sensitivity to over-expression of Ufo1.  
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Discussion  
 
 Of the three UBA–UBL shuttle receptors linked to the proteasome, Ddi1 is the 
least studied and perhaps the most controversial.  Prior data have established that Ddi1 
binds polyubiquitin, albeit with lower affinity than Rad23 and Dsk2 (Bertolaet et al., 
2001b; Fu et al., 2010; Kang et al., 2006; Saeki et al., 2002a). However, while some 
studies report a physical interaction of Ddi1 with Rpn1 or the intact proteasome (Kaplun 
et al., 2005; Saeki et al., 2002a), there are a few reports that question the capacity for 
Ddi1 to bind the proteasome or Rpn1 (Chandra et al., 2010; Fu et al., 2010; Kim et al., 
2004). The disparity in these reports may be due to the qualitative nature of 
immunoprecipitation experiments and the rapid dynamics of UBL binding to and 
dissociation from the proteasome (Wang and Huang, 2008).  Ddi1 has the most divergent 
UBL domain among the known UBA–UBL proteins, and hence, may have the weakest 
affinity interaction with the proteasome (Kim et al., 2004). We have shown that Ddi1 is 
recovered with proteasomes immunoprecipitated from yeast cells, binds Rpn1 in a yeast 
two-hybrid assay, and binds to the proteasome in an in vitro pull-down assay. We have 
further validated these results by identifying an Rpn1 mutation that is selectively 
defective in binding Ddi1 and stabilizes the Ddi1-dependent proteasome substrate Ufo1.  
Hence, we conclude that Ddi1 does indeed interact with the proteasome in a specific and 
functionally-relevant manner. If Ddi1 binds the proteasome more weakly than other 
UBA–UBL proteins, which seems likely, it would explain why the D517A and K484A 
mutations reported here selectively disrupt interaction of Ddi1 with the proteasome.  
 Our study highlights the layered complexity of the interaction of shuttle proteins 
with the proteasome. With a single alanine substitution in the highly conserved D517 
residue of Rpn1 we were able to significantly reduce the binding of Ddi1 to the 
proteasome. However, the interaction of other UBA–UBL proteins with the proteasome 
appears to be more complex. Recovery of Dsk2 with proteasomes was only mildly 
diminished in an rpn1-D517A mutant that also lacked RPN13 or the ubiquitin interaction 
motifs of both RPN10 and RPN13. Meanwhile, recovery of Rad23 was not affected 
appreciably by any mutation in Rpn1 analyzed during the course of this work. There are
 63 
two possible explanations of these results. On the one hand, it is possible that the UBL 
domains of these proteins have a gradient of affinity for Rpn1, with Ddi1 being the 
weakest binder and Rad23 the strongest. In this scenario, Rpn1-D517A may be a 
hypomorph that only modestly perturbs the UBL docking site, such that only the weakest 
binder (Ddi1) is excluded. We attempted to test this hypothesis by making numerous 
combinatorial mutations, (including a V447H K484A D517A triple mutant), none of 
which exhibited a substantially greater UBL binding defect than the D517A or K484A 
alleles (Supplemental Table 3.1). Thus, we do not favor the hypothesis that it is possible 
to disrupt recruitment of Rad23 and Dsk2 by mutating a single binding patch on Rpn1.  
On the other hand, our model for UBL docking to the proteasome suggests that it 
is possible that Ddi1 uses only a single mechanism to bind the proteasome (direct binding 
to the LRR1 domain of Rpn1), whereas, in line with published reports (Matiuhin et al., 
2008b; Zhang et al., 2009), Rad23 and Dsk2 may use multiple mechanisms and thus are 
more resistant to mutation. Additionally, it does not appear that the the K484 or D517 
residues of Rpn1 have any bearing on Rad23 nor Ubp6 association with the proteasome; 
the binding mode for these UBL proteins may be completely distinct (Figure 3.6). Our 
observation that reduction of Dsk2 binding was only seen in an rpn1-D517A rpn13∆ 
double mutant and more strikingly in a rpn1-D517A rpn13∆ rpn10-uim supports the idea 
that Dsk2 may be tethered to the proteasome by either Rpn1, Rpn13, or Rpn10 (Figure 
3.6). The failure to see a significant reduction in binding of Rad23 in any single or double 
mutant may be due to there being multiple independent docking sites for Rad23 on the 
proteasome, although it should be noted that all of these docking sites appear to rely on 
the UBL domain (Fatimababy et al., 2010; Kaplun et al., 2005; Verma et al., 2004; 
Wilkinson et al., 2001). Other studies have shown that Ubp6 may bind proteasome lid 
proteins while Rad23 may also bind Rpt6 (Fatimababy et al., 2010; Leggett et al., 2002), 
and that even Ub chains bound to Rad23 may contribute to its proteasome binding 
(Ghaboosi and Deshaies, 2007). Biochemical data suggest that human Rad23 is recruited 
to the proteasome by the UIM domain of Rpn10 (Hiyama et al., 1999; Walters et al., 
2002), and that even yeast Rad23 can bind Rpn10 (Zhang et al., 2009), but it should be 
noted that this hypothesis had not been tested by genetic manipulation of Rpn10 in cells.  
Thus, the data we present here is the strongest evidence indicating that the intrinsic 
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receptors play a role in recruitment of Rad23 and Dsk2 to the proteasome. Clearly, more 
work is needed to unravel the mechanisms underlying recruitment of Rad23 and Dsk2 
and the deubiquitinase, Ubp6, to the proteasome. 
  
 
Conclusions  
 
The current study identifies residues in the LRR1 domain of Rpn1 that contribute to 
shuttle receptor docking. We validate Ddi1 as a proteasomal shuttle receptor whose stable 
binding to the proteasome depends on Rpn1 residue D517. Consistent with this, D517 is 
also important for the degradation of a Ddi1-dependent substrate.  We also show that in 
the absence of Rpn13, or the dual absence of the ubiquitin binding domains of Rpn13 and 
Rpn10, mutation at the D517 and K484 residues reduces the association of Dsk2 with the 
proteasome. 
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Figure legends 
 
Figure 3.1. A two-pronged strategy identifies 18 Rpn1 residues that may be 
important for binding UBL domain proteins.  
(A) The utilized yeast two hybrid system allows for both positive (growth on -HIS,          
-URA, +3-AT) and negative counter selection (growth on 5FOA) of UBL– Rpn1391-642 
interaction. (B) Rpn1391-642 was sufficient for binding UBA–UBL proteins in a yeast two-
hybrid system. Yeast cells were co-transformed with plasmids expressing Gal4-DBD 
fused to Rpn1391-642 (Rpn1391-642DB) and Gal4-AD fused to either Rad23, Dsk2, Ddi1, 
Upb6, Ddi1∆UBL, or Rpn2.  Protein-protein interaction is indicated by growth on 100 
mM 3-AT and lack of growth on 0.2% 5FOA. (C) Representative rpn1 alleles found in 
the RY2H screen did not interact with Rad23 in the context of an Y2H experiment. (D) 
Sequence and secondary structure prediction alignments of yeast Rpn1 with mouse Rpn1 
were made with MultiAlin (http://multalin.toulouse.inra.fr/multalin/multalin.html) using 
the model structure of Rpn1 (Kajava, 2002). Identical residues (black) and similar 
residues (gray) are indicated. Mutations identified in the RY2H that disrupt the 
interaction of Rpn1391-642 with Rad23 and Dsk2 are indicated in red and rationally 
designed mutations are indicated in blue. Mutant rpn1 alleles were plasmid shuffled into 
an rpn1∆ yeast strain and assayed for viability and proper 26S assembly. The positions of 
the identified mutations are indicated in the figure. A (-) indicates that assembly and 
viability were like wild type, a (+) indicates that we observed defects in proteasome 
stability (Figure 3.S3), and (nd) indicates the strain was inviable. (E) The relative position 
of residues of interest from the RY2H screen and the rational sites chosen in (D) are 
shown on a model structure of Rpn1. Residue A418 is not included in the model. The 
colors represent the residues indicated in the key.  
 
Figure 3.2. Mutant rpn1 alleles display genetic interactions with mutations 
in genes that encode ubiquitin receptors intrinsic to the proteasome. 
Five-fold serial dilutions of cells were plated onto the indicated media. The rpn1 mutants 
(rpn1*) were plasmid shuffled into an rpn1∆ strain containing (from top to bottom) either 
no additional mutations or rpn13∆ (B), rpn13-KKD (C), rpn10-uim (D), rpn13-KKD 
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rpn10-uim (E), or rpn4∆ (F). AZC refers to 5 mM of the proline analog l-azetidine-2-
carboxylic acid (AZC). 
 
Figure 3.3. Recruitment of Ddi1, Dsk2, and Ub conjugates to the proteasome 
is compromised in rpn1-D517A and rpn1-K484A mutants. 
(A) Affinity-purified rpn13∆ rpn1-K484A and rpn13∆ rpn1-D517A proteasomes contain 
reduced levels of Dsk2.  Detergent was present during the binding step of the 
immunoprecipiation as described in the Methods section. (B) Affinity-purified rpn13∆ 
rpn1-D517A proteasomes contain reduced levels of Ddi1 and Ub conjugates. Levels of 
UBA–UBL proteins, the lid subunit Rpn12, and polyubiquitin are shown for affinity 
purified proteasomes (IP) and in the whole cell extract input (WCE). The purification 
shown here was performed in the absence of detergent. Densitometric quantification of 
the blot is shown (right panel). The amount of UBL protein was normalized to Rpn11FLAG 
and wild-type levels were set at 100%.  (C) Proteasomes isolated from rpn1-D517A are 
intact. SDS-PAGE and native gel analysis of affinity purified 26S proteasomes from 
Rpn11-Flag tagged strains. The native gel was incubated with Suc-LLVY-AMC in the 
presence of ATP and 0.05% SDS to visualize RP and CP activity. The isoforms of the 
26S proteasome are indicated. (D) Quantitative SILAC isotopic ratios are shown for all 
subunits of the proteasome isolated from an rpn13∆ strain (labeled with heavy isotopes; 
“H”) in comparison to proteasomes isolated from an rpn13∆ rpn1-D517A strain (labeled 
with light isotopes; “L”).  
 
Figure 3.4. Rpn1-D517A reduces binding of Ddi1 in vitro. 
GST-fused Rad23, Dsk2, Ddi1, and GST alone (as a negative control) were incubated 
with either proteasomes affinity purified from rpn13∆ or rpn13∆ rpn1-V447H K484A 
D517A (VKD) cells. The binding reactions were immobilized on glutathione resin, which 
was then washed and extracted with SDS-PAGE sample buffer.  An Rpt5 immunoblot 
(upper panel) and a commassie stain to confirm equivalent recovery of the GST fusion 
proteins (middle panel) is shown. Inputs were immunoblotted with anti-Rpt5 and are also 
shown (lower panel).   
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Figure 3.5.  rpn1-D517A mutants exhibit a selective defect in protein 
degradation.  
(A) Mutant rpn1-D517A cells degrade the Ufd1/Rad23/Dsk2 substrate CPY* with normal 
kinetics in a cycloheximide chase. Equal loading of extracts was confirmed by blotting 
with an anti-tubulin antibody (lower panel). The quantification of these blots is shown. 
(B) Ufo1 is stabilized in rpn1-D517A and ddi1∆ mutants. Wild-type and mutant cells 
carrying a plasmid that expressed GST-Ufo1 from the GAL1 promoter were grown in 
raffinose medium and then induced with 2% galactose for 14 h. Dextrose was added at T0 
to extinguish expression and samples were taken at the indicated time points. 
Quantification is shown. (C) rpn1-D517A and ddi1∆  do not tolerate over expression of 
Ufo1. The indicated strains containing a plasmid that expresses GST-Ufo1 under the 
control of a galactose-inducible promoter were grown on medium containing either 
glucose (SD, expression OFF) or galactose (SGalactose, expression ON). After 2–3 days, 
the plates were scored for growth. (D) Sensitivity of rpn1-D517A to GST-Ufo1 over-
expression is specific and was not shown by other rpn1 alleles.  
 
Figure 3.6. Model for UBL protein interfacing with the proteasome 
Ddi1 shows a large dependence on the D517 residue of Rpn1 for binding with the 
proteasome. Additionally, deleting the intrinsic receptor Rpn13, or jointly the ubiquitin 
binding domains of Rpn13 and Rpn10, results in decreased binding of Dsk2 to the 
proteasome and reveals a role for the Rpn1-K484 residue in binding UBL proteins. 
However, Rad23 and the deubiquitinase Ubp6 did not show a dependence on residues 
D517 nor K484 of Rpn1. It is possible that Rad23 and Ubp6 interaction with the 
proteasome is stabilized by their interactions with other proteasomal subunits and/or 
other unidentified residues on Rpn1. 
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Figure 3.1. A two-pronged strategy identifies 18 Rpn1 residues that may be 
important for binding UBL domain proteins.  
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Figure 3.2. Mutant rpn1 alleles display genetic interactions with mutations 
in genes that encode ubiquitin receptors intrinsic to the proteasome. 
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Figure 3.3. Recruitment of Ddi1, Dsk2, and Ub conjugates to the 
proteasome is compromised in rpn1-D517A and rpn1-K484A mutants. 
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Figure 3.4. Rpn1-D517A reduces binding of Ddi1 in vitro. 
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Figure 3.5.  rpn1-D517A mutants exhibit a selective defect in protein 
degradation.  
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Figure 3.6. Model for UBL protein interfacing with the proteasome 
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Supplementary data  
 
 
Supplemental Table 3.1.  Additional rational Rpn1 mutants used in this 
study 
 
 
Supplemental Table 3.2.  S. cerevisiae strains used in this Study  
 
 
Supplemental Table 3.3. Plasmids used in this study  
 
 
Supplemental Table 3.4. Antibodies used in this study  
 
 
Supplemental figure legends 
 
Figure S1. Mutant rpn1 alleles derived from both the RY2H screen and 
rational mutations display genetic interactions with mutations in genes that 
encode ubiquitin receptors intrinsic to the proteasome. 
Five-fold serial dilutions of cells were plated onto the indicated media. The rpn1 mutants 
(rpn1*) were plasmid shuffled into an rpn1∆ strain containing either no additional 
mutations (A) or rpn13∆ (B). AZC refers to 5 mM of the proline analog l-azetidine-2-
carboxylic acid (AZC). In panel B, mutations derived from the RY2H screen are 
indicated with a red box. 
 
Figure S2. rpn1-D517A , rpn10-uim rpn1-D571A, and  rpn10-uim rpn13-KKD 
rpn1-D571A limit binding of UBA-UBL proteins Ddi1 and Dsk2.   
(A) Affinity-purified rpn1-D517A proteasomes contain reduced levels of Ddi1 and Ub 
conjugates. Levels of UBA–UBL proteins, the lid subunit Rpn12 and polyubiquitin are 
shown for affinity-purified proteasomes (IP) and in the whole cell extract input (WCE). 
(B) Affinity-purified rpn10-uim rpn1-D517A proteasomes similarly show diminished 
Ddi1 and Ub conjugates. (C) Affinity-purified rpn10-uim rpn13-KKD rpn1-D517A 
proteasomes contain reduced levels of Ddi1, Dsk2, and Ub conjugates in comparison to 
proteasomes from a rpn10-uim rpn13-KKD strain. Densitometric quantification of this 
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blot is shown on the right. The amounts of UBL proteins were normalized to Rpn11FLAG 
and wild-type levels were set at 100%. 
 
 
Figure S3. Mutations at Rpn1 residues A418, N549, F565, and G571 render 
unstable proteasomes.   
Pre1-myc13 tagged proteasomes from strains carrying plasmid-borne Rpn1 alleles in an 
RPN1 null strain, were immunoprecipitated from whole cell extracts and analyzed by 
immunoblotting with the indicated antibodies. As shown, proteasomes with mutations at 
residues A418, N549, F565, and G571 exhibit dissociation of the 19S cap with the 
proteasomal base during immunoprecipitation experiments.  
 
 
Figure S4. rpn1-D517A mutants exhibit a selective defect in protein 
degradation.  
(A) Mutant rpn1-D517A cells degrade the Dsk2 substrate galactose inducible GST-Kre22 
with normal kinetics. Strains carrying a plasmid that expressed GST-Kre22 from the 
GAL1 promoter were grown in raffinose medium and then induced with 2% galactose for 
3 h. Dextrose was added at time zero to extinguish expression and samples were taken at 
the indicated time points.  Below, cells were plated in a five-fold serial dilution onto 
either glucose or galactose containing media and monitored for growth after 2–3 days at 
30°C. (B) Replicate of experiment seen in Figure 3.5A. Mutant rpn1-D517A cells 
degrade the Ufd1/Rad23/Dsk2 substrate CPY* with normal kinetics in a cycloheximide 
chase. Equal loading of extracts was confirmed by blotting with an anti-tubulin antibody 
(lower panel). The quantification of these blots is shown. (C) Replicate of experiment 
seen in Figure 3.5B. Ufo1 is stabilized in rpn1-D517A and ddi1∆ mutants. Wild-type and 
mutant cells carrying a plasmid that expressed GST-Ufo1 from the GAL1 promoter were 
grown in raffinose medium and then induced with 2% galactose for 14 h. Dextrose was 
added at T0 to extinguish expression and samples were taken at the indicated time points. 
Quantification is shown. 
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Supplemental Table 3.1.  Additional rational Rpn1 mutants used in this 
study 
 
 
 
Rpn1 Residue Mutation(s) 1 
Binds 
Ubp6 
Binds 
Rad23 
Binds 
Dsk2 
Binds 
Ddi1 
D482K  nd2 + + nd 
T483R nd + + nd 
D482K T483R K484A (KRA) nd + + nd 
T516R nd + + nd 
D517R nd + + nd 
L518A nd + + nd 
T516R D517R L518A (RRA) nd + +  
I520E nd + + nd 
E521K nd + + nd 
T516R D517R L518A I520E 
E521K (RRAEK) 
nd + + nd 
S500A T537A N539D (STN)  +3 + + + 
D503G T537A N539D (DTN) + + + + 
V447H D517A (VD) + + +  -4 
V447H K484A D517A  (VKD) + + + - 
 
1All listed Rpn1 mutant strains were tested for UBL binding competence in an rpn13∆ 
background.  
2 “nd” indicates that no data was collected. 
3 “+” indicates that binding was observed. 
4 “-” indicates that no binding was observed.  
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Supplemental Table 3.2.  S. cerevisiae strains used in this study 
 
RJD # Genotype Source 
4130 
MATa, leu2-3,112, trp1-901, his3D200, ade2-101, gal4D, gal80D, 
SPAL10::URA3, GAL1::lacZ, HIS3UAS GAL1::HIS3@LYS2, can1R, cyh2R 
(MaV203) Vidal Lab 
4189 
Mata can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS316-Rpn1-URA]  this study 
4626 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6  [pRS315-
Rpn1-LEU]  this study 
4628 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-V447H-LEU]  this study 
4748 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-E466A-LEU]  this study 
4749 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N480A-LEU]  this study 
4750 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-K484A-LEU]  this study 
4751 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-S500A-LEU]  this study 
4629 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-D503G-LEU]  this study 
4752 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-D517A-LEU]  this study 
4633 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N539D-LEU]  this study 
4824 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS316-Rpn1-URA] rpn13::TRP1  this study 
5462 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-LEU] rpn13::TRP1  this study 
5463 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-K484A-LEU] rpn13::TRP1  this study 
5464 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-S500A-LEU] rpn13::TRP1  this study 
5465 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-D517A-LEU] rpn13::TRP1 this study 
5466 
MATa can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-N539D-LEU] rpn13::TRP1 this study 
4920 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-LEU] rpn13KKD::NatMX this study 
4921 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-N480A-LEU] rpn13KKD::NatMX this study 
4922 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-K484A-LEU] rpn13KKD::NatMX this study 
4923 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-S500A-LEU] rpn13KKD::NatMX this study 
4924 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-D517A-LEU] rpn13KKD::NatMX this study 
4925 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-N539D-LEU] rpn13KKD::NatMX this study 
4926 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N480A-LEU] rpn10-UIM::KanMX this study 
4927 MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315- this study 
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Rpn1-K484A-LEU] rpn10-UIM::KanMX 
4928 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-S500A-LEU] rpn10-UIM::KanMX this study 
4929 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-D517A-LEU] rpn10-UIM::KanMX this study 
4930 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
4931 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N480A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
4932 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-K484A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
4933 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-S500A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
4934 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-D517A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
4935 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-N539D-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX this study 
5106 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-LEU] rpn4::TRP1 this study 
5107 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-N480A-LEU] rpn4::TRP1 this study 
5108 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-K484A-LEU] rpn4::TRP1 this study 
5109 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-S500A-LEU] rpnΔ::TRP1 this study 
5110 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6[pRS315-
Rpn1-D517A-LEU] rpn4::TRP1 this study 
5111 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N539D-LEU] rpn4::TRP1 this study 
5459 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS316-
Rpn1-URA] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-
FLAG-HphMX  this study 
5460 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-K484A-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX  this study 
5461 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-D517A-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX  this study 
5558 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-A418V-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX 
this study 
5559 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-V447H-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX 
this study 
5560 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-E466A-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX 
this study 
5561 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-N480A-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX 
this study 
5562 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-
Rpn1-S500A-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 
rpn11::RPN11-FLAG-HphMX 
this study 
5563 MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 this study 
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[pRS315-Rpn1-V447H K484A D517A -LEU] rpn13::TRP1 
arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-FLAG-HphMX 
4797 MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ddi1::KANMX 
Open 
Biosystems 
5289 
MATA leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, -LEU] rpn10-
UIM::KanMX pre1::PRE1-FLAG-6XHIS-URA3 this study 
5290 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1 D517A-LEU rpn10-UIM::KanMX pre1::PRE1-FLAG-
6XHIS-URA3 this study 
5457 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1 -LEU] rpn13KKD::NatMX rpn10-UIM::KanMX pre1::PRE1-
FLAG-6XHIS-URA3 this study 
5458 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1 D517A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX 
pre1::PRE1-FLAG-6XHIS-URA3 this study 
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Supplemental Table 3.3. Plasmids used in this study  
 
Plasmid Description Source 
RDB834 pGEX 4T-3 RJD Lab 
RDB1647 pGEX6P1-Rad23 H. Yokosawa 
RDB1672 pGEX-KG-Dsk2 M. Funakoshi 
RDB2448 pET42a-Ddi1 H. Fu 
RDB2170 pEXP22(AD)-Rad23 this study 
RDB2173 pEXP22(AD)-Dsk2 this study 
RDB2488 pEXP22(AD)-Ddi1 this study 
RDB2490 pEXP22(AD)-Ddi1Ddi1ΔUBL (aa 78-428) this study 
RDB2179 pEXP22(AD)-Ubp6 this study 
RDB2662 pEXP22(AD)-Rpn2 this study 
RDB2115 pEXP32(DB)-Rpn1391-642 this study 
RDB2090 pRS316-Rpn1 this study 
RDB2089 pRS315-Rpn1 this study 
RDB2273 pRS315-Rpn1-V447H this study 
RDB2296 pRS315-Rpn1-E466A this study 
RDB2297 pRS315-Rpn1-N480A this study 
RDB2298 pRS315-Rpn1-K484A this study 
RDB2299 pRS315-Rpn1-S500A this study 
RDB2262 pRS315-Rpn1-D503G this study 
RDB2300 pRS315-Rpn1-D517A this study 
RDB2264 pRS315-Rpn1-N539D this study 
RDB2349 pRS315-Rpn1-S500A T537A N539D this study 
RDB2353 pRS315-Rpn1-D503G T537A N539D this study 
RDB2350 pRS315-Rpn1-V447H D517A this study 
RDB2354 pRS315-Rpn1-V447H K484A D517A this study 
RDB2407 pEGH-GAL-GST-Ufo1 OpenBiosystems 
RDB2409 pEGH Brenda Andrews 
RDB1752 pCPY*HA/URA3 R. Hampton 
RDB2408 pEGH-GAL-GST-Kre22 OpenBiosystems 
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Supplemental Table 3.4. Antibodies used in this study  
 
Antibody  Source  
Rad23 
Kiran Madura, Robert Wood 
Johnson Medical School rabbit 
Rad23 Santa Cruz (yG-20; sc-15556) goat 
Dsk2 
Michael Glickman, Technion, 
Haifa, Israel chicken 
Dsk2 Abcam No.ab4119 rabbit 
Ddi1 
Jeffrey Gerst, Weizmann 
Institute rabbit 
Rpt5 Biomol No. PW8245 rabbit 
Rpn3 
Keiji Tanaka, Tokyo 
Metropolitan Inst. of Med. Sci. rabbit 
Rpn12 Daniel Finley, Harvard rabbit 
myc Covance mouse 
flag Sigma mouse 
UB Chemicon mouse 
UB Enzo rabbit 
Ubp6 Rohan Baker rabbit 
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Figure 3.S1. Mutant rpn1 alleles derived from both the RY2H screen and 
rational mutations display genetic interactions with mutations in genes 
that encode ubiquitin receptors intrinsic to the proteasome. 
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Figure 3.S2. rpn1-D517A , rpn10-uim rpn1-D571A, and  rpn10-uim rpn13-
KKD rpn1-D571A limit binding of UBA-UBL proteins Ddi1 and Dsk2.   
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Figure 3.S3. Mutations at Rpn1 residues A418, N549, F565, and G571 
render unstable proteasomes.   
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Figure 3.S4. rpn1-D517A mutants exhibit a selective defect in protein 
degradation.  
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Chapter 4: 
 
Comparative analysis of 
proteasome cis mutants to 
UBA-UBL null strains 
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Introduction 
 
 
 Rpn1 is the largest subunit of the proteasome and shares ~ 30% identity with 
Rpn2, the second largest subunit of the proteasome (Fôrster et al., 2010). Both proteins 
have two contiguous segments of nearly 250 repetitive residues that are classified as 
proteasome cyclosome (PC) repeats/leucine-rich repeats (LRR) (Lupas et al., 1997).  
LRR repeats are well conserved throughout the eukaryotes and participate in protein-
protein interactions (Kobe and Kajava, 2001). These LRR repeats of Rpn1 and Rpn2 
have been proposed to fold into repetitive α-solenoid structures that curve into a nearly 
closed horseshoe shape (Kajava, 2002).  Newer data suggest that Rpn1 and Rpn2 may 
actually form slightly opened horseshoes instead (Effantin et al., 2009).  
 It had been proposed that the horseshoe-shaped Rpn1 and Rpn2 proteins are 
stacked on top of each other, forming a pre-chamber preceding entry into the core of the 
proteasome (Effantin et al., 2009; Kajava, 2002; Rosenzweig et al., 2008). However, 
recent experimental evidence uncovering the mechanisms of proteasome biogenesis and 
electron microscopy work are not in agreement with this possibility (Fôrster et al., 2010; 
Nickell et al., 2009a; Tomko Jr et al., 2010) 
 Rpn1 has been proposed to play a scaffolding role in the proteasome. Its 
scaffolding functions include binding proteasome interacting proteins (PIPs) (Crosas et 
al., 2006; Elsasser et al., 2004), and serving as a structural support “beam” for supporting 
the formation of the proteasome base during biogenesis (Kaneko et al., 2009; Saeki et al., 
2009).  
 89 
 In line with the proposed roles Rpn1 plays in the proteasome and the 
aforementioned structural evidence, it seems reasonable that one surface of the horeshoe 
may interact with the Rpt ring of the proteasome, while the other may be exposed for 
binding to PIPs.  In this section I began querying this possibility by making a series of 
combinatorial mutations in two distinct surfaces of Rpn1 to test if they have differential 
effects on interaction with UBA-UBL proteins and on turnover of a Ddi1 substrate, Ufo1.  
 I was also interested in knowing if combinatorial mutations on one surface of 
Rpn1 could exacerbate the phenotypes observed in Chapter 3 of the rpn1-D517A mutant.  
 Here I show evidence that one surface of Rpn1 may be important for binding 
UBL-containing proteins. Although, in comparing the data presented here to that in 
Chapter 3, combinatorial mutants may only slightly exacerbate mutant phenotypes. For 
instance, an rpn1-V447H K484A mutant is sensitive to over expression of Ufo1, whereas 
as single mutants, they are not (Chapter 3).  
 With the overwhelming evidence that the rpn1-D517A mutation, and closely 
clustered mutations, contributed to binding of Ddi1 at the proteasome, the next question 
was: Is elimination of the rpn1-D517A site equivalent to the elimination of the UBA-
UBL receptor, Ddi1, itself?  
 I report that the reduction of binding of Ddi1 to a cis proteasome mutant produces 
a cellular physiology distinct from a ddi1∆ null strain.  
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Methods 
 
 
Native immunoprecipitations of 26S proteasomes, growth assays, turnover 
of galactose inducible Ufo1, and yeast strains 
All methods were done as described in detail in Chapter 3. Strains used in this chapter are 
listed, Table 4.1.  
 
HO steady-state concentration measurements 
The steady-state concentration of HO was measured as described (Kaplun et al., 2000). 
Briefly, strains containing pCM190-HO-LacZ were grown to saturation in the presence of 
2 mg/ml doxycycline to prevent HO expression. Next, strains were diluted to an OD600 
0.3 and grown in the absence of doxycycline and allowed to reach steady state. 
Approximately 1 mL of saturated culture was pelleted by centrifugation, washed in Z-
buffer (10 mM KCl, 1 mM MgSO4, 60 mM Na2HPO4, 40 mM NaH2PO4, pH 7), 
pelleted again, and resuspended in 300 µl of Z-buffer before being flash frozen in liquid 
nitrogen for ~ 20 seconds. Frozen samples were thawed in a 30°C water bath for 1 
minute, and then flash frozen and thawed for three subsequent cycles. Next, 160 µl of 4 
mg/ml ONPG (Sigma) dissolved in Z-buffer was added to the cell mixture and incubated in 
a 30°C water bath. Color change was monitored every 5–10 minutes. After a yellow color 
developed, 0.4 ml of 1 M Na2CO3 was added to quench the reaction. Approximately 2 µl 
of sample was used to measure the A420 using a nanodrop.  
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Results 
 
 
One surface of Rpn1 may be necessary for binding UBA-UBL proteins. 
Since Rpn1 is the largest subunit of the proteasome, I wanted to investigate if only a 
distinct surface is dedicated to binding UBA-UBL proteins and Ub conjugates. Based on 
the structural model of Rpn1 and its role as a scaffold in the proteasome (Elsasser et al., 
2004; Kajava, 2002; Nickell et al., 2009a), it seems plausible that one surface of Rpn1 
may be necessary for interacting with shuttle receptors bearing Ub conjugates, while the 
other surface might interact with other proteasome subunits. For instance, we noticed that 
mutations in residues A418, N539, F565, and G571 caused the lid and base of the 
proteasome to nearly completely dissociate during immunoprecipitation experiments 
(Chapter 3). To test this idea, we assayed the binding of clustered mutations (Figure 
4.1A) to ubiquitin conjugates and UBA-UBL proteins.  Ddi1 binding and ubiquitin 
conjugate accumulation was vastly diminished for the rpn13∆ rpn1-V447H K484A 
D517A mutant ('VKD') but not for a rpn13∆ rpn1-S500A T537A N539D (‘STN’) triple-
point mutant, although ubiquitin accumulation is equivalent in a whole cell extract 
(Figure 4.1A). This data is suggestive that the surface containing Rpn1 residues V447, 
K484, and D517 specifically binds UBL proteins, although caveats should also be 
considered. Given that Rpn1-D517A by itself has effects on Ddi1 and Ub-binding, it is 
possible that the phenotype of VKD mutant is due entirely to D517A and that the 
mutations at V447 and K484 are making no contribution.  Further, it is hard to 
understand the role of the STN mutant without any other mutant phenotypes known.  
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The rpn1-VKD mutant shows only slightly more dramatic synthetic lethality 
than rpn1-STN in combination with mutations of intrinsic ubiquitin 
receptors. 
To see if the roles of the ‘VKD’ surface could be distinguished genetically from the 
‘STN’ surface of Rpn1, I tested if either an rpn1-VKD or an rpn1-STN mutant would be 
particularly sensitive to mutations in intrinsic ubiquitin receptors, Rpn10 and Rpn13. On 
their own, rpn1-STN and rpn1-VKD were unaffected by the addition of exogenous AZC, 
a proline analog that induces protein misfolding. In the presence of the rpn13-KKD 
mutation, a mutation that blocks the ability of Rpn13 to bind ubiquitin (Husnjak et al., 
2008), both strains appear slightly sensitive, although rpn1-VKD shows a more dramatic 
sensitivity. I next tested whether these rpn1 mutants exhibited genetic interaction with 
RPN10. The ubiquitin-interaction motif (UIM) of Rpn10 is mutated in the rpn10-UIM 
strain. In the rpn10-UIM background, both rpn1 mutants showed a subtle increase in 
sensitivity to AZC. In an rpn10-UIM rpn13-KKD background, both rpn1 mutants were 
hypersensitive to AZC, however, the rpn1-VKD mutant exhibited the most striking 
sensitivity (Figure 4.1B). As a test for specificity, the rpn1-VKD and rpn1-STN mutations 
were also tested in an rpn4∆ background and appeared wild type (Figure 4.1B).  
 While it is hard to differentiate the cellular roles of the ‘VKD’ surface from the 
‘STN’ surface based on this sensitivity, two facts of notable importance are worth 
mentioning. First, known proteasome assembly mutants show sensitivity to AZC (Saeki 
et al., 2009), hence it is not inconceivable that ‘STN’ mutants may show defects in 
combination with these mutations for reasons other than directly affecting UBA-UBL 
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recruitment.  Secondly, the rpn1-VKD mutant did, in fact, show the most severe 
phenotypes in combinations with intrinsic receptors.  
 
Only Rpn1 ‘VKD’ surface mutations stabilize the Ddi1 substrate Ufo1.  
As seen, the rpn1-D517A mutation stabilizes Ufo1 (Chapter 3). I hypothesized that a 
mutant containing multiple mutations on the ‘VKD’ surface should similarly do so. First, 
I tested if over expression of Ufo1 causes lethality in any combination of ‘VKD’ or 
‘STN’ surface mutants. Only rpn1 mutants with combined mutations on the ‘VKD’ 
surface exhibited lethality when Ufo1 was over expressed. Notably, a mutant that did not 
contain the D517A mutation, the rpn1-V447H K484A, exhibited sensitivity to Ufo1 over-
expression. This effect was exquisitely specific–no ‘STN’ surface mutant conferred 
sensitivity to over-expression of Ufo1 (Figure 4.1C). Since only mutations on the ‘VKD’ 
surface reduced Ddi1 binding (Figure 4.1A) and were sensitive to over expression of 
Ufo1, I postulated that only ‘VKD’ surface mutants would stabilize Ufo1 in a turnover 
experiment. I observed nearly complete stabilization of Ufo1 in an rpn1-VD mutant in 
comparison to a wild-type strain and an rpn1-SN mutant (Figure 4.1D).  
 
Rpn1-D517A and Ddi1 interact genetically.  
My biochemical data suggest that the rpn1-D517A point mutation has a direct impact on 
Ddi1 binding, and this is supported by the Ufo1 degradation assay (Figure 4.1D and 
Chapter 3). Hence, we hypothesized that if we looked at AZC sensitivity of an rpn1-
D517A ddi1∆ double mutant, we would see no exacerbated effects in comparison to 
either single mutant. Contrary to our prediction, we noted that rpn1-D517A ddi1∆ double 
mutants displayed reduced viability compared to either single mutant (Figure 4.2A).  I 
 94 
also tested the sensitivity of an rpn1-D517A ddi1∆ rpn13∆ strain, but no exacerbated 
sensitivity was conferred by the loss of RPN13 (Figure 4.2A). These puzzling data may 
suggest at least one of two things. Firstly, the D517 residue of Rpn1 may do more than 
inhibit binding of Ddi1, for instance, it may reduce the binding of other UBA-UBL 
proteins. Although the reduction of Dsk2 binding was only detected in 
immunoprecipitation experiments, if there was a loss of ubiquitin binding by the intrinsic 
receptors (Chapter 3) it is still plausible that even a subtle inhibition of binding could 
have a physiological impact. Secondly, the rpn1-D517A may not completely block 
binding of Ddi1, otherwise, a ddi1∆ mutation would not aggravate the phenotype of 
rpn1-D517A. From densiometric quantification of Ddi1 on rpn1-D517A proteasomes, 
approximately 80% of Ddi1 binding appears to be lost (Chapter 3). However, maybe the 
20% of residual Ddi1 binding is just enough to yield a seemingly parallel genetic 
interaction between rpn1-D517A and ddi1∆.  
 
The rpn1-D517A does not mimic a ddi1∆ mutant in steady-state 
accumulation of HO endonuclease. 
Since I had previously determined that rpn1-D517A and rpn1-VD mutants stabilized 
Ddi1 substrate Ufo1 (Chapter 3 and Figure 4.1D), I sought to determine if all known 
Ddi1 substrates would be stabilized by these mutations.  Further, considering the genetic 
relationship between rpn1-D517A and ddi1∆, I postulated that understanding how 
universal Ddi1 substrate stabilization is by the rpn1-D517A mutant should give insights 
into if Ddi1 binding to mutant rpn1 is not completely blocked, or if rpn1-D517A does 
more than just inhibit Ddi1 binding.   
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HO endonuclease is a protein that is important in yeast mating type switching. It 
has been shown to be reliant upon Ddi1 for turnover.  In ddi1∆ mutants, HO is stabilized 
and steady-state levels are high (Kaplun et al., 2005). The doxycyline inducible pCM190-
HO-LacZ constructs were transformed into wild-type and rpn1-D517A cells. 
Transformants were grown in the absence of doxycline and allowed to reach saturation, at 
which point, ß-galactosidase activity was determined. A very high level of ß -
galactosidase activity was detected in ddi1∆ cells whereas rpn1-D517A had a 
considerably lower level of ß -galactosidase activity that was comparable to wild-type 
levels (Figure 4.2B).  The lack of increased steady-state HO concentrations in the rpn1-
D517A mutant may be indicative that not all known Ddi1 substrates will be reliant on the 
D517A residue of Rpn1 for turnover. Alternatively, steady-state levels of HO may not be 
fairly representative of turnover defects.  
 
The ddi1∆ dsk2∆ mutant does not have diminished Ub conjugate binding to 
the proteasome. 
A ddi1∆dsk2∆ strain accumulates cellular Ub conjugates in comparison to a wild-type 
yeast strain (Figure 4.2C, left panel). Rpn1 ‘VKD’ surface mutants do not accumulate Ub 
conjugates in a whole cell extract (Figure 4.1A), so I wondered how Ub accumulation 
would appear at ddi1∆dsk2∆ mutant proteasomes. Proteasomes from a fully wild-type 
strain and a double ddi1∆dsk2∆ mutant whose Pre1 subunit contained a Flag epitope, 
were affinity purified and analyzed for ubiquitin conjugate accumulation. I observed that 
similar levels of Ub conjugates are found at a ddi1∆dsk2∆ proteasome as at a wild-type 
proteasome (Figure 4.2C). Similar results were seen when I did the same experiment with 
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a single ddi1∆ strain (data not shown). This result was unexpected considering that rpn1-
VKD mutants actually have fewer ubiquitin conjugates that immunoprecipate with their 
proteasomes.  
 
 
Discussion 
 
 Since only rpn1-VD and rpn1-VKD surface mutants show diminished binding of 
Ddi1, only mutants on this surface show toxicity in the presence of over expressed Ufo1  
and stabilization of Ufo1. Hence, I have shown that multiple mutations on the ‘VKD’ 
surface of Rpn1 reduce binding to Ub conjugates, Ddi1, and lead to stabilization of Ufo1.  
It is hard to say definitively that the ‘STN’ surface plays a role in scaffolding to other 
subunits to maintain proteasome structure, since I do not have an assay to explicitly test  
this hypothesis. However, one could imagine testing for interaction of the ‘STN’ surface 
with the Rpt1 and Rpt2 subunits that were found to form subcomplexes with Rpn1 during 
proteasome biogenesis (Roelofs et al., 2009; Saeki et al., 2009). Further testing will be 
needed to prove my hypothesis: the ‘VKD’ surface of Rpn1 is exposed for binding of 
proteasome interacting proteins.  
 The biochemical mimicry of mutations on the ‘VKD’ surface begged me to test if 
genetically a ddi1 and rpn1-D517A mutant would prove to be working in the same 
functional pathway. However, the genetic analysis produced two intriguing questions: 
1) Does the D517 residue of Rpn1 do more than inhibit binding of Ddi1?  
2) Does the rpn1-D517A not completely block binding of Ddi1, such that genetically 
they will appear to work in parallel pathways?  
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The loss of ubiquitin conjugates at rpn1-D517A proteasomes seems to imply that this 
mutation does do ‘more’ than just bind Ddi1, since loss of DDI and, even jointly, DDI1 
and DSK2 does not reduce Ub conjugate binding by the proteasome (Figure 4.2C and 
data not shown). Interestingly, rad23∆dsk2∆ mutants do exhibit loss of ubiquitin 
conjugate binding at their proteasomes (Elsasser et al., 2004). With the aforementioned 
result in mind, in terms of a functional role for the Rpn1-D517A mutation, what could the 
‘more’ be? One hypothesis is that the ‘VKD’ surface of Rpn1 binds unidentified 
receptors and/or has even subtle effects on delivery of Rad23 substrates to the 
proteasome.  
Explaining the genetic interaction between rpn1-D517A and Ddi1 is also challenging 
because based on a strict genetic view, it appears that they are contributing in parallel to 
protein turnover. One hypothesis is that the lack of Ddi1 binding at the proteasome in a 
rpn1-D517A causes a morer distinct phenotype than does the deletion of Ddi1. Perhaps 
the upstream roles Ddi1 plays before binding to the proteasome leads to this apparent 
difference in physiology. For instance, Ddi1 is known to have an aspartyl protease 
domain, although no functional role has been identified for this domain other than it is 
necessary for homodimerization (Gabriely et al., 2008). It is possible that the intrinsic 
protease activity of Ddi1 may preclude having an rpn1-D517A mutant fully mimic its 
phenotype. Additionally, the greatest loss of Ddi1 binding to rpn1-D517A proteasomes I 
have seen is an 80% decrease in comparison to wild-type levels. Perhaps the remaining 
20% of Ddi1 binding is what creates the unique physiology.   
 Finally, the redundancy of UBA-UBL binding at the proteasome that I have 
discovered (Chapter 3) might further confound the analysis of RPN1 mutant alleles and 
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may contribute to the disparity between these proteasome cis mutants and UBA-UBL null 
strains.  Future studies will be needed to investigate this complexity. For instance, it 
would be interesting to determine if UBA-UBL proteins deliver a different set of 
substrates to each of their different docking sites at the proteasome and how this is altered 
in a cis proteasome mutant. 
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Figure legends 
 
Figure 4.1. The ‘VKD’ surface of Rpn1 may be responsible for binding UBA-
UBL proteins. 
(A) Ddi1 and Ub conjugate accumulation is diminished for the rpn1-V447H K484A 
D517A triple mutant ('VKD') and rpn1-V447H D517A double mutant ('VD') proteasomes 
but not for rpn1-S500A T537A N539D ('STN') and rpn1-D503G T537A N539D (‘DTN’) 
which harbor mutations on the opposing surface of Rpn1.  Rpn11-Flag tagged 
proteasomes were immunoprecipitated and immunoblotted with the indicated antibodies. 
Inputs, whole cell extracts (WCE) are also shown.  (B) Five-fold serially diluted cells 
were plated onto either YPD or YPD containing 4 mM AZC, a proline analog. The Rpn1 
allele mutants (rpn1*) were plasmid shuffled into an rpn1 null strain containing (from top 
to bottom) either no additional mutations or in an rpn13-KKD, rpn10-UIM, rpn13-KKD 
rpn10-UIM double, or rpn4∆ background. (C) Sensitivity to GST-Ufo1 over expression 
by rpn1 mutants of clustered residues on the same surface (rpn1-VK and rpn1-VD) is 
specific (i.e., not shown by other rpn1 mutants from the ‘STN’ surface). (D) Ufo1 is 
stabilized in the rpn1-V447H D517A mutant. Wild-type and mutant cells containing a 
GAL1 promoter regulated GST tagged Ufo1 were grown in raffinose media preceding 
induction of expression with 2% galactose. Samples were taken after promoter shut off 
with the addition of dextrose at the indicated time points. 
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Figure 4.2. rpn1-D517A and ddi1∆ mutants may have some parallel 
functions in protein turnover. 
(A) The indicated strains were serially diluted to equal concentrations of cells and grown 
on either YPD (control) or YPD media containing 5 mM AZC, a proline analog.  (B) The 
steady-state levels of HO-LacZ were determined by an ONPG assay. Strains (wild type, 
rpn1-D517A, and ddi1∆) were transformed with pCM190-HO-LacZ constructs and ß -
galactosidase activity was determined after transformants were allowed to reach 
saturation after 18 hours of growth in the absence of doxycyline. (C) Pre1 flag tagged 
affinity-purified proteasomes from wild type and ddi1∆dsk2∆ mutants were resolved on 
SDS PAGE and immunoblotted with the indicated antibodies (IP, right panel). Input 
whole cell extracts are also shown (WCE, left).   
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Table 4.1 Strains used in this chapter 
Yeast strains 
RJD # Genotype Source 
Tgy38 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D-LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-
FLAG-HphMX  this study 
Tgy39 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 D503G 
T537A N539D -LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-
FLAG-HphMX this study 
Tgy40 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
D517A -LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-FLAG-
HphMX this study 
Tgy41 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A -LEU] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-
FLAG-HphMX  this study 
5377 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU]  
this study 
5378 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU]  
this study 
5402 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU] rpn13::TRP1 
this study 
5403 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU] rpn13::TRP1 
this study 
5381 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU] rpn13KKD::NatMX 
this study 
5382 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU] rpn13KKD::NatMX 
this study 
5383 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU] rpn10-UIM::KanMX 
this study 
5384 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU] rpn10-UIM::KanMX 
this study 
5385 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU] rpn13KKD::NatMX rpn10-UIM::KanMX 
this study 
5386 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU] rpn13KKD::NatMX rpn10-UIM::KanMX 
this study 
5379 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 S500A 
T537A N539D -LEU] rpn4::TRP1 
this study 
5380 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 V447H 
K484A D517A-LEU] rpn4::TRP1 
this study 
5154 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS316-Rpn-URA] 
ddi1::HIS3 
this study 
5347 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 D517A-
LEU] ddi1::HIS3 
this study 
5456 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS316-Rpn-URA] 
ddi1::HIS3 rpn13::TRP1 
this study 
5348 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS315-Rpn1 D517A-
LEU] ddi1::HIS3 rpn13::TRP1 
this study 
5456 MatA ddi1::KanMX dsk2::KANMX bar1∆ pre1::PRE1-Flag-6XHIS (URA3) this study 
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Figure 4.1. The ‘VKD’ surface of Rpn1 may be responsible for binding UBA-
UBL proteins. 
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Figure 4.2. rpn1-D517A and ddi1∆ mutants may have some parallel 
functions in protein turnover. 
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Chapter 5: 
 
Insights into the binding of  
Rad23 and Ubp6  
to the 26S proteasome 
 105 
Introduction 
 
 
 After an exhaustive genetic screen for mutations in the proteasome base subunit, 
Rpn1 (Chapter 3), that would inhibit binding of all UBL domain proteins, Ubp6, Rad23, 
Dsk2, and Ddi1, only two residues were verified to partially disrupt binding of Ddi1 and 
Dsk2. Interestingly, the effects on Dsk2 were only seen in the absence of one or more 
mutations in intrinsic receptors Rpn10 and Rpn13. However, no combination of 
manipulations to Rpn1, discussed in Chapter 3, seems to disrupt binding of Rad23 and 
Ubp6. In addition to Rpn1, Ubp6 is known to bind subunits within the lid of the 
proteasome, Rad23 may bind Rpn10, and human hHR23 binds hRpn13 (Husnjak et al., 
2008; Leggett et al., 2002; Matiuhin et al., 2008b). Hence, in this chapter, I queried a 
small number of additional proteasomal perturbations to see if there was any reasonable 
genetic approach to impinge upon binding of Rad23 and Ubp6 to the proteasome. 
 Here, I report that Rad23 binding to the proteasome is diminished in a rpn10-uim 
rpn13-kkd double mutant and in an ufd2Δ mutant in comparison to a fully wild-type 
strain. Furthermore, a reduction in the levels of Rad23 at the proteasome appears to 
coincide with an increase in Ubp6. This is an unexpected result since it has been reported 
that Rad23 and Ubp6 do not compete for binding at the proteasome (Elsasser et al., 
2004). To the best of my knowledge, no reports indicate that Ubp6 binds Rpn13 and 
Rpn10. It therefore seems reasonable that the increase in abundance of Ubp6 at Rad23-
diminished proteasomes may be a physiological response to the loss of receptor docking. 
This data raises the question: Contrary to published reports, is Rpn1 truly the major 
docking site for Rad23 and Ubp6 (Fatimababy et al., 2010)?  
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Methods 
 
All methods are the same as those described in Chapter 3. Please see Table 5.1 for a list 
of strains used in this chapter.  
 
 
 
Results 
 
 
 
Rpn10 and Rpn13 contribute to docking of UBA-UBL receptor proteins. 
I was interested in understanding the contribution of the roles of Rpn10 and Rpn13 to 
binding UBA-UBL proteins in a rpn10-uim rpn13-KKD rpn1-D517A mutant. To address 
this, I compared proteasomes from a fully wild-type strain containing no genetic 
perturbations in receptor genes to proteasomes from the rpn10-uim rpn13-KKD rpn1-
D517A strain. As expected, Ub conjugates, Ddi1, and Dsk2 were again reduced (Figure 
5.1C). However, unexpectedly, we noticed that the levels of Rad23 were reduced while 
those of Ubp6 were increased. The decrease in Rad23 levels in mutant proteasomes is not 
dependent upon the Rpn1-D517A mutation as when rpn10-uim rpn13-KKD rpn1-D517A 
proteasomes are compared to rpn10-uim rpn13-KKD proteasomes, no difference is seen 
in the levels of Rad23 binding (Figure 5.1B). Hence, this is likely to be an effect due to 
either Rpn10 or Rpn13 or to the combinatorial deletion of both of their ubiquitin binding 
domains.  
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A sole deletion of Rpn13 is not sufficient to interrupt binding of any 
ubiquitin receptor protein to the proteasome. 
The possible or dual necessity for Rpn10 and Rpn13 in binding UBA-UBL proteins was 
intriguing. To investigate this further, I used a quantitative mass spectrometry technique, 
stable isotope labeling with amino acids, SILAC, to analyze if the levels of ubiquitin 
receptors and/or UBL proteins were dependent on the presence of Rpn13. To assay this, 
rpn13∆  Rpn11FLAG cells were labeled with light lysine and arginine while wild-type 
Rpn11FLAG cells were labeled with heavy lysine and arginine. The cells were mixed prior 
to lysing, and a proteasome affinity purification was carried out. The immunoprecipitate 
was analyzed on a mass spectrometer. I confirmed that all of the 26S subunits had 
approximately a 1:1 ratio (data not shown). There were also a plethora of proteins that 
were less (Table 5.2) and more (Table 5.3) abundant at rpn13∆ proteasomes. However, 
amongst the proteins that were unchanged between wild-type and rpn13∆ proteasomes, 
were Rad23, Ddi1, Ubp6, and intrinsic ubiquitin receptor Rpn10 (Table 5.4). 
Unfortunately, Dsk2 was not measured in this experiment. Other PIPs such as the 
deubiquitinases Ubp3 and Ubp1 were also unaltered. Interestingly, I also saw Cdc48 in 
the proteasome preparation and there were no changes in the levels of this protein. The 
Cdc48/p97 pathway is also involved in the targeted delivery of specific substrates to the 
proteasome (Barbin et al., 2010; Verma et al., 2011), although it is unknown how Cdc48 
binds to the proteasome.  
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Proteasomes from ufd2∆ are less abundant for Rad23. 
There could be any number of factors that could potentially be restricting the Rpn1-
Rad23 interaction in vivo.  Ufd2 is one such factor, and Pth2 is another. It has been 
shown that Pth2, a mitochondrially-localized peptidyl-tRNA hydrolase, interacts with 
Rad23 and Dsk2 (Ishii et al., 2006). However, there is no evidence that speaks to the 
significance of such an interaction.  I questioned if Rad23 or Dsk2 are bound to 
proteasomes in a PTH2 null strain. Ufd2, an E4/chain elongation enzyme, has been 
postulated to hand off Rad23 to the proteasome (Kim et al., 2004).  So, I questioned how 
the levels of Rad23 might be affected in a deletion mutant. Proteasomes purified from a 
pth2∆ null mutant have wild-type levels of Rad23 and Dsk2 proteins, however, ufd2∆ 
proteasomes have less Rad23 associated with them than a wild-type proteasome does 
(Figure 5.2) although they have equivalent amounts of another UBA-UBL protein, Dsk2.  
 
 
Discussion 
 
 Here I observed that the simultaneous absence of the ubiquitin interaction 
domains of Rpn10 and Rpn13 was sufficient for reducing Rad23 interaction with 
proteasomes. However, since the sole loss of Rpn13 does not impinge on loss of Rad23 
(Table 5.4), it may be true that either only Rpn10 contributes to binding of Rad23, or that 
both intrinsic receptors must be mutated to create this change. While no perturbation in 
Rpn1 in combination with either Rpn10 or Rpn13 diminished binding, it seems 
questionable as to which subunit of the proteasome is the main docking site for Rad23.  
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 I also show that deletion of Ufd2, an E4 enzyme, decreases the presence of Rad23 
at the proteasome. The structure of Ufd2 binding to the UBL domains of Rad23 and Dsk2 
has been solved (Hänzelmann et al., 2010). The interaction of Rad23/Dsk2 with Ufd2 has 
been shown to be important for the turnover of some substrates (Richly et al., 2005). 
Hence, this interaction is physiologically relevant towards protein turnover. Since Ufd2 
promotes substrate degradation and delivery, it is not likely that it competes for binding 
to Rad23 and Dsk2 with the proteasome. It seems more reasonable that there is some 
cooperativity between Ufd2 and the proteasomes. It is unclear, how the UBL domains of 
Rad23/Dsk2 could potentially interact simultaneously with Ufd2 and docking sites on the 
proteasome.  
 No mutational perturbations decreased Ubp6 binding to the proteasome, and 
binding to either Rpn1 and/or lid subunits is enhanced by dual mutations in Rpn10 and 
Rpn13. Dissecting the increased presence of Ubp6 at Rad23-derived proteasomes may 
prove to be challenging. Perhaps studying the activity of substrates and PIPs known to 
rely on Ubp6 might shed some light in this arena.  
 Taken together, the interaction of UBA-UBL proteins creates a very complicated 
binding landscape. The interactions for Dsk2 and Rad23 appear to be, at a minimum, 
bidentate. 
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Figure legends 
 
Figure 5.1. Rpn10 and Rpn13 contribute to docking of UBA-UBL receptor 
proteins.   
(A) Affinity-purified rpn10-UIM rpn13-KKD rpn1-D517A proteasomes contain reduced 
levels of Ub conjugates in comparison to proteasomes from an rpn10-UIM rpn13-KKD 
strain. (B) rpn10-UIM rpn13-KKD rpn1-D517A proteasomes contain less Ddi1 and Dsk2 
in comparison to proteasomes from a rpn10-UIM rpn13-KKD, as shown in the 
densitometric quantification of UBA-UBL proteins found in affinity-purified 
proteasaomes represented in (A). (C) Affinity-purified rpn10-UIM rpn13-KKD rpn1-
D517A proteasomes contain reduced levels of Rad23, Dsk2, Ddi1, and Ub conjugates in 
comparison to a fully WT strain containing no genetic manipulations in receptor genes. 
Levels of UBA–UBL proteins, the lid subunit Rpn12, and polyubiquitin are shown for 
affinity-purified proteasomes (IP) and in the whole cell extract input (WCE). (D) Affinity 
purified fully wild-type proteasomes are compared to rpn10-UIM rpn13-KKD 
proteasomes.   
 
Figure 5.2. Ufd2 contributes to recruitment of Rad23 to the 26S 
proteasomes. 
(A) PRE1FLAG ufd2∆ and pth2∆ proteasomes were immunoprecipitated from cells under 
native conditions. Immunoprecipitates were resolved by SDS-PAGE, transferred to 
nitrocellulose and immunoblotted with the indicated antibodies.  
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Table 5.1 Strains used in this chapter 
Yeast strains 
RJD # Genotype Source 
RJD4299 MatA leu2 his3 ad2 pth2::KanMX pre1::PRE1-FlagHIS6 this study 
RJD4300 MatA leu2 his3 ad2 ufd22::KanMX pre1::PRE1-FlagHIS6 this study 
RJD5034 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS316-Rpn1-
URA] arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-FLAG-HphMX  this study 
RJD4830 
MATa leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 [pRS316-Rpn1-
URA] rpn13::TRP1 arg4::KanMX lys2::HIS3 CAN1 rpn11::RPN11-FLAG-HphMX this study 
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Table 5.2. PIPS that are less abundant in rpn13∆ proteasomes 
 
Gene Peptides 
Sequence 
Coverage [%] Ratio H/L Significance 
Variability 
[%] 
DLD3 4 9.5 1.7 6.5E-04 14.5 
PMA2 5 7.1 1.6 9.7E-04 13.5 
G3P2 17 52.1 1.5 5.4E-03 13.7 
MXR1 5 28.3 1.5 6.9E-03 14.2 
OYE2 3 10.2 1.5 7.1E-03 30.3 
REI1 8 27.2 1.5 7.3E-03 9.3 
FAF1 2 2.9 1.5 8.0E-03 2.5 
YJ11B 10 7.9 1.4 8.6E-03 3.9 
DHYS 2 5.2 1.4 1.2E-02 0.3 
YG3Y 3 9.8 1.4 1.4E-02 16.4 
SPE3 2 9.6 1.4 1.5E-02 15.6 
ENO2 18 48.1 1.4 1.5E-02 18.8 
TRM8 3 11.5 1.4 1.6E-02 19.7 
RRB1 4 11 1.4 1.7E-02 26.5 
RIO1 4 9.9 1.4 1.7E-02 16.9 
APA1 1 4 1.4 1.9E-02 4.7 
NOP4 14 26.1 1.4 2.0E-02 20.9 
DBP2 19 41 1.4 2.1E-02 20.6 
IF4A 2 8.1 1.4 2.4E-02 7.0 
REX4 1 5.5 1.4 2.6E-02 6.3 
SSF1 7 21 1.3 2.9E-02 5.7 
LEU1 44 53.8 1.3 3.1E-02 17.2 
REP2 1 5.1 1.3 3.2E-02 12.5 
YNL010W 1 4.1 1.3 3.5E-02 10.7 
RNT1 4 10.4 1.3 3.7E-02 4.6 
SDA1 2 3.8 1.3 3.9E-02 0.4 
NSR1 17 40.1 1.3 3.9E-02 14.5 
MAE1 4 9 1.3 3.9E-02 15.0 
ALFT 8 36.2 1.3 4.0E-02 10.2 
NMD3 9 19.7 1.3 4.0E-02 10.2 
PGK 11 33.9 1.3 4.1E-02 10.8 
YC16 2 13.1 1.3 4.3E-02 9.6 
MRD1 11 15.8 1.3 4.5E-02 15.0 
MAS5 15 37.2 1.3 4.6E-02 8.9 
NOP13 14 36.7 1.3 4.9E-02 33.9 
NOC3 2 3.2 1.3 4.9E-02 17.7 
ESF1 24 43.5 1.3 5.0E-02 8.6 
CCT1 5 12 1.3 5.1E-02 14.6 
YD173 2 6.1 1.3 5.2E-02 8.4 
CF130 2 1.1 1.3 5.3E-02 20.7 
ARP5 4 6 1.3 5.4E-02 13.8 
OTU2 5 18.6 1.3 5.5E-02 27.2 
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PYC2 3 3.3 1.3 5.6E-02 16.5 
GLN1 6 15.9 1.3 5.6E-02 15.2 
URA3 5 19.9 1.3 5.7E-02 21.0 
YIJ1 4 6.2 1.3 5.8E-02 7.6 
YDR341C 4 7.6 1.3 5.8E-02 11.2 
SQT1 1 4.2 1.3 5.8E-02 13.9 
CPR1 2 21 1.3 5.9E-02 6.2 
IPI3 7 16 1.3 6.2E-02 13.3 
AROC 6 18.6 1.3 6.3E-02 10.7 
ADH1 14 45.1 1.3 6.7E-02 6.4 
TEF4 16 37.1 1.3 6.7E-02 9.9 
RL22B 4 45.1 1.3 6.8E-02 4.7 
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Table 5.3. PIPS that are more abundant in rpn13∆ proteasomes 
Gene Peptides 
Sequence 
Coverage 
[%] 
Ratio 
H/L Significance 
Variability 
[%] 
YPL168W 1 1.6 0.02 2.4E-04 31.794 
PDC1 29 69.1 0.04 6.0E-03 145.27 
OSH6 3 10.7 0.05 1.0E-02 126.98 
SIL1 1 5.5 0.05 1.1E-02 27.955 
PYK1 47 81.8 0.05 1.2E-02 118.92 
SAM2 27 62 0.05 1.4E-02 81.893 
GPM1 22 83 0.05 1.5E-02 106.42 
MET6 54 68.3 0.05 1.5E-02 100.29 
PGK1 42 80 0.06 1.8E-02 95.571 
ADH1 25 68.7 0.06 2.0E-02 135.93 
FUR1 7 51.9 0.06 2.0E-02 89.866 
YNL010W 10 62.2 0.06 2.1E-02 80.56 
PMI40 5 26.1 0.06 2.1E-02 102.34 
HEM2 2 11.7 0.06 2.2E-02 69.463 
TDH2 27 63.9 0.06 2.2E-02 65.311 
ELP4 2 9.2 0.06 2.4E-02 17.587 
TDH3 36 91.3 0.06 2.5E-02 116.57 
TMA19 6 31.1 0.06 2.7E-02 80.741 
TIF11 3 22.9 0.06 2.8E-02 71.455 
INO1 12 33.8 0.07 2.8E-02 126.63 
GND1 17 42.9 0.07 2.8E-02 89.841 
HAM1 4 42.6 0.07 2.9E-02 44.718 
SAH1 27 57.2 0.07 2.9E-02 129.49 
RPE1 4 24.8 0.07 3.1E-02 133.26 
FBA1 21 69.6 0.07 3.3E-02 105.88 
FUM1 2 6.6 0.07 3.5E-02 19.147 
TIM44 2 7.7 0.07 3.5E-02 66.81 
ADE8 2 15 0.07 3.5E-02 45.027 
SPE3 9 38.6 0.07 3.5E-02 77.763 
FPR1 6 57.9 0.07 3.5E-02 87.846 
TPI1 13 50 0.07 3.6E-02 75.258 
EFT1 46 64.4 0.07 4.0E-02 91.02 
YPL184C 2 5.4 0.07 4.1E-02 102.96 
ACO1 18 36 0.07 4.1E-02 92.781 
IPP1 11 61.7 0.08 4.2E-02 99.526 
ENO2 41 74.4 0.08 4.2E-02 114.84 
HPT1 8 40.7 0.08 4.3E-02 110.13 
TAL1 20 56.1 0.08 4.4E-02 93.278 
PGM1 2 3.9 0.08 4.4E-02 2.9083 
ACS2 13 27.8 0.08 4.5E-02 64.316 
YKR043C 2 11.4 0.08 4.5E-02 75.563 
HOM6 13 57.4 0.08 4.5E-02 91.978 
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YNL134C 9 38 0.08 4.6E-02 57.544 
TRM10 1 2.7 0.08 4.7E-02 33.759 
FPP1 7 29.3 0.08 4.7E-02 96.144 
ARG3 10 44.7 0.08 4.8E-02 71.591 
OLA1 21 63.7 0.08 4.8E-02 95.232 
ARF1 6 34.3 0.11 4.9E-02 60.556 
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Table 5.4. Ubiquitin receptor levels are unchanged in rpn13∆ proteasomes. 
 
Gene Peptides 
Sequence 
Coverage [%] 
Ratio H/L 
Normalized Significance 
Variability 
[%] 
 
DDI1 1 6.8 1.01 0.44 17.9 
 
RAD23 7 24.6 0.90 0.31 13.1 
 
UBP6 8 18 0.93 0.36 27.9 
 
RPN10 11 47.8 0.94 0.39 26.1 
 
UBP3 5 5.6 
 
0.97 
 
0.45 36.5 
 
UBP1 7 13.8 0.97 0.44 14.6 
 
CDC48 36 47.2 0.99 0.49 12.1 
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Figure 5.1. Rpn10 and Rpn13 contribute to docking of UBA-UBL receptor 
proteins.   
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Figure 5.2. Ufd2 contributes to recruitment of Rad23 to the 26S 
proteasomes. 
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Chapter 6: 
 
Mitochondrial import and 
methionine synthesis 
pathways are perturbed by 
interference of UBA-UBL 
binding to the proteasome 
 120 
Introduction 
 
 I recently described the rpn1-D517A mutant that impairs binding of the UBA-
UBL protein Ddi1 (Chapter 3). Little is known about the contribution Ddi1 makes to 
substrate delivery to the proteasome. This question has been hard to tackle considering 
the breadth of roles Ddi1 plays in other biochemical pathways that may or may not be 
related to its role in the UPS (Díaz-MartÌnez et al., 2006; Gabriely et al., 2008; 
Lustgarten and Gerst, 1999). 
 Here, I use the rpn1-D517A proteasome cis mutant as an indicator of how a 
specific impingement upon Ddi1 binding to the proteasome may perturb cell physiology 
in a UPS-dependent manner. Although the rpn1-D517A mutant does not strictly mimic 
loss of DDI1 (Chapter 4), probing further into the physiology of this mutant may provide 
revelations even towards that point.  
 Each UBA-UBL receptor has a specific substrate repertoire it delivers to the 
proteasome (Verma et al., 2004).  One natural question was: can novel Ddi1- specific 
UPS substrates be discovered with the rpn1-D517A mutant? To identify novel substrates 
and understand the physiological consequences of the deletion of the natural Ddi1 
binding site,  rpn1-D517A mutant proteasomes were analyzed using a quantitative mass 
spectrometry technique. Proteins that were found both more and less abundant at mutant 
proteasomes were probed further and revealed novel roles for the proteasome in cysteine 
and methinonine biosynthetic pathways and in mitochondrial protein import. Further, I 
identify a potential new substrate of the proteasome, Aac2, a mitochondrial ADP/ATP 
carrier.   
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Methods 
 
Yeast strains and culture methods 
Strains were grown and crossed according to standard procedures. Table 6.1 lists all 
strains used in this chapter.   
 
SILAC analysis of 26S proteasomes  
Done as described in detail in Chapter 3.  
 
Rpn1-D517A strain construction 
For the preparation of the rpn1-D517A strain, a 3.2 kb fragment was PCR amplified 
using primers TG269 and TG270 from RDB2300 bearing 85 bp in the 5’ UTR, the entire 
Rpn1 ORF containing internal AvrII and EagI silent mutations and a D517A mutation, 
and 85 bp past the stop codon. A second PCR product of 1.6 kb was amplified using 
primers TG271 and TG272 from pFA6a-KanMX6 (Longtine et al., 1998) containing 
flanking overlapping sequences with primer TG270, the entire KanMX6 cassette, and 
sequences overlapping with nucleotides beginning 86 bp downstream of the Rpn1 stop 
codon. A fusion PCR was performed to fuse these amplification products together. This 
4.8 kb fusion PCR product was then transformed into RJD4006 using a standard LiAc 
protocol creating RJD5151. Integrants were verified by PCR, and the presence of the 
mutation was determined by restriction mapping with AvrII and EagI and sequencing. 
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High-throughput yeast strain crossing 
High-throughput crossing via the SGA method was used to cross GFP-tagged ORF 
strains to RJD4006 or RJD5151 (Tong et al., 2001). For SGA analysis, the MATα starting 
strains, lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 pdr5Δ::ADHpr-
NLS-mRFP1-URA3 (RJD 4006) or lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 
can1Δ::STE2pr-LEU2 pdr5Δ::ADHpr-NLS-mRFP1-URA3 rpn1::rpn1-D517A-KanMX6 
(RJD 5151), were mated to 87 individual MATA strains from the Invitrogen yeast GFP 
collection, his3Δ leu2Δ, met15Δ ura3Δ XXX-GFP-HIS3. These strains were mated on 
SC–His–Ura. Diploids were selected on SC–His–Ura plates for 1 day at 30°C and then 
pre-sporulated for 1.5 days at 25°C on GNA plates. Cells were sporulated on SPO plates 
at 25°C for 10–14 days. To select for MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 
can1Δ::STE2pr-LEU2 pdr5Δ::ADHpr-NLS-mRFP1-URA3 XXX-GFP-HIS3 (+/-
rpn1::rpn1-D517A-KanMX)  haploids, spores were haploid selected on either SD-Ura–
Arg-Lys supplemented with canavanine and S-AEC +/- MSG and G418 for 2 days at 
30°C. Haploids were again reselected in the appropriate haploid selection media prior to 
preparation of  glycerol stocks of the resultant strains.  
 
High-throughput microscopy 
Cells were grown in 96-well plates until saturated in haploid selection liquid culture. 
Three hundred microliters of C/AA/Dex liquid media (1.6 g Yeast Nitrogen Base without 
ammonium sulfate and amino acids, 5 g Ammonium Sulfate, 11 g Succinic Acid, 6.9 g 
Sodium Hydroxide, +amino acids, +2% dextrose, up to 1 L with water) was inoculated 
with 5 µL of saturated culture and allowed to grow overnight. The next day, 100 µl of 
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C/AA/Dex media was inoculated with 5 µl of overnight culture and grown at 30°C for 2 
hours. Cells were pelleted, washed in TE, and then resuspended in 100 µl of TE, in which 
they are transferred to glass-bottom 96-well plates coated with Concanavalin A. Cells 
were allowed to settle for 20 minutes before imaging on the 96-well plate microscope. A 
fluorescence microscopy system (Image Express Micro; Molecular Devices) was used to 
acquire images. The data collected was analyzed in MatLab.  
 
Protein turnover experiments 
For galactose promoter shutoffs, yeast transformed with GAL1 promoter-driven 
expression plasmids were grown in synthetic medium with raffinose as the sole 
carbohydrate source. When the cultures reached an OD600 0.5, galactose was added to 2% 
for 2–3 hours. Expression was shut off by the addition of 2% dextrose, at which point 
samples were collected for up to 120 minutes after promoter shut off. For cycloheximide 
chases, yeast strains were grown to an OD600 ~ 0.5, and then treated with 100 µg/ml 
cycloheximide, at which point a chase was initiated. Lysates were prepared by making 
boiling extracts. Immunoblotting was done using the indicated antibodies. The Aac2 
antibody was a kind gift from Carla Koehler (UCLA).  
 
In vivo Hsp60 precursor accumulation assay 
Assessment of Hsp60 precursor accumulation was done as described (Schiller et al., 
2008). Briefly, strains were grown in YPD at 30°C until they reached an OD600 ~ 0.5, at 
which point half of the culture was shifted to 37°C for 4–5 hours. Samples were taken 
and prepared by making boiling extracts. Lyasates were resolved by 6% SDS-PAGE, 
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transferred onto nitrocellulose membranes, and immunoblotted with anti-Hsp60 (Novus 
Biologicals).  
 
Yeast boiling extract preparation 
Cells were pelleted and washed in stop buffer (50 mM Tris-HCl pH 7.5, 0.02% NaN3, 50 
mM NaF). Next, 0.3 mL of glass beads per 8 OD units were directly added to the cell 
pellets and the samples were boiled for 3 minutes. An equal volume of 1X SDS buffer 
was added prior to fastprepping for 60 seconds at maximum speed. The samples are then 
boiled again for another 5 minutes and spun at top speed for 2 minutes prior to being 
loaded onto SDS-PAGE gels.  
 
 
 
 
Results 
 
Rpn1-D517A proteasomes show diminished amounts of specific PIPs. 
In our efforts to understand the physiological consequence of having a cis mutation in the 
proteasome, we performed quantitative mass spectrometry using the stable isotope 
labeling with amino acids  method (SILAC). Rpn11FLAG rpn13∆ cells were labeled with 
heavy lysine and arginine while Rpn11FLAG rpn13∆ rpn1-D517A cells were labeled with 
light lysine and arginine. The cells were mixed prior to lysing, and a proteasome affinity 
purification was carried out. The SILAC analysis revealed a list of proteins that were 
found less abundantly in light-labeled rpn13∆ rpn1-D517A proteasomes when compared 
to heavy-labeled rpn13∆ proteasomes (Table 6.2). Some of the less-abundant PIPs were 
also identified in a prior report as specific proteasome-interacting proteins (Guerrero et 
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al., 2008). Others had been identified as unstable proteins (Belle et al., 2006), or even 
UPS substrates (SCUD; http://scud.kaist.ac.kr/index.html). I hypothesized that novel 
substrates may be represented in this class of SILAC hits in which the protein was found 
less abundantly in Rpn1-D517A-containing proteasomes and that were known unstable 
proteins. Based on further suggested criteria for selecting putative UPS substrates (Verma 
et al., 2011), I chose a handful of SILAC hits to test for their dependence on rpn1-D517A. 
In turnover experiments (done either by galactose promoter shutoff or cycloheximide 
chases), I observed that most of the proteins I tested were fairly stable proteins (Figure 
6.1). There were a few proteins that were unstable (Rot1, Aro8, Sam1, Rrp6, and Aac2). 
Notably, Aac2 appeared to be the only protein whose turnover may have been slightly 
stabilized in the rpn1-D517A mutant. For the other tested proteins, it is unclear what their 
role is at the proteasome and if the decrease in their abundance is directly or indirectly 
related to mutation of Rpn1.  
 
Galactose-inducible Aac2 appears to be stabilized in rpn1-D517A.  
I was intrigued by the subtle, but consistent stabilization of galactose-inducible HA- 
tagged Aac2 (Figure 6.1I).  A replicate of this experiment is shown (Figure 6.2A). 
Interestingly, at least two lower-molecular-weight species also appear more stable in the 
rpn1-D517A mutant cells than in a wild-type strain. Aac2 is an inner mitochondrial 
membrane ADP/ATP carrier (Lawson and Douglas, 1988). I questioned if I would see 
turnover defects of endogenous pools of Aac2. Using an Aac2 antibody, I analyzed 
endogenous Aac2 turnover by initiating a cycloheximide chase at 30°C for 90 minutes.  
Under these experimental conditions, endogenous Aac2 appears to be only slightly 
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unstable and the rpn1-D517A mutant does not seem to have a drastic effect on turnover 
(Figure 6.2B).    
 
Cellular concentrations of Sam2, Cys3, and Fsr1 are shifted in rpn1-D517A 
mutants.  
In the search for more novel substrates and insights into the potential physiological 
consequences of the rpn1-D517A mutation, I chose to look at steady-state levels of 
proteins that were both less abundant (Table 6.3) and more abundant (Table 6.4) at rpn1-
D517A containing proteasomes via a high-throughput method. Using SGA technology, I 
mated an rpn1-D517A containing strain against 87 GFP-tagged ORFs that were selected 
from the SILAC datasets. The resultant strains were then analyzed on a high-throughput 
microscope that quantified the fluorescence intensity of each cell line. I hypothesized that 
proteins that were less abundant in mutant proteasome preparations and which met the 
proposed substrate criterion would have higher steady-state concentrations (Verma et al., 
2011). To my surprise, from the proteins found in Table 6.3 that were used in the high-
throughput analysis, two proteins appeared to have a higher steady-state concentration 
(Sam2 and Cox4) and two proteins had lower steady state concentrations in an rpn1-
D517A background (Cys3, Ado1). No proteins queried from those selected from Table 
6.4 were found to have steady-state levels outside of the GFP florescence standard 
deviation (Figure 6.3). 
 Based on these results, Sam2, Cox4, Cys3, and Ado1 were analyzed further by 
immunoblotting lysates of log phase cells that were treated with a translation inhibitor, 
cycloheximide, for 1 hour, and cells that were not treated. Several other potentially 
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unstable proteins (Belle et al., 2006) were also tested in parallel for dependence on rpn1-
D517A for turnover.   Surprisingly, no tested proteins appeared unstable after 
cycloheximide treatment. In agreement with the GFP fluorescence experiment, more 
lower-molecular-weight species of Sam2 were present in rpn1-D517A cells while a 
higher-molecular-weight species of Cys3 was less abundant.  However, no effect on 
Ado1 and Cox4 was detected. Interestingly, I also observed less of a lower-molecular- 
weight species of Frs1 in the rpn1-D517A mutant (Figure 6.4).   
 No changes were noted in steady-state levels of some of the mitochondrial 
proteins that were found to be more abundant in mutant proteasomes (Table 6.4) when 
they were similarly probed by immunoblotting log phase cell lysates with or without 
cycloheximide (Figure 6.5).  
  
Methionine and cysteine biosynthesis pathways appear perturbed in rpn1-
D517A cells. 
The change in steady-state levels of potential modified and unmodified forms of these 
metabolic enzymes I discovered to be perturbed in rpn1-D517A cells is intriguing 
because these enzymes are known to regulate interconnected metabolic pathways, 
cysteine/methionine bisoynthesis, and the methyl cycle (Lafaye et al., 2005). 
Furthermore, I found that many of the other enzymes in this pathway, including: Met6 
and Sah1 were also found in decreased levels at mutant proteasomes (Table 6.3). 
Additionally, over expression of Met6 caused slow growth in an rpn1-D517A mutant. 
Taken together, there appears to be some perturbation in this pathway that could be 
probed further (Figure 6.6).  
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rpn1-D517A mutants have an abundance of mitochondrial proteins at  their 
proteasomes and respiration defects. 
From the SILAC dataset of proteins that were found more abundantly at rpn1-D517A 
mutant proteasomes, there appeared to be enrichment for mitochondrial proteins (Table 
6.4). In fact, more than 60% of these SILAC hits were mitochondrial proteins (Figure 
6.7A). Similarly, in my prior rpn13∆ SILAC analysis, I found that mitochondrial proteins 
are also enriched at mutant proteasomes in comparison to wild type,  albeit to a lower 
extent (Chapter 5, Table 5.3). This result caused me to postulate that the rpn1-D517A 
mutant may have mitochondrial defects.  Many yeast strains with mitochondrial defects 
are characterized by an inability to respire/grow on a non-fermentable carbon source, 
such as glycerol (Sherman and Slonimski, 1964). I observed that rpn1-D517A cells did 
not have respiratory defects. However, since the SILAC analysis was performed on 
rpn13∆ rpn1-D517A cells, I also tested this cell line and found it to show lethality on 
glycerol media. Similarly a ρ° strain lacking mitochondrial DNA also shows lethality on 
glycerol (Figure 6.7B).   
 
rpn13∆ rpn1-D517A mutants accumulate precursor forms of Hsp60. 
Interestingly, 100% of the mitochondrial proteins that accumulate at rpn13∆ rpn1-D517A 
proteasomes are encoded by nuclear DNA (Table 6.4). Since these proteins must be 
imported into the mitochondria, I asked if there is an accompanying defect in the import 
of mitochondrial preproteins in vivo. Hsp60 is a nuclear-DNA-encoded heat shock 
protein that is imported into mitochondria (Cheng et al., 1989). To test for the 
accumulation of precursors in vivo, mutant strains were grown to mid-logarithmic phase 
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and then shifted to 37°C for 4-6 hours. Cell extracts were analyzed for precursor and 
mature forms of Hsp60. As a control, a tim44-R180K strain, a strain harboring a mutant 
in a mitochondrial inner membrane transport protein, was also used in this assay (Schiller 
et al., 2008). The rpn13∆ rpn1-D517A mutant accumulated Hsp60 precursors similarly to 
the tim44-180K mutant after growing at 37°C (Figure 6.8A). To test if general 
proteasome perturbation influences accumulation of Hsp60 precursors, a panel of 
proteasome subunit mutants was also tested. A proteasome mutant containing a mutation 
in an ATPase subunit, rpt6-1, also showed pHsp60 accumulation, even when grown at 
just 30°C (Figure 6.8B). Additionally, an rpn4∆ rpn1-D517A accumulated precursors as 
well as a rpn10-uim rpn1-D517A mutant, although to a lesser extent (Figure 6.8C). Since 
binding of both Ddi1 and Dsk2 is reduced in an rpn13∆ rpn1-D517A strain, a ddi1∆ 
dsk2∆ strain was also tested, and appears to accumulate precursor Hsp60 as well (Figure 
6.8C). A pdr5∆ strain treated with proteasome inhibitor, MG132, also appeared to 
accumulate a barely detectable level of pHsp60.  Taken together, this data is indicative 
that inhibition of proteasome degradation, by mutation, drug treatment, or elimination of 
Ub receptor docking, leads to accumulation of precursor Hsp60 in vivo.  
 
Discussion  
 
Here I report that the mitochondrial ADP/ATP carrier, Aac2 is slightly stabilized in an 
rpn1-D517A mutant when over expressed. To validate Aac2 further as a substrate, an 
observation of ubiquitlyated Aac2, identifying Ddi1as a receptor of Aac2 and finding the 
ideal conditions for turnover of endogenous Aac2 would be essential. Already, two 
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proteomic studies have independently assigned Aac2 as a UPS substrate (Mayor et al., 
2007; Tagwerker et al., 2006).   
 The notion of Aac2 acting as a UPS substrate is intriguing since very few 
mitochondrial proteins have ever been validated as proteasome substrates. Fzo1, a 
mitochondrial transmembrane GTPase important for mitochondrial fusion, has been 
validated as an UPS substrate through basic biochemical methods and in a proteomic 
screen (Cohen et al., 2008; Tagwerker et al., 2006), although there also appears to be a 
non-proteolytic pathway that may also degrade it (Escobar-Henriques et al., 2006). The 
mitochondria does itself not have a UPS system, although there appear to be some 
bacterial-like proteases (Weber et al., 1996), and an N-end rule type protease system that 
controls mitochondrial protein stability (Vögtle et al., 2009). Since proteasomes are 
localized to the cytoplasm and nucleus, how do mitochondrial proteins become 
proteasome substrates? It has been postulated that Cdc48, in conjunction with Vsm1 as an 
adaptor, acts as segragase at the mitochondria, extracting mitochondrial proteins so that 
they are accessible to the proteasome for degradation. Such a role has already been 
shown to be essential for degradation of Fzo1 (Heo et al., 2010).  
 In further probing possible physiological consequences of having a cis 
proteasome mutant, I stumbled across changes in the equilibrium of potentially modified 
and unmodified forms of proteins, Fsr1, Cys3, and Sam2.  FRS1 is an essential gene that 
codes for a subunit of cytoplasmic phenylalanyl-tRNA synthetase (Sanni et al., 1991).  
My SILAC could not be used to determine how Frs1 is possibly post translationally 
modified in cells. It will be interesting to see if the disequilibrium of the forms of Frs1 
has any effects on protein translation.   
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 Levels of potentially modified forms of the enzymes Sam2 and Cys3 also 
exhibited perturbations in an rpn1-D517A mutant. More interestingly, a seemingly large 
number of closely related enzymes are also perturbed. Since this class of enzymes 
regulates the synthesis of methionine, cysteine, sulfur metabolism, and the methyl cycle 
(the flux between S-Adenosylhomocysteine and homocysteine (Lafaye et al., 2005) it 
may be interesting to use biochemical testing for observing possible defects in the levels 
of key biosynthetic intermediates. Additionally, are these putative posttranslational 
modifications I observe in my immunoblots active/unactive forms of these enzymes? 
Currently, to my knowledge, there is no published data indicating if these enzymes are 
regulated by post-translational modifications.  
 I have also demonstrated that chemical or mutational perturbations to proteasome 
degradation led to import defects of Hsp60. The UPS has already been implicated in 
playing a role in mitochondria metabolism, however, I report the first role for the UPS in 
the import of mitochondrial proteins. The reported roles for the UPS in mitochondria 
function are broad and have no mechanistic basis. Pth2, a protein that binds Rad23 and 
Dsk2, is a negative regulator of mitochondrial function (Ishii et al., 2006).   
Rpn11, a deubuiqintase enzyme that is a lid subunit of the proteasome, causes 
mitochondria fission defects (Rinaldi et al., 2002). Human Rpn13 has also been observed 
to effect the localization of mitochondria within the cell and tRNA import into the 
mitochondria (Brandina et al., 2007; Qiu et al., 2006).  To my knowledge, there is no 
literature which links the UPS to mitochondrial protein import.  
 I propose that the rpn13∆ rpn1-D517A mutant may effect import of Hsp60 in one 
of two ways. First, accumulation of some unknown substrate may have inhibitory effects 
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on mitochondrial import.  Alternatively, rpn13∆ rpn1-D517A may have defects in 
degrading precursor Hsp60 that is not imported, due to damage, misfolding or other 
cellular events that would limit translocation of mitochondrial proteins (Figure 6.9).  
 In summary, the rpn1-D517A mutation limits binding of Ddi1 (Chapter 3) and 
disrupts the equilibrium of steady-state levels of Frs1, Cys3, and Sam2. The rpn13∆ 
rpn1-D517A mutant diminishes binding of Dsk2 and Ddi1 (Chapter 3), and leads to 
mitochondrial respiration and Hsp60 import defects. Hence, as a whole, the rpn1-D517A 
mutant leads to a broad pleiotrophic defects in multiple biochemical pathways. The rpn1-
D517A mutant can be used as a tool, not only for studying docking of UBA-UBL proteins 
to the proteasome, but also for uncovering unknown facets of these diverse biochemical 
pathways. 
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Figure legends 
 
Figure 6.1. Screening for putative rpn1-D517A substrates from the SILAC 
data set 
Wild-type and rpn1-D517A cells carrying a plasmid that expressed GST-X or HA-X from 
the GAL1 promoter were grown in raffinose medium and then induced with 2% galactose 
for 1–3 hours. Dextrose was added at T0 to extinguish expression and samples were taken 
at the indicated time points. Some turnover experiments were done as cycloheximide 
chases where either GFP or HA tagged ORFs which were integrated at the endogenous 
gene locus. For cycloheximide chases, cells were grown to an OD600 0.5–1 before 
initiation of a chase period with cycloheximide. Multiple proteins were screened by one 
of these methods: Rot1 (A), Dop1 (B), Gde1 (C), Aro8 (D), Sam1 (E), Met6 (F), Aro9 
(E), Rrp6 (G), Dop1 (H), and Aac2 (I). 
 
Figure 6.2. Galactose-inducible Aac2 is slightly stabilized in rpn1-D517A. 
(A) Wild-type and rpn1-D517A cells carrying a pGAL1-HA-Aac2 were grown in 
raffinose medium prior to induction with 2% galactose for 2 hours. Dextrose was added 
at T0 to extinguish expression and samples were taken at the indicated time points. To the 
right, quantification is shown. (B) Endogenous Aac2 turnover was assayed in a 
cycloheximide chase initiated once the indicated strains had reached an OD600 ~ 1. 
Boiling extracts were made at the indicated time points, resolved by SDS-PAGE, 
transferred to nitrocellulose and immunoblotted with an Aac2 antibody. (C) Schematic of 
Aac2 in the mitochondrial innermembrane.  
 134 
Figure 6.3. Steady-state concentrations of multiple GFP tagged ORFs 
change in an rpn1-D517A mutant. 
ORFS identified in the SILAC analysis as either more or less abundant in rpn1-D517A 
rpn13∆ cells in comparison to rpn13∆ were crossed into either a wild-type or a rpn1-
D517A strain using SGA high-throughput crossing methodology.  The resultant strains 
were grown to log phase, and GFP intensity was measured on a high-throughput 
fluorescence microscope. The change in fluorescence intensity between wild type and 
rpn1 mutant strains was quantified in MatLab. The dashed line indicates the standard 
deviation. Any change falling within the standard deviation is considered non-significant. 
Several ORFS appeared to have either higher (Sam2 and Cox4) or lower (Cys3 and 
Ado1) steady-state concentrations in the rpn1-D517A mutant background.  
 
Figure 6.4. Steady-state concentrations of ORFs found less abundantly in 
rpn13∆ rpn1-D517A proteasomes 
GFP-tagged ORFS of proteins identified in the SILAC analysis as less abundant in 
rpn13∆ rpn1-D517A proteasomes were crossed into either a wild-type or rpn1-D517A 
mutant strain background using SGA methodology. Some of the strains were individually 
analyzed for being unstable (by treatment with cycloheximide for one hour) and for any 
changes in steady state (no cycloheximide treatment). Frs1, Sam2, and Cys3 were found 
to have differences in steady states of particular molecular weight species. An anti-GFP 
was used for immunoblotting and ponceaus S is shown to demonstrate even loading of all 
samples. 
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Figure 6.5. Steady-state concentrations of ORFs found more abundant in 
rpn13∆ rpn1-D517A proteasomes 
GFP-tagged ORFS of proteins identified in the SILAC analysis as more abundant in 
rpn13∆ rpn1-D517A proteasomes were crossed into either a wild-type or rpn1-D517A 
mutant strain background using SGA methodology. Some of the strains were individually 
analyzed for being unstable (by treatment with cycloheximide for one hour) and for any 
changes in steady state (no cycloheximide treatment). An anti-GFP was used for 
immunoblotting and ponceaus S is shown to demonstrate even loading of all samples 
 
Figure 6.6. Methionine and cysteine biosynthetic pathways contain multiple 
enzymes that are perturbed in rpn1-D517A.  
A summary figure of the methionine and cysteine biosynthetic pathways. Bolded 
enzymes were found in the SILAC data set to be less abundant in rpn13∆ rpn1-D517A 
proteasomes. Interestingly, when GFP-ORF cell lines were assayed with and without 
cycloheximide, Cys3 and Sam2 showed different compositions of high and low 
molecular weight species in an rpn1-D517A strain. Additionally, over expression of  
galactose-inducible Met6 is slightly toxic in an rpn1-D517A strain.  
 
Figure 6.7. rpn13∆ rpn1-D517A mutants have mitochondrial defects 
(A) The data in this graph is a cellular functional grouping of the proteins represented in 
Table 6.4. More than 60% of proteins that are found more abundantly at proteasomes 
from rpn13∆ rpn1-D517A mutants are mitochondrial proteins. Nearly 55% of the 
mitochondrial proteins found are ribosomal (inset). (B) Equivalent concentrations of the 
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indicated strains, including a ρ° mutant (a strain lacking mitochondrial DNA) were 
spotted at five-fold dilutions on plates containing either dextrose (YPD) or glycerol 
(YPG) at 30°C or 37°C for 2–3 days.  
 
Figure 6.8. rpn13∆ rpn1-D517A mutants accumulate Hsp60 precursor 
proteins. 
Accumulation of Hsp60 preprotein in vivo was assayed in the indicated yeast strains, 
including a tim44-R810K mutant that was used as a positive control (A). Cells were 
grown at 30°C until they reached an OD600 0.5, and subsequently shifted to 37°C for 4–6 
hours. Extracts were analyzed by SDS-PAGE and immunoblotted with an Hsp60 
antibody. Premature Hsp60 (p) and mature Hsp60 (m) are indicated on the figure. Panels 
A, B, and C are three separate experiments.  
 
Figure 6.9 Two hypotheses describe pHsp60 accumulation in proteasome 
mutants.  
The genetic or chemical inhibition of the proteasome may affect import of Hsp60 in one 
of two ways. First, accumulation of some unknown substrate may have inhibitory effects 
on mitochondrial import (A).  Alternatively, rpn13∆ rpn1-D517A may have defects in 
degrading precursor Hsp60 that is not imported due to damage, misfolding, or other 
cellular events that would limit translocation across the mitochondrial membrane (B).  
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Table 6.1. Strains used in this chapter 
Yeast strains 
RJD # Genotype Source 
RJD5133 
Mata can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-LEU] aro8::ARO8-3HA this study 
RJD5134 
Mata can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-D517A-LEU] aro8::ARO8-3HA this study 
RJD5136 
Mata can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-LEU] sam1::SAM1-3HA this study 
RJD5136 
Mata can1-100, leu2-3, his3-11,-15, trp1-1, ura3-1, ade2-1, rpn1::KanMX6 
[pRS315-Rpn1-D517A-LEU] sam1::SAM1-3HA this study 
RJD4006 
lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 
David 
Toczyski 
RJD5151 
lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 rpn1::rpn1-D517A-KanMX6 this study 
RJD5352 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Gde1-GFP-HIS3  this study 
RJD5355 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Gde1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Vas1-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Vas1 -GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cdc60-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cdc60-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Sac6-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Sac6-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Dpm1-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Dpm1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5568 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Frs1-GFP-HIS3  
this study 
RJD5569 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Frs1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Tif3-GFP-HIS3  
this study 
TGY96well MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 this study 
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plate pdr5Δ::ADHpr-NLS-mRFP1-URA3 Tif3-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
RJD5353 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Sam2-GFP-HIS3  
this study 
RJD5356 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Sam2-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Aro2-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Aro2-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5570 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cox4-GFP-HIS3  
this study 
RJD5571 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cox4-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Ado1-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Ado1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Gpp1-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Gpp1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5351 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Dop1-GFP-HIS3  
this study 
RJD5354 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Dop1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5566 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Met6-GFP-HIS3  
this study 
RJD5567 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Met6-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Aro9-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Aro9-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5564 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cys3-GFP-HIS3  
this study 
RJD5565 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 Cys3-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
TGY96well 
plate MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
this study 
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pdr5Δ::ADHpr-NLS-mRFP1-URA3 MSS116-GFP-HIS3  
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 MSS116-GFP-HIS3 rpn1::rpn1-
D517A-KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 MRPL4-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 MRPL4-GFP-HIS3 rpn1::rpn1-
D517A-KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 MRPL10-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 MRPL10-GFP-HIS3 rpn1::rpn1-
D517A-KanMX 
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 PDB1-GFP-HIS3  
this study 
TGY96well 
plate 
MATa lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 can1Δ::STE2pr-LEU2 
pdr5Δ::ADHpr-NLS-mRFP1-URA3 PDB1-GFP-HIS3 rpn1::rpn1-D517A-
KanMX 
this study 
RJD5152 W303 ρ°  
David Chan 
Lab 
RJD5255 
his3 leu2 lys2-801 trp1 ura3-1 ade2-1 met2 tim44::LYS2 ycplac33-TIM44-
R180K 
Elizabeth 
Craig Lab 
RJD1786 MATa can1 leu2 his3 trp1 ura3 ade2 rho+ mrp1-1 RJD Lab 
RJD3330 MATa Ura3 leu2Δ his3Δ TRP+ pep4::KanMX rpt6-1  
J. Dohmen 
Lab 
RJD4340 MATa leu2Δ his3Δ ade2-101 trp1 ura3Δ::TRP1  rpn2-1   
Mark 
Hochstrasser 
Lab 
RJD5427 MatA ddi1::KanMX dsk2::KANMX bar1∆ 
DJ Clarke 
Lab 
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Table 6.2. Plasmids used in this chapter 
Plasmid Description Source 
RDB2492 pEGH-GAL-GST-Rot1 OpenBiosystems 
RDB2506 pBG1805-Met6 OpenBiosystems 
RDB2507 pBG1805-Aro9 OpenBiosystems 
RDB2500 pBG1805-Rrp6 OpenBiosystems 
RDB2499 pBG1805-Dop1 OpenBiosystems 
RDB2501 pBG1805-Aac2 OpenBiosystems 
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Table 6.3. PIPs that are reduced in rpn13∆ rpn1-D517A 26S proteasome 
preparations 
 
 
ORF H/L Ratio Peptides 
Seq. Coverage 
(%) 
No. of 
Experiments 
GCV3 38.5**  2  11.8  1/3 
AAC2 32.4**  1  6.3  1/3 
HXK2† 29.0** 2 6 1/3 
DPM1† 11.8** 2 16.9 1/3 
COX4 24.9** 2 25.2  1/3 
GPP1  25.7**  2  11.2  1/3 
URA3  19.7**  4  19.1  1/3 
DPM1  11.8**  2  16.9  1/3 
PPX1  11.4**  2  7.8  1/3 
VPH1† 9.9** 2 4.2 1/3 
DLD3† 8.3** 2 5.8 1/3 
CBR1 7.3** 2 13.4 1/3 
SEC53† 6.7** 6 23.2 1/3 
BAT1† 6.6** 3 11.2 1/3 
SAC6† 6.4** 3 7.9 1/3 
ARP4  5.9**  3  4.7  3/3 
CYS3  5.7**  2  18  1/3 
ARO9  4.9**  2  3.9  1/3 
PTC2  4.7**  2  6.5  1/3 
VAS1† 4.5** 3 3.5 1/3 
LEU1† 4.5** 65 73.9 3/3 
URA7† 4.4** 6 14 1/3 
SPA2 4.2** 3 2.8 2/3 
RNR2† 3.7** 7 10.8 1/3 
TIF3† 3.6** 5 20.9 2/3 
TRP5† 3.3** 4 7.5 1/3 
GFA1† 3.3** 7 13.8 2/3 
SAM1† 3.0** 19 51.8 2/3 
MET6† 2.9** 16 31.8 3/3 
APA1† 2.9** 2 7.8 1/3 
RSM25 2.7** 2 7.6 1/3 
CDC60† 2.7** 3 3.4 1/3 
ADO1† 2.5** 10 46.2 3/3 
SYN8 2.5** 5 18 3/3 
SAM2† 2.5** 20 58.3 3/3 
ERG6† 2.5** 7 18 1/3 
TUB2† 2.4** 7 24.3 2/3 
FRS1† 2.4** 7 17.3 2/3 
BGL2 2.4** 2 5.8 1/3 
VMA2† 2.2** 19 48.7 3/3 
SAH1† 2.1** 13 30.1 3/3 
 142 
ILV5† 1.8** 13 41 3/3 
ARO8† 1.8** 13 32 3/3 
RRP6  1.8**  4  32  3/3 
KRE6  1.6*  11  7.4  3/3 
DED1† 1.6* 19 44.9 3/3 
ARO2† 1.6* 2 6.1 2/3 
ROT1  1.6* 2  17.2  3/3 
PBI2  1.6* 2  22.7  3/3 
GUA1† 1.5* 5 13.5 1/3 
IPP1† 1.3* 5 17.1 3/3 
URA6  1.2* 4  24.5  1/3 
PPN1  1.2* 2  3  1/3 
†  Indicated PIPs are proteasome interacting proteins that were seen in the SILAC assay 
reported here and in Guerrero et al., 2008.      
* Denotes 0.005< P < 0.05.  
** Denotes P << 0.005.  
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Table 6.4. PIPs that are increased in rpn13∆ rpn1-D517A 26S proteasome 
preparations† 
 
 
ORF H/L Ratio Peptides 
Seq. Coverage 
(%) 
No. of 
Experiments 
TDH1  0.3**  12  36.7  3/3 
PIM1  0.3**  31  32.6  3/3 
ATP3  0.3**  2  11.6  3/3 
PMA1  0.4**  15  24.4  3/3 
MNP1  0.4**  5  28.4  3/3 
YML6  0.4**  3  20.3  3/3 
EXG1  0.4**  5  13.4  3/3 
MRPL24  0.4**  3  12.8  3/3 
MRP7  0.4**  8  20.8  3/3 
IDH1  0.4**  4  13.6  3/3 
YGP1  0.4**  6  23.7  3/3 
MRPL22  0.4  5  26.5  2/3 
MRPL17  0.4**  4  10.7  3/3 
MRPL10  0.4**  2  5.6  2/3 
MRPL25  0.4**  4  25.5  2/3 
MRPL40  0.4**  6  24.2  3/3 
MRPL32  0.4**  1  6  2/3 
MRPL35  0.4**  10  27  3/3 
MRPL1  0.5**  3  11.9  2/3 
YGL004C  0.5**  15  39.6  3/3 
ATP2  0.5**  5  17.6  3/3 
MRPL31  0.5**  3  26.7  3/3 
MRPL13  0.5**  5  35.2  3/3 
RML2  0.5**  4  14.8  2/3 
ENO1  0.5**  15  41.2  3/3 
QCR2  0.5**  5  17.9  2/3 
PFK26  0.5**  38  55.4  3/3 
IDH2  0.5**  5  22.8  3/3 
MRPL4  0.5**  3  14.1  2/3 
MRPL16  0.5**  4  20.3  2/3 
PDB1  0.6**  10  37.7  3/3 
MSS116  0.6**  9  19.4  3/3 
HSP60  0.6**  27  57  3/3 
ESC1  0.6**  58  41.7  3/3 
THI20  0.6**  39  72.6  3/3 
RIM15  0.6**  3  2.5  3/3 
MRPL9  0.6**  2  7.1  2/3 
GDE1  0.6**  19  20.9  3/3 
NAS2  0.6**  6  25  3/3 
RNH202  0.6*  4  14.6  3/3 
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PGK1  0.7*  20  63  3/3 
ADH1  0.7  18  67.2  3/3 
PDA1  0.7*  24  57.9  3/3 
ASK10  0.7*  6  6.4  3/3 
PDX1  0.7*  12  40.7  3/3 
MPM1  0.8*  3  16.7  3/3 
SLK19  0.8*  7  10.6  3/3 
* Denotes 0.005< P < 0.05.  
** Denotes P << 0.005. 
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Figure 6.1. Screening for putative rpn1-D517A substrates from the SILAC 
data set 
 
 
 146 
 
Figure 6.2. Galactose-inducible Aac2 is slightly stabilized in an rpn1-D517A 
strain. 
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Figure 6.3. Steady-state concentrations of multiple GFP tagged ORFs 
change in an rpn1-D517A mutant.  
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Figure 6.4. Steady-state concentrations of ORFs found less abundantly in 
rpn13∆ rpn1-D517A proteasomes. 
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Figure 6.5. Steady-state concentrations of ORFs found more abundant in 
rpn13∆ rpn1-D517A proteasomes. 
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Figure 6.6. Methionine and cysteine biosynthetic pathways contain 
multiple enzymes that are perturbed in rpn1-D517A.  
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Figure 6.7. rpn13∆ rpn1-D517A mutants have mitochondrial defects. 
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Figure 6.8. rpn13∆ rpn1-D517A mutants accumulate Hsp60 precursor 
proteins. 
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Figure 6.9 Two hypotheses describe pHsp60 accumulation in proteasome 
mutants. 
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Chapter 7: 
 
Findings, implications,  
and 
future directions 
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Summary  
 
 The goal of this dissertation work was to map key residues on the largest subunit 
of the proteasome, Rpn1, that are essential for docking the UBA-UBL ubiquitin shuttle 
receptors, Rad23, Dsk2, and Ddi1, to the 26S proteasome. Secondly, such a cis 
proteasome mutant was to be used as a tool for discovering the consequences yielded by 
selective inhibition of substrate delivery.  
 The largest contribution of my dissertation work is the proof I have provided that 
Ddi1 does in fact interact with the proteasome as a shuttle receptor. Such a point has been 
controversial and my genetic evidence closes the book on such controversy, however, 
there are undoubtedly enigmas and differences in the way Ddi1 may contribute to 
substrate turnover in comparison to the other UBA-UBL receptors (Chapter 4).  
 Secondly, on the tails of in vitro studies that show that other proteasomal 
subunits, such as the intrinsic ubiquitin receptors (Rpn10 and Rpn13) are important for 
binding UBA-UBL proteins, I provide the first genetic evidence that such interactions are 
physiologically relevant (Fatimababy et al., 2010; Husnjak et al., 2008; Matiuhin et al., 
2008b).  I show that the binding landscape at the 26S proteasome is very complicated and 
there are layers of built in redundancy that potentially help to ensure proper degradation 
of ubiquitylated substrates.  
 Mutation of Rpn1 alone was not sufficient for disrupting interactions with all 
UBL domain-containing proteins. Below I summarize my major findings for the three 
shuttle receptors I followed, as well as Ubp6, a UBL domain containing deubiquitinase 
that is also presumed to bind Rpn1 (Leggett et al., 2002).   
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Rad23 
In the present study, no mutations made in Rpn1 diminished binding of Rad23 to the 
proteasome. However, simultaneous deletion of the ubiquitin binding domains of Rpn10 
and Rpn13 limit binding of Rad23 (Chapter 5). Since multiple independent studies, 
including my own, have verified in vitro binding of Rpn1 to Rad23, I believe the 
interaction is real (Elsasser et al., 2002; Fatimababy et al., 2010; Rosenzweig et al., 
2008). Therefore, Rad23 may interact with up to three subunits at the proteasome in vivo, 
Rpn1, Rpn10, and Rpn13.  There are two modes of additonal binding to the 26S 
proteasome that Rad23 might utilize that I did not test in combination with my genetic 
perturbations: docking at Rpt6 (Fatimababy et al., 2010) and stabilization to the 
proteasome through the ubiquitin chains it carries (Ghaboosi and Deshaies, 2007).  
 
Dsk2 
Dsk2 interacts with Rpn1 using residues D517, and to a lesser extent, K484. Mutation of 
Rpn1 alone is not sufficient to disrupt binding of Dsk2. Dsk2 also appears to interact with 
Rpn13 and possibly Rpn10 in intact proteasomes. Deletion of Rpn13 or simultaneous 
deletion of the Ub interaction motifs of Rpn10 and Rpn13 in an rpn1-D517A or rpn1-
K484A background reduce binding of Dsk2 to the proteasome. However, deletion of the 
UIM of  Rpn10 alone is not suffient for reducing Dsk2 interaction with the proteasome.  
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Ddi1 
Rpn1 residues D517 and K484 are also important for binding Ddi1. Ddi1 may interact 
solely with Rpn1, as great diminishment of Ddi1 is seen with just singular mutations in 
this base subunit.  
 
Ubp6 
Intriguingly, no genetic conditions tested decreased association of Ubp6 with the 
proteasome. However, under conditions in which all three UBA-UBL protein levels were 
diminished (in a rpn10-uim rpn13-kkd background), Ubp6 levels actually increase at the 
proteasome. A correlative increase in Ubp6 is puzzling since Ubp6 has been shown to not 
compete for binding with Rad23 at the proteasome (Elsasser et al., 2004). It should be 
noted that Ubp6 may also bind lid subunits of the proteasome (Leggett et al., 2002). 
 
It will be interesting for future research to follow up on how the substrate repertoire of 
these UBA-UBL proteins depends, if at all, on which subunit of the proteasome they 
dock to. Furthermore, my Rpn1 cis proteasome mutant can be used as a tool for the 
discovery of novel UPS substrates, and for dissecting the substrate specificity of each 
dockings site.  
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Future directions 
 
My work on the consequences of the deletion of the Ddi1 docking site to the protesome 
also led to several other key findings, some of which have great potential for future 
research projects: 
 
 1) The mitochondrial ADP/ATP carrier, Aac2, may be a substrate dependent on  
 docking at Rpn1-D517. I suggest follow up studies on this result.  
 
 2) To my knowledge, no other study has shown that proteasome function is  
 essential for mitochondrial import of nuclear encoded proteins. Unraveling the 
 mechanism behind this observation will likely yield novel insights into the UPS 
 and mitochondrial metabolism.  
  
 3) I suggest follow-up studies on the role of the UPS in the yeast methyl cycle. I 
 see great changes in the steady-state and proteasome association levels of 
 enzymes that regulate this cycle.  
 
 4) My SILAC data indicates that the deubiquitinase, Otu2, is less abundant in 
 rpn13∆ proteasomes. Human Rpn13 has been shown to associate with a DUB. 
 
 Overall, this thesis characterizes a cis proteasome mutant that could be used to 
study the implications of inhibiting the ubiquitin-proteasome pathway in a very selective 
manner. I hope that this tool, and the future directions I have laid out, will help contribute 
to understanding the plethora of cellular roles in which the UPS plays a vital role.  
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